{
  "name" : "zero.sci-hub.se_6709_dfddc168138195ad08d01350eb159b4f_shakeel2015.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "Toxicity of Nano-Titanium Dioxide (TiO2-NP) Through Various Routes of Exposure: a Review",
    "authors" : [ "Muhammad Shakeel", "Farhat Jabeen", "Samina Shabbir", "Muhammad Saleem Asghar", "Muhammad Saleem Khan", "Abdul Shakoor Chaudhry" ],
    "emails" : [ ],
    "sections" : [ {
      "heading" : null,
      "text" : "either avoided or strictly managed to minimise risks for human health in various situations.\nKeywords TiO2 nanoparticles . Exposure . Toxicity . Routes"
    }, {
      "heading" : "Introduction",
      "text" : "Titanium dioxide (TiO2) particles are being synthesized and used in various different sizes including fine particles with the size of approximately 0.1–2.5 μm and nanosize particles with the primary size of <0.1 μm [1]. Humans may be exposed to TiO2 nanoparticles during manufacturing as well as by their use. The exposure to TiO2 nanoparticles can be in the form of aerosols, suspensions or emulsions. At the workplace, the major routes through which TiO2 nanoparticles can be encountered are inhalation and dermal exposure in relevance to toxicology. Robertson et al. [2] reported more than 150 items of manufacturer-identified nanotechnology-based consumer products that would have long-term dermal contact. TiO2 nanoparticles are the most common of the nanomaterials found in dermally applicable consumer products [2].\nTitanium dioxide nanoparticles are being used in toothpaste, food colorants and nutritional supplements on a large scale, and therefore, oral exposure to TiO2 nanoparticles may happen through consumption of such products. According to a recent study, candies, sweets and chewing gums have a higher amount of TiO2 nanoparticles (<100 nm) [3]. TiO2 nanoparticulate carriers are delivered into the human body through intravenous or subcutaneous injection in nanomedicine [4]. Saber et al. [5] investigated that titanium dioxide nanoparticles found in products like paint are less dangerous, unless they become free by sanding. Gao et al. [6] studied testicular damage and alterations in gene expression profiles in male mice induced by intragastric * Farhat Jabeen farjabeen2004@yahoo.co.in 1 Department of Zoology, Government College University Faisalabad, Faisalabad, Pakistan 2 School of Agriculture, Food and Rural Development, Newcastle University, Newcastle upon Tyne NE1 7RU, UK\nadministration of TiO2 nanoparticles (NPs). They observed that TiO2 NPs crossed the blood-testis barrier to reach the testis and resulted in testicular lesions, sperm malformations and alterations in serum sex hormone levels. Therefore, the production and application of TiO2 NPs should be carried out cautiously, especially by humans of reproductive age.\nDifferent routes of exposure that can lead to the systemic disposal of these nanoparticles, and the most prevalent ones are oral, subcutaneous, dermal, intravenous and, lastly, respiratory. Respiratory exposure threats are mostly increased in the form of occupational risk. Earlier works showed that over 150 different cosmetic products can lead to long-term dermal exposure of titanium dioxide nanoparticles. The whitening properties of TiO2 nanoparticles render them useful as a food colorant. It is well known that several common food products have these nanoparticles in them, along with likely daily exposure to humans of various age groups [7]. Continual use of TiO2 containing nanoparticles can lead to chronic level of exposure and accumulation in numerous organs.\nWhatever the route of exposure to TiO2 nanoparticles is, once they entered into the circulatory system, the nanoparticles are transported into various parts of the body as illustrated in Fig. 1 [8].\nIt may be concluded that the occupational exposure to TiO2 nanoparticles may primarily occur by the route of inhalation. The use of antimicrobial spray which contains TiO2 nanoparticles may possibly be responsible for consumer inhalation. The use of food products containing TiO2 nanoparticle additives may cause oral exposure. The applications of sunscreens and other cosmetics are the source of dermal contact to TiO2 nanoparticles. The medical application of TiO2 nanoparticles may be in the form of their intravenous injections.\nIn this paper, the main focus will be on current information regarding the toxicity of TiO2 nanoparticles. In order to gather the knowledge about the toxic effects of TiO2 nanoparticles on humans, the studies done on rats or other mammalian organisms as experimental models will be reviewed. The main focus will be on the in vivo studies; however, very few of the in vitro studies will also be included in order to comprehend the results. Studies performed on TiO2 nanoparticles and their mixtures with other substances and the studies that focused on the effects of TiO2 nanoparticles on aquatic ecosystems or the environment will be avoided to be discussed in this review."
    }, {
      "heading" : "Dermal/Skin and Intradermal Exposure",
      "text" : "A number of consumer products like sunscreens and cosmetics may contain TiO2 nanoparticles, and hence, the study of dermal absorption of these nanoparticles is of interest. The outer layer of the human skin is a tough layer called the stratum corneum. Penetration of a number of inorganic particles through it is difficult. Normally, cosmetics and sunscreens containing TiO2 nanoparticles are applied on an undamaged skin. However, certain conditions such as sunburn or physical force can cause slight injuries to the skin. Therefore, a number of in vivo and in vitro studies have been performed to investigate the penetration of TiO2 nanoparticles on both intact skin as well as on the stripped skin to evaluate the effect on the injured skin [9]. Some of these studies, such as those of Newman et al. [10] and Sadrieh et al. [11], have shown no significant penetration of TiO2 nanoparticles through the intact skin. Sadrieh et al. [11] found that TiO2 nanoparticles (uncoated submicron sized, uncoated nanosized and"
    }, {
      "heading" : "Circula",
      "text" : "2 Shakeel et al.\ndimethicone/methicone copolymer-coated nanosized) do not significantly penetrate the intact normal minipigs’ epidermis when applied 5 % by weight in a sunscreen topically at 2 mg/ cm2 of the skin at the rate of 4 applications per day and 5 days per week for 4 weeks. No increase in the titanium levels in the lymph nodes and liver was observed; however, an elevated titanium level was observed in the treated epidermis of minipigs with sunscreens containing TiO2 nanoparticles. The dermis of the abdominal and neck of minipigs treated with coated and uncoated TiO2 nanoparticles showed increased titanium. Electron microscopy and energy-dispersive X-ray analysis revealed that all types of TiO2 nanoparticles were observed in the upper follicular lumens and stratum corneum, and most of the particles visible were coated TiO2 nanoparticles. The presence of isolated titanium particles was also detected at various positions in the dermis of the treated animals with sunscreens containing TiO2 nanoparticles. However, distribution pattern or pathology suggested that the particles were the result of contamination, and the few isolated particles were a very small fraction of the total TiO2 nanoparticles applied. Senzui et al. [9] applied 35 nm non-coated TiO2 nanoparticles, 35 nm coated TiO2 nanoparticles, 100 nm TiO2 nanoparticles coated with alumina and silicon and 250 nm TiO2 nanoparticles non-coated to the intact and stripped skins of Yucatan micropigs at the rate of 2 μL suspension per cm2 of skin. Results showed no penetration of TiO2 particles through viable skin, even though the stratum corneum was damaged. Scanning electron microscopy (SEM) showed the presence of some TiO2 nanoparticles in vacant hair follicles; however, there was no penetration through the dermis or viable epidermis. The method of tape stripping using adhesive tape is widely used for studying the localization and distribution of drugs in the stratum corneum [12].\nFilipe et al. [13] found that coated 20 nm TiO2 nanoparticles dispersed in three sunscreen formulations were not likely to penetrate the stratum corneum towards the underlying keratinocytes in normal human skin even after 48 h under realistic in vivo conditions in normal and altered skin. However, deposition of the nanoparticles was observed in the openings of the pilosebaceous follicles. Similarly, Monteiro-Riviere et al. [14] demonstrated both in vivo and in vitro in pigs that penetration of TiO2 nanoparticles of sunscreen formulations was slightly enhanced in the skin damaged by ultraviolet B. However, they detected no transdermal absorption. Sunscreens containing rutile crystallite-coated TiO2 nanoparticles (90–460 nm) with the primary particle size 10×50 nm and mean agglomerates of 200 nm and 10 % oil/ water or water/oil emulsion were dermally applied on skin in flow-through diffusion cells for 24 h. Skin exposed to ultraviolet B had typical sunburn histology.\nBennat and Müller-Goymann [15] showed that TiO2 nanoparticles can penetrate through hairy skin on application as oilin-water emulsion. They applied 5 % TiO2 nanoparticles to\nhuman skin with the size of 20 nm as aqueous suspension or oil-in-water emulsion via tape stripping method and observed penetration of the TiO2 nanoparticles through the hair follicles or pores. Furukawa et al. [16] found that there was no penetration of titanium dioxide nanoparticles through topical application in the epidermis of up to 20 mg silicon-coated TiO2 nanoparticles and up to 100 mg non-coated TiO2 nanoparticles in c-Ha-ras. Analysis of rat skin indicated that both doses of TiO2 nanoparticles were not able to penetrate through either of the healthy or damaged skin. Furthermore, silicon-coated TiO2 nanoparticles could not penetrate the human epidermis model in vitro [17, 18].\nWu et al. [19] found no penetration of TiO2 nanoparticles of various sizes through the stratum corneum of isolated porcine skin exposed for 24 h in vitro. However, in vivo studies showed quite different results. Titanium dioxide nanoparticles (4 and 60 nm) penetrated through the horny layer and reached the deep layer of pig ear epidermis applied topically for 30 days. Similarly, TiO2 nanoparticles penetrate through the skin of hairless mice dermally exposed for 60 days. These nanoparticles reached different tissues and caused various pathological lesions in many major organs. Interestingly, 21- nm-sized TiO2 nanoparticles exhibited wider tissue distribution and even reached the brain. However, they did not induce any pathological changes. TiO2 nanoparticles caused the most severe pathological changes in the skin and liver than all other organs studied and significant alterations in malondialdehyde (MDA) and superoxide dismutase (SOD) levels. These findings revealed that the deposition of the TiO2 nanoparticles caused the oxidative stress that resulted in the pathological lesions. In this way, the collagen content represented as HYP content in mouse skin samples also reduced significantly. This indicates that topically applied TiO2 nanoparticles in the skin for a long period can induce skin ageing. This study revealed that dermal exposure to TiO2 nanoparticles over a relatively prolonged time may pose a health risk in humans [19].\nFurukawa et al. [16] investigated that titanium dioxide nanoparticles do not possess post-initiation potential for mouse skin carcinogenesis. Topical application of up to 20 mg silicon-coated TiO2 nanoparticles and up to 100 mg non-coated TiO2 nanoparticles in c-Ha-ras protooncogene transgenic mice and rats, sensitive to skin carcinogenesis, respectively, and their wild-type siblings that were initially treated with a single dose of 7,12-dimethylbenz[a]anthracene showed no carcinogenesis-promoting effects in the skin due to no penetration through the epidermis. Analysis of rat skin indicated that both formulations of TiO2 nanoparticles were not able to penetrate through either of the healthy or damaged skin. Furthermore, silicon-coated TiO2 nanoparticles could not penetrate the human epidermis model in vitro [17]. A similar study was performed by Xu et al. [18] with similar results on the c-Ha-ras protooncogene transgenic (Hras128)\nToxicity of Titanium Dioxide (TiO2) Nanoparticles 3\nrats (sensitive to skin carcinogenesis) and their wild-type siblings treated with ultraviolet B-initiated skin carcinogenesis. TiO2 nanoparticles were present in the upper stratum corneum. However, they were not detected in the underlying skin tissue layers. TiO2 particles were also not able to penetrate a human epidermis model in vitro.\nWarheit et al. [20] investigated acute dermal irritation in the local lymph node assay in mice and rabbits using 0, 5, 25, 50 or 100 % anatase/rutile (80/20) TiO2 nanoparticles with the size of 129.4 nm in H2O for three consecutive days, and TiO2 nanoparticles did not cause skin irritation or dermal sensitivity. In another study, at 1, 24 or 48 h post-exposure, acute tests on the dermal, eye and vaginal mucous membrane in mice treated with TiO2 nanoparticles at the dose of 1000, 2150, 4640 and 10,000 mg/kg body weight showed no significant irritation [21]. Topically applied 14, 28, 42 and 56 mg/kg 20- nm-sized TiO2 nanoparticles on Wistar rat skin caused shortterm toxicity in a 14-day toxicity study by Unnithan et al. [22] at the biochemical level expressed as decreased glutathione Stransferase and catalase activity and increased lactate dehydrogenase activity and lipid peroxidation, and the levels of glutamic pyruvic transaminase and glutamic oxaloacetic transaminase in the serum, blood urea nitrogen and creatinine were also increased. However, there were no observable histopathological effects at the tissue level. They concluded that renal as well as hepatic toxicity was caused due to short-term dermal exposure of rats to 42 mg TiO2 nanoparticles per kilogram body weight of rats. They investigated that TiO2 nanoparticles may penetrate into the live skin through the hair follicles.\nExposure of the skin to TiO2 nanoparticles causes barrier dysfunction or defect which can intensify symptoms of atopic dermatitis through T helper-2 immune responses. TiO2 nanoparticles can initiate and/or promote skin diseases after the barrier dysfunction/defect due to histamine release even when there is no allergen present. On treating male NC/Nga mice with 20 μg of 15, 50 or 100 nm rutile TiO2 nanoparticles by intradermal injections, allergen+TiO2 showed atopic dermatitis, enhanced ear thickening and inflammatory action (increased eosinophils, interleukin-4, mast cells and decreased interferon-γ; TiO2 increased interleukin-13) [23]. They observed that intradermal injection of TiO2 nanoparticles can decrease the local expression of interferon-γ in the presence of allergen. In serum, expression of interleukin-13 and histamine levels significantly increased the ear thickness in mice."
    }, {
      "heading" : "Pulmonary Absorption",
      "text" : "The pulmonary system consists of the nose and nasal cavity, paranasal sinuses and pharynx (the upper respiratory tract), larynx, trachea, bronchi and the lungs (the lower respiratory tract). Here is a brief review of the studies performed on the\neffects of TiO2 nanoparticles through inhalation, intranasal (oropharyngeal) exposure and intratracheal instillation (Fig. 2).\nFigure 2 explains the distribution of TiO2 nanoparticles after inhalation based on the study by Simkó and Mattsson [24]. Arrows denote downward movement of the nanoparticles through the respiratory tract. Most of the particles with size ranging 1–5 nm are distributed all through the three regions. Twenty-nanometer particles are mostly distributed in the alveolar regions. Particles of 0.5–10 μm size remain on the epithelial surface of the airways and alveoli."
    }, {
      "heading" : "Inhalation",
      "text" : "Inhalation may be included in the major routes of exposure of the human body to TiO2 nanoparticles especially at workplaces during handling processes. A number of studies have been performed to find out the cellular, genetic or physiological toxicity of TiO2 nanoparticles using inhalation as the exposure route.\nUp till now, there is no data available regarding the absorption of TiO2 nanoparticles through inhalation in humans. However, a large number of studies have been performed on rodents [25]. Mühlfeld et al. [26] observed the transportation of a small fraction of 20-nm-sized TiO2 nanoparticles from the airway lumen to the interstitial connective tissue of adult male rats exposed to 0.11 mg/m3 TiO2 aerosols for 1 h and released into their systemic circulation (capillary lumen) after 1- and 24-h dose. Similarly, van Ravenzwaay et al. [27] exposed male Wistar rats to anatase-rutile TiO2 mixture (20–30 nm) and rutile TiO2 (200 nm) in the form of aerosols of 100 and 250mg/m3 of uncoated and pigmentary TiO2, respectively, for 6 h per day and five consecutive days via inhalation. TiO2 nanoparticles were distributed in the lungs and mediastinal lymph node.\nIn response to ultrafine titanium dioxide particles in the form of aerosols, rats and mice developed progressive epithelial and fibroproliferative changes in the lung and lymph\n4 Shakeel et al.\nnodes. There was a marked impairment in the clearance of TiO2 nanoparticles from the lung of exposed mice and rats [28]. A dose-dependent deposition of Ti in the lung tissue and an increase in neutrophils in bronchoalveolar lavage (BAL) fluid indicated an inflammatory effect in mice [29]. TiO2 nanoparticles produced reactive species and endogenous nitric oxide. Nanoparticle exposure considerably enhanced microvascular oxidative stress up to about 60 % and elevated nitrosative stress 4-fold in conjunction with microvascular dysfunction. Spinotrapezious arteriolar endothelium dilation was impaired in male Sprague-Dawley rats exposed to 1.5– 16 mg/m3 P25 anatase-rutile TiO2 (21 nm) for 240–720 min [30]. Nanoparticle exposure via inhalation significantly impairs endothelium-dependent vasodilation in sub-epicardial arterioles [31]. Nanoparticle exposure as aerosol inhalation reduces bioavailability of the microvascular nitric oxide and alters the vasoreactivity. In addition, the greater adrenergic receptor sensitivity indicates an amplified sympathetic responsiveness [32]. The significant impairment of endotheliumdependent vasoreactivity in coronary arterioles has also been observed by LeBlanc et al. [33]. Inhalation exposure to 6 mg/ m3 P25 anatase-rutile TiO2 (21 nm) for 240 min impaired coronary arteriolar endothelium dilation and increased oxidative stress (reactive oxygen species (ROS)) in coronary microvascular walls of male Sprague-Dawley rats. Such disturbances in coronary microvascular function may result in the cardiac disturbances associated with the exposure to TiO2 nanoparticles. Endothelium-dependent arteriolar dilation was significantly decreased in rats exposed to TiO2 nanoparticles. The production of endogenous microvascular nitric oxide was decreased after inhalation of TiO2 nanoparticles in a dosedependent manner. Microvascular oxidative stress was increased significantly [34].\nInhalation of nanoparticulate up-regulates the expression of lung neurotrophins in an age-dependent fashion, and this effect is associated with airway hyperresponsiveness and inflammation vulnerability in earlier stages of lung development, which may lead to a higher risk of developing asthma. Inhalation of P25 Degussa (21 nm) TiO2 nanoparticles (12 mg/m3; 5.6 h/day for 3 days) in weanling (2-week-old), newborn (2-day-old) and adult (12-week-old) male and female Fischer 344 rats showed neurotrophin expression (nerve growth factor, brain-derived neurotrophic factor and their receptors), which increased in 2-day-old and 2-week-old rats. The airway resistance was increased in 2-week-old mice [35]. A long-term lung inflammation in time-mated adult female mice was induced by exposure to TiO2 nanoparticles (42.4± 2.9 mg/m3 TiO2; 21 nm, average crystallite size aerosolized powder 97 nm (peak size), rutile elongated modified with Al, Si and Zr and coated with polyalcohols; for 1 h a day on gestation days 8–18). Gestationally exposed offsprings displayed moderate neurobehavioral alterations [36]. The inhalation of the surface-coated TiO2 nanoparticles causes\nalterations in the expression of genes in the lungs related with acute phase, inflammation and immune response with concomitant changes in several miRNAs [37]. Noël et al. [38] found that bronchoalveolar lavage fluid (BALF) indicated that large aerosols (>100 nm) caused an acute inflammatory response, as shown by the significantly enhanced number of neutrophils, while small aerosols (5, 10–30 or 50 nm) produced significant oxidative stress damages and cytotoxicity in the lungs of male rats exposed to TiO2 nanoparticles at 20 mg/m3 for 6 h. In both aerosols, the 10–30 nm TiO2 nanoparticles induced the marked pro-inflammatory effects as compared to the controls.\nIn an inhalation study, rats were exposed to aerosols at the dose of 2, 10 and 50 mg/m3 rutile-anatase TiO2 mixture with 25.1-nm-sized TiO2 nanoparticles by inhalation for 6 h/day for 5 days [39]. Necropsies were performed either immediately after the last exposure or after 3 and 16 days post-exposure. Lung inflammation was associated with a dose-dependent increase in BALF total cell and neutrophil counts, polymorphonuclears, total protein contents, enzyme activities (Γ-glutamyl transpeptidase, lactate dehydrogenase, alkaline phosphatase (ALP), N-acetyl-glucosaminidase) and number of cell mediators. No indications of systemic effects were found by measurement of appropriate clinical pathological parameters. Cell replication increased in bronchi and bronchioles. Similarly, van Ravenzwaay et al. [27] exposed male Wistar rats to anatase-rutile TiO2 mixture (20–30 nm) and rutile TiO2 (200 nm) in the form of aerosols of 100 and 250 mg/m3 uncoated and pigmentary TiO2, respectively, for 6 h/day on five consecutive days through inhalation. TiO2 nanoparticles were distributed in the lungs and mediastinal lymph node. Both TiO2 increased total cell count, polymorphonuclears, total protein content, ALP, lactate dehydrogenase, Γ-glutamyl transpeptidase and N-acetyl-glucosaminidase in bronchoalveolar lavage that are indicators of increased inflammatory action. In an inhalation study on mice by Grassian et al. [40], when exposed to 2–5 nm TiO2 nanoparticles at the dose of 8.88 mg/m3 for 4 h per day for 10 days, there were higher counts of total cells and alveolar macrophages in the bronchoalveolar lavage fluid. However, the mice recovered after 3 weeks. These inhalation studies revealed that TiO2 nanoparticles can cause pulmonary inflammation in both rats and mice at sufficient lung burdens. Nurkiewicz et al. [34] observed that inhalation of nanoparticles (21 nm) or the fine TiO2 (1 μm) at the dose of 1.5 and 20mg/m3 for 24 h post-exposure induced a failure to respond to dilators which indicated microvascular dysfunction of the arterioles in the shoulder muscle. The TiO2 nanoparticles were 6 to 7 times more potent than the fine particles. In a recent study by the same research group, it was found that the peripheral vascular effects were linkedwith the exposure to particulate matter of TiO2 fine particles (710 nm) and nanoparticles (100 nm) inhaled at the dose of 1.5–16 mg/m3 for 4–12 h inducing the activation of\nToxicity of Titanium Dioxide (TiO2) Nanoparticles 5\ninflammatory and/or neurogenic mechanisms [34]. In addition, it was observed that the inhalation of 6 mg/m3 21 nm P25 and a mixture of anatase (80 nm)/rutile (20 nm) TiO2 nanoparticles for 240 min caused an increased spontaneous arteriolar basal tone, a reduced flow and a reduced responsiveness of the coronary arterioles to dilators 1 day post-exposure in male Sprague-Dawley rats in another study [31]. It is noteworthy that microvascular dysfunction was stated at low lung burdens that did not significantly change the measures of bronchoalveolar lavage fluid in lung inflammation or damage. These findings are interesting as there are known links between particulate matter and cardiovascular diseases. Exposure to particulate matter can result in significant alterations in many cardiovascular indices, like blood pressure, heart rate, heart rate variability and blood coagulability [41].\nSurprisingly, Rossi et al. [42] observed that if mice were repeatedly exposed to TiO2 nanoparticles through the airway, the airway inflammation is modulated. This modulation of the airway inflammation depends upon the immunological condition of the exposed mice. They exposed ovalbumin-sensitized (asthmatic) female mice to silica-coated rutile TiO2 nanoparticles with 10–40 nm primary particle size in the form of aerosol (10–1000 nm size range) via inhalation at a concentration of 10 mg/m3 for 2 h per day, 3 days a week and continued for 4 weeks. The results were surprising, that is, a substantial decrease in the levels of antibodies, leucocytes, eosinophils, chemokines and cytokines, alveolar macrophages, periodic acid-Schiff+ goblet cells, interleukin-1β, tumour necrosis factor-α, interleukin-4, interleukin-13 and interleukin-10 was observed that are the characteristics to allergic asthma and inflammatory action. It indicated that the allergic pulmonary inflammation was suppressed dramatically in asthmatic mice exposed to TiO2 nanoparticles. The airway reactivity was decreased by silica TiO2, while it was increased by fine TiO2 (<5 μm). In another study by Rossi et al. [43], the exposure of mice by inhalation for 2 h for four consecutive days for 4 weeks to uncoated rutile and anatase TiO2 nanoparticles did not induce significant inflammation. Only the rutile TiO2 nanoparticles coated with SiO2 caused an obvious pulmonary neutrophilia along with elevated expression level of tumour necrosis factor-α and neutrophil-attracting chemokine in the lung tissue. Almost exclusive accumulation of TiO2 was observed in the alveolar macrophages. Morimoto et al. [44] also reported that inhaled TiO2 nanoparticles (rutile 51±9 nm; 2.8×105/cm3 for 4 weeks; 6 h/day) did not induce inflammation or fibrosis in male Wistar rats. Inhalation of titanium dioxide nanoparticles did not induce the gene expression of matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) messenger RNA (mRNA) in rat lungs. There were no changes of the gene expression of MMP-2, TIMP-2 and type I collagen. Another study by Leppänen et al. [45] showed no inflammatory action in male mice exposed to TiO2 nanoparticles (primary particle size\n20 nm; geometric mean diameters of 91, 113 and 130 nm anatase+brookite (3:1); 8–30 mg/m3 for 0.5 h (acute exposure); 30 mg/m3 for 1 h a day, 4 days a week for 4 weeks (sub-chronic exposure)) through inhalation. However, reduction in expiratory flow in all the exposure situations was observed.\nA sub-chronic inhalation study comparing pulmonary responses to TiO2 nanoparticles in several species was performed [28]. Female mice, rats and hamsters that were exposed to different aerosol concentrations of 0.5, 2.0 and 10 mg/m3 P25 TiO2 nanoparticles (21 nm) for 13 weeks 6 h per day and 5 days per week showed an increase in retained lung burdens in a dose-dependent fashion in all three groups. However, significant species differences were observed in the pulmonary responses to the inhaled TiO2 nanoparticles. Rats showed more severe inflammatory responses under similar conditions of lung burdens of TiO2 nanoparticles than mice and, as a result, developed increased epithelial and fibroproliferative alterations. In the mice and rats that were exposed to 10 mg/m3 TiO2 nanoparticles, clearance of particles from the lung was significantly impaired, while in the hamsters, clearance was not affected at any of the administered doses.\nSilicon dioxide (SiO2)-coated 40 nm rutile TiO2 nanoparticles inhaled at the concentrations of 10mg/m3 for 2 h on four consecutive days for 4 weeks induced pulmonary neutrophilia and increased the expression of tumour necrosis factor-α and neutrophil-attracting chemokine CXCL 1 in lung tissues [43]. However, they linked these effects to the surface coating with SiO2. Minimal inflammatory effects in the lungs, leucopenia and decreased β-glucuronidase by inhalation of TiO2 nanoparticles have been observed [46].\nChronic lung inhalation studies [47, 48] that exposed pigs or rats, respectively, to TiO2 nanoparticles have reported findings of pulmonary pathology such as increased incidences of pneumonia, squamous metaplasia [48], sustained pulmonary responses [49], enhanced proliferation of pulmonary cells, defects in macrophage function [50], alveolar epithelial metaplasia, progressive fibroproliferative lesions [51] and accumulation of macrophages in interalveolar septa [8, 47].\nIntratracheal Instillation\nIntratracheal instillation is a technique in which single or repeated doses of specific volumes of substances are administered directly into the lungs. Although the studies on the exposure through inhalation are thought to be the gold standard, studies on the exposure through intratracheal instillation may prove useful for the assessment of risks [8, 52]. Sager et al. [53] intratracheally instilled 0.26–1.04 mg/rat 21-nm-sized TiO2 nanoparticles in rats and observed the migration of a significant portion to the interstitial space after 42 days. The extent of migrated TiO2 nanoparticles to the alveolar\n6 Shakeel et al.\ninterstitium was significantly greater than their fine counterparts after both inhalation exposure and intratracheal instillation [8, 53]. A small fraction of pulmonary TiO2 nanoparticles may enter the blood circulation and reach other tissues like the liver and kidneys after 28 days of being intratracheally instilled [54]. When male Kunming mice were treated with 3.3 mg/kg once a week for 4 weeks of anatase TiO2 (3 nm) nanoparticles by intratracheal instillation, increased Ti brain content, oxidative stress (O2−, OH−, H2O2, MDA) in brain and exudates, inflammatory infiltration and necrosis were observed.\nIntratracheal instillation of TiO2 nanoparticles had shown inflammatory effects in rats andmice [55–59]. The toxic effect of intratracheally instilled TiO2 nanoparticles in lung tissue exhibited a dose-response relationship. After exposure to TiO2 nanoparticles, TiO2 nanoparticles induced standing pulmonary lesions and may suppress the phagocytotic ability of alveolar macrophages. Male and female Sprague-Dawley rats treated with 0.5, 5 or 50 mg/kg TiO2 nanoparticles with 5, 21, and 50 nm primary particle size by intratracheal instillation showed inflammatory action (lactate dehydrogenase and ALP increased in the lung by 5 and 50 nm TiO2), inflammatory infiltration, alveolar wall thickening and alveolar macrophage phagocytic ability altered by 5 and 50 nm TiO2 [57]. Smaller particles induced greater inflammation in the short-term observations. Long-term effects (>1 week post-instillation) include pulmonary inflammation. However, this pulmonary inflammation was remarkably recovered [56]. In two experiments by Kobayashi et al. [56], male rats were treated with 5 mg/kg anatase TiO2 (4.9 nm) (1st experiment), anatase TiO2 (23.4 nm) and anatase TiO2 (154.2 nm) (2nd experiment) by intratracheal instillation. The 4.9- and 23.4-nm TiO2 nanoparticles increased the total cell count, neutrophils and lactate dehydrogenase, while in the second experiment, agglomerated TiO2 increased total cell count, neutrophils and lactate dehydrogenase. All treated groups showed epithelium hypertrophy. Inflammatory responses in the lungs have also been reported by Park et al. [55] and Roursgaard et al. [60]. Nemmar et al. [61] also demonstrated that intratracheal exposure to 1.5 mg/kg rutile Fe-doped nanorod TiO2 (length 80 nm; diameter 7 nm) can promote pulmonary as well as systemic inflammation (neutrophils and interleukin-6 increased) and caused oxidative stress (SOD activity decreased in bronchoalveolar lavage) along with histological changes (inflammatory cell infiltration) inWistar rats. Blood parameters likeWBC, interleukin-6 and SOD were reduced, while glutathione and platelets increased. Lung damage and change in the permeability of the alveolar-capillary barrier have also been observed by Li et al. [54] and Tang et al. [59]. The TiO2 nanoparticles can enter blood circulation and reach extrapulmonary tissues, e.g. the liver and kidney [54]. Male Kunming mice exposed to 3.3 mg/kg anatase (3 nm) TiO2 once a week for 4 weeks showed inflammatory action,\nincreased acid phosphatase, ALP in bronchoalveolar lavage and destroyed alveolar walls. Intratracheally instilled TiO2 nanoparticles may accumulate significantly in the lungs as reported by Sun et al. [62, 63]. TiO2 nanoparticles may significantly accumulate in the lungs and may increase the lung indices and inflammation and bleeding in the lungs. This may result into severe inflammatory response, pulmonary oedema and pneumonocyte apoptosis for 90 days [62]. With increasing exposure, TiO2 nanoparticles may significantly accumulate and cause the production of the reactive oxygen species in the lung [63]. A dose-dependent retention of TiO2 nanoparticles has been observed in the lungs up to 28 days after instillation by Husain et al. [64]. A dose-dependent manner of infiltration of inflammatory cells has also been observed in lung tissues by Nemmar et al. [61]. The intratracheal exposure induced a significant and dose-dependent increase in neutrophils in the bronchoalveolar lavage and an increase in interleukin-6 and caused a dose-dependent decrease of superoxide dismutase activity [61]. A study conducted by Roursgaard et al. [60] showed sub-chronic lung inflammation in a dose-dependent manner due to an increase in BALF macrophages. Histology showed little inflammation overall. Rutile TiO2 nanoparticles were the most inflammogenic, while amorphous TiO2 nanoparticles were the most potent in regard to acute tissue damage. There was a dose-dependent acute increase in neutrophils, IL-6 and total protein in BALF in all TiO2 nanoparticle-treated groups [60].\nTiO2 nanoparticles generate pulmonary inflammation in mice that could be due to the oxidative stress and expression of inflammatory cytokines. Exposure to TiO2 nanoparticles significantly enhance the reactive oxygen species and lipid peroxidation and decrease the capacity of the antioxidant in the lung [62]. Retention of TiO2 nanoparticles in the absence of inflammation over time in low-dose groups may possibly upset calcium and iron homeostasis and disturb smooth muscle activities. In high dose, nanoparticles caused lung inflammation. However, in low andmedium doses, the inflammation resolved and there was no neutrophil influx in the lung fluid [64].\nLow-dose instillation of TiO2 nanoparticles (5 nm; 0.8, 4, 20 mg/kg) can recoverably impact metabolic function (acetate, valine, dimethylamine, taurine, hippurate and 2- oxoglutarate) because the scattered nanoparticles may be transported from the lung to other organs or tissues like the liver or kidney, but particles in higher doses aggregate and deposit in the lung without migration and cause pulmonary inflammation along with expanded lung gaps and hyperemia [59]. Biochemical parameters showed blood urea nitrogen and creatinine to be increased, while high nuclear magnetic resonance urine analysis showed increases in valine, lactate, acetate, succinate, 2-oxoglutarate, creatinine, taurine, trimethylamine-N-oxide, allantoin and hippurate 1–2 and decreases in citrate and dimethylamine. Oxidative stress may be\nToxicity of Titanium Dioxide (TiO2) Nanoparticles 7\ninduced by the intratracheal exposure to TiO2 nanoparticles induced in the liver and kidney, but does not affect renal or hepatic functions. Glutathione peroxidase activity of the kidney and superoxide dismutase activity of plasma in the lowdose group significantly decrease, while malondialdehyde levels of the kidney and liver significantly increase. There were no apparent pathological changes in the liver and kidney [65], whereas inflammatory responses have been observed by Park et al. [55]. Liang et al. [65] treated male and female Sprague-Dawley rats with 5 and 21 nm at a dose of 0.5– 50mg/kg by intratracheal instillation. Biochemical parameters such as total protein, albumin, ALT, AST, blood urea nitrogen and creatinine showed no changes. But oxidative stress (decreased SOD and glutathione peroxidase and increased MDA activity) was observed in the liver, kidney and plasma, mostly by 5 nm. Li et al. [54] reported the entrance of intratracheally instilled TiO2 nanoparticles into the blood and liver and kidney injury due to these particles. Nemmar et al. [61] reported that the liver showed slight infiltration of inflammatory cells, mainly lymphocytes, of few portal tracts. The plasma superoxide dismutase and reduced glutathione activities decreased dose-dependently, while AST and ALT increased [61]. Increased levels of aspartate aminotransferase, lactate dehydrogenase, alkaline phosphatase, blood urea nitrogen and creatinine, which indicated a slight injury in the liver and kidney, as well as an increase in alveolar macrophages, expanded lung gaps, hyperemia and alveolar thickness were also reported by Tang et al. [66] in male Sprague-Dawley rats exposed to intratracheal instillation of 0.8, 4 and 20 mg/kg anatase (5± 1 nm) TiO2 nanoparticles. Biochemical parameters changed (ALT and blood urea nitrogen increased). High nuclear magnetic resonance urine analysis showed increases in valine, lactate, acetate, succinate, 2-oxoglutarate, creatinine, taurine, trimethylamine-N-oxide, allantoin and hippurate 1-2; decreases in citrate, dimethylamine, ketone bodies, choline and low-density lipoprotein; increases in alanine and glutamic acid; and decreases in creatine and pyruvate. TEM analysis of the kidney revealed tubule epithelial cell damage and vascular deformity. Intratracheally instilled TiO2 nanoparticles may change the permeability of the alveolar-capillary barrier. TiO2 nanoparticles might pass through the blood-brain barrier and induce brain injury through oxidative stress response in mice [54].\nA significant increase in the levels of lactate dehydrogenase and liver enzymes, i.e. aspartate aminotransferase and alanine aminotransferase in plasma, was reported by Nemmar et al. [61]. An increase in the levels of choline, ketone bodies, alanine and low-density lipoprotein; a decrease in the levels of lactate, pyruvate and creatine; an increase in the levels of aspartate aminotransferase, lactate dehydrogenase and alkaline phosphatase; and an increase in the levels of blood urea nitrogen and creatinine in serum indicated a slight injury in the liver and kidney. Transmission electron\nmicroscopy revealed particle-related alterations in the structure of the lungs, liver and kidneys. It also revealed apoptosis due to the localization of nanoparticles within cells. Biochemical parameters changed, e.g. albumin and glutamic acid increased. High nuclear magnetic resonance serum analysis showed that ketone bodies, choline, low-density lipoprotein, alanine and glutamic acid increased and lactate, creatine and pyruvate decreased when male Sprague-Dawley rats were treated with anatase (5±1 nm) nanoparticles at 0.8, 4 and 20 mg/kg. TEM analysis showed swollen hepatocytes and congested sinusoids [66].\nTiO2 nanoparticles possibly cause chronic inflammatory diseases in mice. The expressions of genes related with antigen presentation and genes related with the induction of chemotaxis of immune cells markedly increase. ICR mice exposed to 5, 20 and 50 mg/kg of P25 TiO2 (21 nm) by a single intratracheal instillation showed inflammatory action (interleukin-1, tumour necrosis factor-α, interleukin-6, interleukin-12, interferon-γ, interleukin-4, interleukin-5, interleukin10 and IgE increased in bronchoalveolar lavage), histology changes (inflammatory proteins, granulomas) and upregulation of genes involved in antigen presentation and immune cell chemotaxis [55]. Intratracheally instilled TiO2 nanoparticles caused a transitory response of proinflammatory cytokines and T-cell-activating cytokines in the airways, along with an influx of neutrophils and eosinophils. Gustafsson et al. [67] have demonstrated a dynamic response in the lungs of Dark Agouti rats to TiO2 nanoparticles, starting with an activation of the innate immunity of eosinophils, neutrophils, natural killer cells and dendritic cells, followed by a long-lasting activation of lymphocytes of adaptive immunity. Intratracheal instillation of 1, 5 and 7.5 mg/kg bw P25 Degussa TiO2 resulted in a transient increase in eosinophils and neutrophils in bronchoalveolar lavage, followed by a recruitment of dendritic cells and natural killers. Elevated levels of interleukin-1, interleukin-2, interleukin-6 and cytokine induced neutrophil chemoattractant-1 and granulocytemacrophage colony-stimulating factor.\nAs a result of exposure to intratracheally instilled TiO2 nanoparticles, both damage to the cell structure and dysfunction of pulmonary alveolar macrophages may happen, leading to a reduction in both specific and non-specific immune responses in individuals exposed to small-sized TiO2 nanoparticles [68]. Heart rate, systolic blood pressure, plasma interleukin-6 and number of leukocyte and platelet increased [61]. Intratracheal exposure to TiO2 nanoparticles may trigger the systemic immune response. Immune function response may be considered as an increase in the proliferation of T cells and B cells after mitogen stimulation and increased killing activity of natural killer cell in the spleen, along with an increase in the number of B cells in the blood. There were no significant changes in cytokines [69].\n8 Shakeel et al.\nFurthermore, exposure to TiO2 nanoparticles can induce the expression of heme oxygenase-1, Nrf-2 and glutamatecysteine ligase catalytic subunit from an exposure of 15 to 75 days, while there were significant decreases in the expression levels of the three factors in the lung at 90-day exposure. The Nrf-2 expression induction is an intracellular adaptive response to oxidative stress induced by TiO2 nanoparticles in the mouse lung [63]. Furthermore, exposure to TiO2 nanoparticles activated nuclear factor-κB and increased the levels of cyclooxygenase-2, heme oxygenase-1, tumour necrosis factor-α, interleukin-(IL)-2, IL-4, IL-6, IL-8, IL-10, IL-18, IL-1β and CYP1A1 expression. However, the exposure to TiO2 nanoparticles reduced nuclear factor kappa-light-chainenhancer of activated B cells (NF-κB)-inhibiting factor and expression of heat shock protein 70 in mice [62].\nSingle intratracheal instillations of 18, 54 and 162 μg per mouse altered approximately 3000 genes as revealed by DNA microarray analysis. Several inflammatory mediators were altered in a dose-dependent and time-dependent manner at the mRNA as well as protein level. Although the low dose did not show influx of neutrophils, alterations in the expression of a number of genes and proteins related with inflammation were observed. Inflammation resolved at the medium dose, while the low dose showed no neutrophil influx in the lung fluid. These effects were associated with down-regulation of genes responsible for ion homeostasis and regulation of muscle [64]. However, Naya et al. [70] found in a study carried out on Sprague-Dawley male rats that intratracheal instillation of anatase TiO2 nanoparticles is not genotoxic in rats. The comet assay revealed no increase in tail %DNA in the dosage of 1.0 or 5.0 mg/kg body weight and 0.2 or 1.0 mg/kg body weight once a week for 5 weeks. Cho et al. [71] also reported no inflammatory responses in the bronchoalveolar lavage and histology of the lung in rats after 24 h and 4 weeks of treatment of intratracheally instilled 50 and 150 cm2/rat TiO2 nanoparticles (30–40 nm). A slight congestion in the spleen and deposition of brown particulate in cervical and axillary lymph node due to exposure to TiO2 nanoparticles have been demonstrated by Fu et al. [69] in Sprague-Dawley rats.\nZhang et al. [72] evaluated the microdistribution of TiO2 nanoparticles in the lungs of rats using X-ray fluorescence microscopy. Rats were intratracheally administered with 10 mg/kg TiO2 nanoparticles with a microsprayer. The intensity of Ti in lung sections was measured using X-ray fluorescence. The beam size was 100 μm. The distribution of TiO2 nanoparticles was more in the right caudal and accessory lobes, located downstream of the direction of administration and the lower portion of each lobe.\nHowever, Courtois et al. [73] found no altered effect in the intralobar arteries’ vasomotor responses to prostaglandin F2α, KCl and acetylcholine in male Wistar or Sprague-Dawley rats exposed to 100μg TiO2 in 0.5 mL saline of P25 Degussa TiO2 nanoparticles (15 nm) by intratracheal instillation.\nLiu et al. [57] treated rats by intratracheal instillation with a single dose of 0.5, 5 or 50 mg of 5, 21 and 50 nm TiO2 nanoparticles per kg body weight. Histopathological examinations of the lung tissue 1 week post-exposure indicated that TiO2 nanoparticles caused dose-dependent inflammatory lesions. Pulmonary toxicity caused by 5 nm TiO2 nanoparticles was more severe as compared to those due to 21 or 50 nm TiO2 nanoparticles. Kobayashi et al. [56] reported the time course of pulmonary responses at 1 and 7 days after intratracheal instillation of 5 mg/ml of 19 and 28 nm TiO2 nanoparticles in rats. The pulmonary inflammation was greater after 24-h exposure then after 1-week exposure to TiO2 nanoparticles. The inflammation was dose dependent and locally distributed and recovery was probable. Liu et al. [68] investigated the effects of TiO2 nanoparticles on the immune function of rat alveolar macrophages exposed to intratracheally instilled 5 and 200 nm TiO2 nanoparticles at the concentration of 0.5, 5 or 50 mg/kg. They reported damaged cell structure and dysfunction of alveolar macrophages, resulting in reduced non-specific as well as specific immune responses. The phagocytic ability of the macrophages was inversely related to the changes in the dose of TiO2 nanoparticles. The chemotactic ability of macrophages and expression of some receptors on the cell surface was decreased. Nitric oxide (NO) and expression of TNF-α by the alveolar macrophages were gradually enhanced by the increased dosage of TiO2 nanoparticles. TiO2 nanoparticles produced more NO and TNF-α than fine particles [74]. Pulmonary inflammation and airway hyperresponsiveness were increased by low pulmonary doses of 99.9 % anatase 15 nm TiO2 nanoparticles in toluene diisocyanate-induced asthma mice treated on the dorsum of both ears (20 μL) on days 1 and 8 [75]. The mice were administered oropharyngeally with 40 μL of a TiO2 nanoparticle suspension (0.8 mg/kg body weight) on day 14. Airway hyperresponsiveness increased 2-fold, and total cell count of bronchoalveolar lavage fluid, mainly consisting of neutrophils and macrophages, increased 3-fold. Inflammation, epithelial damage and edema increased. These studies propose that TiO2 nanoparticles may be airway irritant."
    }, {
      "heading" : "Sub-acute Study",
      "text" : "Zhang et al. [76] intratracheally instilled rats with TiO2 nanoparticles at the dose of 1 and 10 mg/kg body weight. LDH activity, MDA, total protein and the number of leukocytes as well as pulmonary inflammation were increased significantly at 10 mg/kg body weight dose. Oberdorster et al. [77] observed a significant pulmonary inflammation due to TiO2 nanoparticles (20 nm) in rats and mice, expressed by the increase of total protein in branchioalveolar lavage fluid, acidglucosidase and LDH activity. Li et al. [54] studied the effects of intratracheally instilled 3-nm-sized TiO2 nanoparticles once a week for 28 days in mice after a total dose of 13.2 mg/kg\nToxicity of Titanium Dioxide (TiO2) Nanoparticles 9\nbody weight. Lung damage and change in the permeability of the alveolar-capillary barrier were observed. TiO2 nanoparticles entered the blood circulation and reached extrapulmonary tissues, e.g. the liver and kidneys, and caused tissue injury. TiO2 nanoparticles were also found to pass through the blood-brain barrier and caused injury via oxidative stress. In some other areas, TiO2 nanoparticles at the dose of 1.0, 0.5 and 0.1 mg/ml twice per week for 6 weeks induced dyslipidemia and enhanced the atherosclerosis and plaque rupture in intratracheally instilled mice [78]."
    }, {
      "heading" : "Sub-chronic Study",
      "text" : "Warheit et al. [79] compared several types of TiO2 fine particles and nanoparticles with different sizes, surface areas and crystal structures by intratracheal instillation of TiO2 nanoparticles with the size of 25 or 100 nm and dose of 1 and 5 mg/kg body weight for 24 h, 1 week and 3 months into rats. In the comparison between these particles, even though the surface areas differed as large as 30-fold, the lung inflammation observed was almost similar for the two particle sizes. Therefore, they concluded that toxicity of TiO2 particles is not dependent on the particle size or surface area through lung instillation. Moreover, the same research group suggested that toxicity depends upon particle surface properties instead of surface areas. When mice were intratracheally instilled with single fixed doses (5, 50 and 500 μg) of TiO2 fine as well as rutile nanoparticles, Roursgaard et al. [60] found an increase in interleukin-6 and total protein in bronchoalveolar lavage fluid as well as airway inflammation at the highest doses in the acute phase by both fine as well as nanoparticles."
    }, {
      "heading" : "Nasal Exposure (Intranasal Instillation)",
      "text" : "Breathing mostly takes place through the nose and is called nasal breathing. The nasal cavity has a respiratory segment and an olfactory segment. The former is lined with pseudostratified ciliated columnar epithelium with much vascularized lamina propria that allows the venous plexuses of the conchal mucosa which helps more blood passing through this segment, controlling airflow and directing air in the nose. The latter is lined with the olfactory epithelium containing receptors for smell. Different types of cells are present here including bipolar neurons and supporting (sustentacular) cells along with basal cells and Bowman’s glands. Axons of these bipolar neurons make the olfactory nerve (cranial nerve I) that enters the brain via the cribiform plate.\nTitanium dioxide nanoparticles showed a 2-fold increase in airway hyperreactivity and a 3-fold increase in bronchoalveolar lavage total cell counts, mainly comprising neutrophils and macrophages in mice with diisocyanate-induced asthma. Histological analysis revealed increased oedema, epithelial damage and inflammation in the lungs [75]. Yu et al. [80] have\nalso reported that chronic exposure to TiO2 nanoparticles may result in atherogenesis in combination with pulmonary inflammation. Wang et al. [81, 82] demonstrated on murine brain that intranasally instilled 80 nm rutile and 155 nm anatase TiO2 nanoparticles at 500 μg/ml for 2, 10, 20 and 30 days can be taken up and translocated by sensory nerves to the brain. Intranasally instilled TiO2 nanoparticles to female mice directly entered the brain through the olfactory bulb, especially deposited in the hippocampus region and caused the pathological changes in the hippocampus and olfactory bulbs, such as irregular neuronal arrangement and condensated chromatin, and inflammatory action such as increased tumour necrosis factor-α and interleukin-1β levels. The oxidative damage expressed as lipid peroxidation, glutathione peroxidase, glutathione S-transferase, SOD, reduced glutathione and malondialdehyde increased significantly [82]. Nasally instilled TiO2 nanoparticles can be translocated towards the central nervous system and may cause lesion of the brain. The hippocampus may be the main target within the brain. Female CD-1 (ICR) mice treated with rutile (80 nm) or anatase (155 nm) at the dose of 500 μg every other day for 15 times by intranasal instillation showed Ti brain distribution mainly in the olfactory bulb and hippocampus, causing oxidative stress (decreased catalase activity, malondialdehyde; protein carbonyls increased, SOD), and neurotransmitters like acetylcholinesterase, glutamic acid and NO were increased [81]. Chen et al. [83] have also suggested that the TiO2 nanoparticles can translocate among the organs and pass through the blood-brain and the blood-heart barrier after long-term exposure.\nTiO2 nanoparticles caused haemorrhage and overproliferation of spongiocytes in the mouse brain. The exposure of mouse to TiO2 nanoparticles also increased reactive oxygen species production and peroxidation of lipid, protein and DNA [84]. TiO2 nanoparticles can be translocated and accumulated in the brain, leading to oxidative stress, all glial cell overproliferation, tissue necrosis and hippocampal cell apoptosis. Moreover, TiO2 nanoparticles showed significant alterations in the expression of certain genes related to oxidative stress, immune response, apoptosis, metabolic process, DNA repair, brain development, signal transduction, memory and learning, response to stimulus and cellular process [85]. TiO2 nanoparticles induce oxidative damage in the brain of mouse. This damage may take place through the p38-Nrf-2 signalling pathway [84]. Chen et al. [83] studied chronic toxicity of TiO2 nanoparticles and found obvious adverse effect to zebrafish (Danio rerio), including timedependent and concentration-dependent inhibition of growth and decrease in the liver weight ratio of zebrafish. TiO2 nanoparticles were also found to be distributed and accumulated in the gill, heart, liver and brain.\nYu et al. [80] observed that the long-term exposure to TiO2 nanoparticles may cause atherosclerosis and pulmonary inflammation. Chronic exposure to TiO2 nanoparticles (1.25,\n10 Shakeel et al.\n2.5, 5 mg/kg body weight; nasal instillation; 9 months consecutively) caused pulmonary inflammation and atherogenesis, accompanied by alterations of many different serum parameters like carbohydrates, lipid and protein contents and metabolites.\nAlthough there are few studies about the exposure of TiO2 nanoparticles with respect to inhalation, intratracheal instillation or intranasal exposures, these studies suggest the translocation of the TiO2 nanoparticles from the lungs into the circulatory system and systemic tissues or from the nasal cavity into the nervous system through the sensory nerves. The available data suggest the low rate of migration of nanoparticles to the circulatory system [8]."
    }, {
      "heading" : "Sub-chronic Studies",
      "text" : "Wang et al. [86] investigated the influence of intranasally instilled TiO2 nanoparticles (25, 80 or 155 nm) on monoaminergic neurotransmitters at different post-exposure times at the dose of 50 mg/kg for 2, 10, 20 or 30 days in female mice. The monoaminergic neurotransmitters such as norepinephrine (NE), 3,4-dihydroxyphenylacetic acid (DA), 5-hydroxyindole acetic acid (5-HT), 5-hydroxyindole acetic acid (5-HIAA), dopamine (DOPAC) and homovanillic acid (HVA) were found out by reversed-phase high-performance liquid chromatography with an electrochemical detector. Increased accumulation of TiO2 nanoparticles was observed in murine brain for the 25-nm group after 10 days (059.3±293.5 ng/g) that declined slowly after 20 days post-exposure (654.7±269.2 ng/g) but did not further decreased after 30 days post-exposure. The levels of norepinephrine and 5-hydroxyindole acetic acid increased significantly after exposure to 80- and 155-nm-sized TiO2 nanoparticles, while decreases in the levels of 3,4- dihydroxyphenylacetic acid, dopamine, homovanillic acid and 5-hydroxyindole acetic acid were observed due to the deposition of TiO2 nanoparticles in the brain. Thus, inhaled TiO2 nanoparticles may translocate and deposit in the brain after absorption through the nasal mucosa and may affect the release and metabolism of monoaminergic neurotransmitters in the brain."
    }, {
      "heading" : "Oral Exposure",
      "text" : "The gastrointestinal tract (GIT) may be an important route for the absorption of TiO2 nanoparticles because food products, water and liquid beverages and drug carriers may contain TiO2 nanoparticles [87, 88]. The gastrointestinal absorption of nanomaterials has been the subject of the recent efforts in the field of nanomedicine to develop effective carriers which increase the oral uptake of drugs and vaccines [89]. TiO2 nanoparticles produced a marked harmful effect on male fertility and biochemical parameters as well as produced\nhistopathological changes. Orally administered TiO2 nanoparticles affected the liver, testes, serum and seminal vesicle [90–92].\nOrally administered TiO2 nanoparticles caused high coefficients of the liver in rats [91]. Alterations of serum biochemical parameters such as ALT, AST, lactate dehydrogenase and pathology, i.e. spotty necrosis of hepatocytes and the hydropic degeneration around the central vein of the liver [91], and a significant increase in serum nitric oxide, hepatic SOD, glutathione reductase (GR) enzyme activities and MDA concentration [90] were observed, which indicate the hepatic injury by the nanoparticles. The liver showed vacuolar and hydropic degeneration and cell death of some hepatic cells [90]. Oral exposure to TiO2 nanoparticles produced a significant oxidative stress in red blood cells, liver and brain of male mice, which is clear from the higher levels of reactive oxygen species, and changed antioxidant enzymes activities. There was also a substantial increase in the levels of dopamine and norepinephrine in the brain cerebral cortex. It suggests that the TiO2 nanoparticles have neurotoxic potential. The presence of these nanoparticles within the cytoplasm and nucleus was detected by transmission electron microscopy [93].\nFadda et al. [94] observed the level of lipid peroxidation enhanced in rat liver and a dramatic increase in serum glucose level (marker of metabolic disorder) and the pro-inflammatory biomarkers including tumour necrosis factor-α, interleukin-6, C-reactive protein and immunoglobin G as well as the vascular endothelial growth factor (VEGF) (angiogenic factor) and NO, oxidative (DNA) damage, the alteration in the apoptosis marker, caspase-3, and the drug metabolizing enzymes, cytochrome P450 (CYP450), in rat livers.\nA number of studies have shown that the orally administered TiO2 nanoparticles with size less than 100 nmmay cause hepatic and renal toxicity in rats. Vasantharaja et al. [95] orally administered a dose of 50 and 100 mg/kg body weight TiO2 nanoparticles to adult male Wistar rats. These nanoparticles mainly affected the liver and kidney as shown by the changes in the serum parameters. The altered levels of total protein, glucose, AST, ALTand ALP indicated that TiO2 nanoparticles induced hepatic damage. A significant increase in blood urea nitrogen and uric acid points out that TiO2 nanoparticles damage the kidney.\nBu et al. [92] observed disturbances in energy and amino acid metabolism and the gut microbes in Wistar rats orally administered with different doses of TiO2 nanoparticles that may be attributable to some injury to the liver and heart due to TiO2 nanoparticles. The metabonomics analysis of serum showed altered levels of amino acids in rats treated with TiO2 nanoparticles. TiO2 nanoparticles raised AST, creatine kinase and lactate dehydrogenase and caused mitochondrial swelling in heart tissues.\nThe significant change of serum alpha-HBDH and lactate dehydrogenase in TiO2 nanoparticle-exposed groups showed\nToxicity of Titanium Dioxide (TiO2) Nanoparticles 11\nmyocardial damage. The nephrotoxicity and pathology alteration of the kidneys was also observed. TiO2 mainly accumulated in the liver, spleen, lungs and kidneys. This indicates the transportation of TiO2 particles to other tissues and organs after absorption by the gastrointestinal tract [91].\nThere was a significant decrease in body weight gain, sperm motility percentage, sperm cell concentration, sperm viability and serum testosterone level, while there was a significant increase in sperm abnormalities and a reduction in the number and size of the epithelial lining of the tubuloalveolar gland and hyperplastic glandular epithelium of the seminal vesicle. The testes showed mild spermatogenesis besides congested testicular blood vessels [90].\nThe exposure to TiO2 nanoparticles induced major degenerative changes in the albino rat visual cortex. The cytoplasm showed some inclusion bodies, swollen mitochondria, dilated rough endoplasmic reticulum and swollen Golgi apparatus. The dendrites and axonal bundles showed thinning and disintegration of the myelin sheath. The oligodendroglial cell showed small shrunken nucleus with peripherally clumping chromatin and dilated rough endoplasmic reticulum [96].\nThe effects on serum and heart tissue of adult rats after oral exposure to TiO2 nanoparticles showed increases in serum tumour necrosis factor-α, immunoglobulin G, interleukin 6, C-reactive protein, vascular endothelial growth factor, myoglobin, troponin, creatine kinase-MB and nitrite levels and DNA damage. TiO2 nanoparticles caused an increase in all serum and tissue parameters in a dose-dependent manner [97]. The Morris water maze and the passive avoidance tests on lactating Wistar rats showed that exposure to TiO2 nanoparticles by gavage can significantly harm the memory and learning in the offspring [98].\nTiO2 nanoparticles can cause neuroinflammation that may cause changes in the cytokine expression in mouse hippocampus. Ze et al. [99] treated mice orally with 2.5, 5 and 10 mg/kg body weight with TiO2 nanoparticles for 90 consecutive days. Titanium accumulated in the hippocampus and caused neuroinflammation and spatial memory damage. Also, the expression of Toll-like receptors, e.g. TLR-2 and TLR-4, tumour necrosis factor-α, NF-κB-inducible kinase, NF-κB2(p52), nucleic IκB kinase, nucleic factor-κB and RelA(p65) was significantly activated, while the expression of IκB and interleukin-2 was significantly suppressed.\nHowever, Geraets et al. [100] observed that titanium content levels in the liver and spleen above the detection limit were found only in some rats. Low levels of titanium could be detected in mesenteric lymph nodes. From these results, it may be concluded that some minor absorption, but to a very limited extent, may take place in the gastrointestinal tract. This very low oral bioavailability (limited uptake) and slow tissue clearance might result in potential accumulation in the tissues in the long run.\nWarheit et al. [20] conducted acute oral toxicity studies in rabbits. Treatment with 129.4 nm fine particles and anatase/ rutile (80 nm/20 nm) TiO2 nanoparticles in H2O at the dose of 175, 550, 1750 or 5000 mg/kg at 48 h intervals for 14 days caused very low toxicity and short-term and reversible ocular conjunctiva redness. Another study investigated the acute toxicity in mice after a single oral administration of 25, 80 and 155 nm TiO2 particles at the dose of 5 g/kg body weight [91]. After 2 weeks of exposure, there was no noticeable acute toxicity. However, there were increased hepatic coefficients in the female mice treated with 25 and 80 nm TiO2 nanoparticles. Hepatic and renal injury was apparent from serum biochemical parameters (lactate dehydrogenase, BUN, AST, ALT) and the pathology of the kidney and liver. Significant alterations of serum LDH in 25 and 80 nm TiO2 nanoparticletreated organisms indicated myocardial damage. These studies showed biochemical changes due to oral exposure but did not confirm systemic toxicity. Bu et al. [92] treated Wistar rats with TiO2 nanoparticles at the dose of 0.16, 0.4 and 1 g/kg. The urine and serum analysis by HNMR showed enhanced levels of citrate, taurine, hippurate, histidine, citrulline, trimethylamine-N-oxide, alphaketoglutarate, acetate and phenylacetylglycine.\nThe use of engineered nanoparticles in consumer products results in the presence of nanoparticles in drinking water sources, although the concentration of Ti compounds in drinking water is mostly low [8]. Although the majority of aggregated or stable nanoparticles were removed by simulated conventional and advanced treatment using bench-scale coagulation/flocculation/sedimentation-simulated conventional treatment, as well as using microfiltration and ultrafiltrationsimulated advanced treatment, nanoparticle metals were detectable in 2–20, 3–8, and 48–99 % of Ag, TiO2, and ZnO nanoparticles or their dissolved ions, respectively, that remained in finished water. So the consequent nanoparticle increase into treated drinking water is a potential route for the exposure and threat for human health [101]. Trouiller et al. [102] demonstrated in vivo in mice the genotoxicity, oxidative DNA damage and inflammation by TiO2 nanoparticles in drinking water. The comet assay, the micronuclei assay, and the γ-H2AX immunostaining assay showed induced 8-hydroxy-2′-deoxyguanosine, γ-H2AX foci (indicative of DNA double-strand breaks), micronuclei and DNA deletions, a moderate inflammatory response (mRNA levels of inflammatory cytokines in the peripheral blood).\nIntraperitoneal Injection\nIntraperitoneal (IP) injection is the injection of a substance into a body cavity (the peritoneum). The method is widely used in humans to administer chemotherapy drugs for the treatment of some cancers, especially ovarian cancer.\n12 Shakeel et al.\nAlthough this method is controversial, but still this particular use has been recommended as a standard of care [103]. Intraperitoneal studies may be done to address the effects of possible TiO2 nanoparticles use in nanomedicine [8]. Intraperitoneal injection of TiO2 nanoparticles has been shown to affect blood. The nanoparticles did not activate platelets in vitro but caused prothrombotic effects in the microcirculation in vivo [104], while Younes et al. [105] reported that blood cell count remained unchanged with the exception of the platelet count that increases after the intraperitoneal injection of 20 mg/kg body weight TiO2 nanoparticles every 2 days for 20 days into rats. Intraperitoneal injection affects the spleen [106–109], lung [106, 110], serum, heart, kidney, liver [106, 107], brain [111], inflammatory response [110, 111] and reproductive system [107]. Guo et al. [107] treated male ICR mice with 200 and 500 mg/kg body weight TiO2 nanoparticles every other day for 5 times by intraperitoneal injections as a result of which ALT and AST/ALT as well as blood urea nitrogen were increased showing the effect on the liver and renal system. Reduced sperm density and motility, increased sperm abnormality and germ cell apoptosis were also observed. Intraperitoneally injected anatase TiO2 nanoparticles interfere with antioxidant defence mechanisms that results in oxidative stress in hepatocytes due to production of reactive oxygen species promoting apoptosis and necrosis [112].\nSymptoms of acute toxicity, e.g. passive behaviour, appetite loss, tremor and lethargy, were also induced. Slightly elevated levels of the serum enzymes ALP and AST were found from the biochemical tests, whereas blood urea nitrogen was not significantly changed [106]. The highest accumulation of TiO2 was in the spleen and resulted in the lesion and congestion and proliferation of lymph nodule of spleen tissue and caused apoptosis of the splenocyte [106, 108]. TiO2 nanoparticles can induce the spleen pathological changes, apoptosis, leading to the reduction of immunity of mice [108]. TiO2 was also deposited in the lung, liver and kidney of adult male and female ICR mice when treated with 324, 648, 972, 1296, 1944 or 2592 mg/kg of 80 and 110 nm, mostly being 100 nm anatase TiO2 nanoparticles. Histopathological examinations showed the entrance of some TiO2 particles into the spleen which cause severe lesions and neutrophil infiltration. These nanoparticles also caused thrombosis in the pulmonary vascular system that may be attributed to blocking of blood vessels. Moreover, hepatocellular necrosis and apoptosis, hepatic fibrosis, hydropic degeneration, swelling of renal glomerulus, proteinic liquids in renal tubules and interstitial pneumonia were also observed in the high-dose groups that may be associated with the alveolar septal thickening [106]. Intraperitoneally injected anatase TiO2 nanoparticles caused hydropic degeneration and fatty degeneration of hepatocytes, portal and lobular infiltration by inflammatory cells, cloudy\nswelling and congested dilated central veins, cytoplasmic degeneration and damaged nuclei of hepatocytes [112].\nThere were also a decrease in the coefficients of the liver, heart and kidneys and a significant increase in serum biochemical parameters such as the ALT, ALT/AST and BUN, as well as significantly reduced sperm density and motility, increased sperm abnormality and germ cell apoptosis. But damage on the liver and kidney function is slight in a dosedependent manner [107]. Intraperitoneally injected anatase TiO2 nanoparticles changed serum alkaline phosphatase and glutamate oxaloacetate transaminase activity [112]. Jeon et al. [113] intraperitoneally injected anatase TiO2 nanoparticles with the average diameter <25 nm for 7 days. Glutamic oxaloacetic transaminase, glutamic pyruvic transaminase and alkaline phosphatase were enhanced approximately 18, 35 and 69 %, accumulated in the periphery of sinusoid in the liver. Enzymes, such as superoxide dismutase, catalase and aldehyde dehydrogenase, were significantly inhibited by 22, 38 and 15 %, respectively, and glutathione peroxidase was constant. An increase in the AST/ALT enzyme ratio and activity of lactate dehydrogenase was observed after sub-acute exposure to TiO2 nanoparticles as IP injection of 20 mg/kg body weight every 2 days for 20 days [105].\nMoon et al. [110] found that intraperitoneal administration of TiO2 nanoparticles induces acute lung inflammation and exhibits additive or synergistic effects with lipopolysaccharide, to some extent, at least, through activation of oxidantdependent inflammatory signalling and the nuclear factor NF-κB pathway, that results in the increase of proinflammatory mediators, e.g. tumour necrosis factor-α, interleukin-1β, and macrophage inflammatory protein-2 in bronchoalveolar lavage fluid and mRNA expression of tumour necrosis factor-α and interleukin. They treated mice with 40 mg/kg of P25 TiO2 (21 nm) through intraperitoneal injections and observed inflammatory action on neutrophils, total protein content, tumour necrosis factor-α, interleukin-1β and macrophage inflammatory protein-2 increased by TiO2 or TiO2+lipopolysaccharide. Another research shows that intraperitoneal injection of TiO2 nanoparticles in mouse effectively activated caspase-3 and caspase-9, decreased the Bcl-2 levels of gene and protein, increased the levels of Bax, cytochrome c genes and their protein expression and promoted ROS accumulation [108].\nHistological examination by Younes et al. [105] showed that intraperitoneal injection of 20 mg/kg body weight TiO2 nanoparticles every 2 days for 20 days induced a little inflammation overall. Furthermore, pathological changes in the liver of rats were induced by the TiO2 nanoparticles. Titanium accumulated in the lung, liver and brain.\nNanosized TiO2 promotes increased neuro-inflammatory responses that may be due to an increase in microglial activation in pre-inflamed brain. When male mice were treated with <1 μm (rutile) or 21 nm (P25) at the dose of 40 mg/kg for\nToxicity of Titanium Dioxide (TiO2) Nanoparticles 13\n30 min after 5 mg/kg lipopolysaccharide through intraperitoneal injections, the inflammatory action was increased by TiO2 nanoparticles as expressed by increased interleukin-1β, tumour necrosis factor-α and inducible nitric oxide synthase and induced microglial activation, as well as they showed enhanced ROS that represent oxidative stress [111]. TiO2 nanoparticles when injected intraperitoneally may damage the development and proliferation of B and T lymphocytes, reduce the activity of macrophages and decrease natural killer (NK) cell population levels, outcomes that appear to lead to an increase in tumour growth in situ. This suggested that TiO2 nanoparticles might have the potential to enhance tumour growth through immunomodulation of B and T lymphocytes, macrophages and NK cells. TiO2 nanoparticles (<25 or <100 nm) intraperitoneally injected once a day for 7 days into mice decreased splenocytes, CD4+ and lipopolysaccharidestimulated natural killer cells CD8+, while B-lymphocyte development and lipopolysaccharide-stimulated spleen cell proliferation were retarded [109]. TiO2 nanoparticles can change the neurobehavioral performance of adult Wistar rats. Younes et al. [105] reported significantly increased anxious index in rats shown by the elevated plus-maze test after sub-acute treatment of TiO2 nanoparticles at 20 mg/kg body weight every 2 days for 20 days injected intraperitoneally.\nAt the higher doses of an intraperitoneal exposure study in mice, 5 nm anatase TiO2 nanoparticles intraperitoneally injected to mice at the concentration of 5, 10, 50, 100 and 150 mg/kg body weight daily for 14 days caused serious damage to the kidneys, liver and myocardium and altered blood sugar and lipid levels. On treating female CD-1 (ICR) mice with anatase TiO2 (5 nm), bulk rutile TiO2 (10–15 μm) at the dose of 5– 150 mg/kg body weight anatase TiO2 nanoparticles and 150 mg/kg bulk TiO2 every day for 14 days by intraabdominal injections, biochemical parameters, such as creatine kinase, lactate dehydrogenase, aspartate aminotransferase and alpha-hydroxybutyrate dehydrogenase, were increased by both TiO2 [114]. Furthermore, with increasing doses of TiO2 nanoparticles, liver function indicators, e.g. ALT, total protein, leucine acid peptide, albumin levels and pseudocholinesterase, were enhanced significantly; the kidney function indicators, e.g. BUN and uric acid, were decreased; and the myocardium function indicators, e.g. LDH, alpha-hydroxybutyrate dehydrogenase, triglycerides, glucose and high-density lipoprotein cholesterol levels, and the activities of AST and creatine kinase were increased. The accumulation of TiO2 nanoparticles in the organs was related to the inflammatory responses and the differences in the coefficients of organs of mice. The LD50 value of intraperitoneally injected TiO2 nanoparticles in mice was found to be 150 mg/kg body weight. Signs of acute toxicity, like passive behaviour, tremor, loss of appetite and lethargy,\nwere observed in mice intraperitoneally injected with 50- nm-sized TiO2 nanoparticles at the dose of 324, 648, 972, 1296, 1944 or 2592 mg/kg for 24 and 48 h and 7 and 14 days. ALT and AST levels were slightly elevated. Some TiO2 nanoparticles entered and caused lesions in the spleen. Thrombosis was observed in the pulmonary vascular system. Furthermore, the high-dose group showed hepatic fibrosis, renal glomerular swelling, hepatocellular necrosis and apoptosis and interstitial pneumonia related to alveolar septal thickening. Ma et al. [115] observed inflammatory responses and liver injury by 5- nm-sized TiO2 nanoparticles intraperitoneally injected at the dose of 5, 10, 50, 100 and 150 mg/kg body weight daily for 14 days. TiO2 nanoparticles significantly altered the mRNA and protein expression of numerous inflammatory pathways, together with NF-κB, macrophage migration inhibitory factor, tumour necrosis factor-α, interleukin-6, interleukin-1β , cross-react ion protein, interleukin-4 and interleukin-10. Neurons turned into filamentous shapes or inflammatory cells after translocation of TiO2 nanoparticles from the abdominal cavity [116]. A cascade of reactions was triggered by oxidative stress and the injury of the brain, like lipid peroxidation, decreases in the total antioxidation capability and antioxidative enzyme activities, the too much release of NO, reduced glutamic acid and down-regulation of acetylcholinesterase activity. Intraperitoneal injection of TiO2 nanoparticles causes acute systemic toxicity, involving pathological as well as biochemical effects on the kidney, liver, heart and brain.\nAnother study investigated an adjuvant effect of photocatalytic 28-nm-sized rutile TiO2 nanoparticles administered through intraperitoneal injection at the dose of 2, 10, 50 and 250 μg, in combination with ovalbumin (OVA) in mice [117]. The inbred female mice in this study were immunized with 1 μg OVA alone or in combination with either 2, 10, 50 or 250 μg TiO2 by intraperitoneal injections. The TiO2 nanoparticles promoted an immune response with high serum levels of ovalbumin-specific IgE and IgG1 and influx of neutrophils, eosinophils and lymphocytes in bronchoalveolar lavage fluid."
    }, {
      "heading" : "Subcutaneous and Intramuscular Injection",
      "text" : "A subcutaneous injection is given in the fatty layer of tissue just under the skin. There is little blood flow to fatty tissue, and the injected medication is generally absorbed more slowly, sometimes over 24 h. Growth hormone, insulin, epinephrine and other substances are injected subcutaneously. Subcutaneous injection of TiO2 nanoparticles causes various functional and pathologic disorders, for example reduction in sperm production and olfactory bulb of the brain, also in the next generation. When pregnant Slc:ICR mice were treated\n14 Shakeel et al.\nwith 100 μL at 1 mg/mL of 25–70 nm anatase TiO2 nanoparticles at 3, 7, 10 and 14 days post-coitum by subcutaneous injections, TiO2 nanoparticles were found in the cortex and olfactory bulb of offspring brain, and markers for features of apoptosis were seen in olfactory cells. The reproductive system was also affected by the nanoparticles as expressed by disrupted and disorganised seminiferous tubules, decreased sperm production, few mature sperm, number of Sertoli cells and epidididymal sperm motility [118]. Similarly, Umezawa et al. [119] demonstrated that prenatal exposure by subcutaneous injections may affect the brain. Differential expression of the genes associated with the striatum during the prenatal period, dysregulation of the gene expression for the regions related to dopamine neuron system and the prefrontal region have been observed by Umezawa et al. [119].\nThe gene expression involved in the development and function of the foetal central nervous system in offsprings may be affected after maternal exposure of mice to TiO2 nanoparticles. Shimizu et al. [120] injected TiO2 subcutaneously into pregnant mice on gestational days 6, 9, 12 and 15. Brain tissues from male foetuses on embryonic day 16 and from male pups on postnatal days 2, 7 14, and 21 were analysed by complementary DNA (cDNA) microarray analysis. The expression level of the genes related with apoptosis as well as brain development was changed in the offspring. The genes responsible for oxidative stress in the brain were changed in mice age 2–3 weeks. The expression of genes for neurotransmitters and psychiatric diseases was also changed [120].\nTakahashi et al. [121] demonstrated in mice that maternal exposure to TiO2 nanoparticles subcutaneously may affect the development of the central dopaminergic system in the next generation. In pregnant Slc:ICR mice subcutaneously injected with 100 μL at 1 mg/mL of 25–70 nm anatase TiO2 nanoparticles at gestational days 6, 9, 12, 15 and 18, monoamine levels (dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, 3-methoxytyramine-hydrochloride) were increased in the prefrontal cortex and neostriatum.\nHansen et al. [122] treated male Sprague-Dawley rats with TiO2 (70 nm) and bulk TiO2 (diameter 0.9 mm; height 1 mm) in the back of rats for 6 or 12 months by subcutaneous (bulk) and intramuscular (Nanoparticles) implantation. This induced local reaction such as the presence of granulomas (nanoparticles) and inflammatory infiltrates (bulk) and no local intolerance (both). There is another similar study by Gatti et al. [123] who treated male Sprague-Dawley rats with TiO2 (70 nm) and bulk TiO2 (diameter 6–12 mm; height 2 mm) in the back of rats for 6 or 12months by subcutaneous (bulk) and intramuscular (nanoparticles) implantation and observed local reaction in the form of granulomas (nanoparticles) and inflammatory infiltrates (bulk).\nOnuma et al. [124] treated female C57BL/6 mice by subcutaneous injections with hydrophilic rutile TiO2 (minor axis 40–70 nm; major axis 200–300 nm) treated with\nZrO2Al(OH)3 and with hydrophobic rutile TiO2 (minor axis 40–70 nm; major axis 200–300 nm) treated with ZrO2Al(OH)3 and steric acid (only QR-32 cells or QR-32 cells mixed with 5 mg/0.1 mLTiO2; or TiO2 30 and 70 days before injecting QR-32 cells) and observed the carcinogenicity and metastatic ability in tumour cell lines resulting from QR-32 cells injected in site pre-implanted with both the TiO2. QR-32 cells turned into tumorigenic after the injection in sites implanted with hydrophilic TiO2 for 30 or 70 days\nIntravenous Injection\nIntravenous treatment is the infusion of liquid substances directly into a vein. In recent days, in nanomedicine, TiO2 nanoparticulate carriers are intravenously injected directly into the blood and it has elevated public concerns in regard to their toxicity to humans [4, 125]. Scown et al. [126] quantified the content of titanium in the blood, brain, gills, liver and kidney of rainbow trout (Oncorhynchus mykiss) at time points. Upon a single high-dose exposure to TiO2 nanoparticles via the bloodstream injected intravenously, TiO2 accumulates in the kidneys but has a minimal effect on kidney function such as urine production or glomerular filtration rate [126].\nHigh doses of titanium dioxide nanoparticles intravenously injected to mice caused death on the second day of injection of TiO2 nanoparticles, while the lower doses caused acute toxicity symptoms like decreased physical activity, food and water intake and increased white blood cell count. The spleen of the TiO2 nanoparticle-treated mice showed higher tissue weight/ body weight coefficients and lower liver and kidney coefficients. The TiO2 nanoparticle treatment induced damage in the liver, spleen, brain, lung and kidneys; however, the heart showed no pathological effects [125]. Yamashita et al. [127] showed that intravenously injected 0.8 mg of 35 nm TiO2 nanoparticles for two consecutive gestational days to pregnant mice showed pregnancy complications, e.g. the accumulation of TiO2 nanoparticles in the placenta, brain and liver of the foetus and smaller uteri and foetuses.\nGeraets et al. [100] observed the rapid distribution of titanium through the systemic circulation in the liver, spleen, kidney, brain, heart, lung and thymus and reproductive organs after single and repeated intravenous exposure. The main targets of titanium were the liver, spleen and lung. Some decrease in the levels of titanium was also observed during the 90-day post-exposure period. The maximum relative decrease was 26 %. Slight variations in kinetic profile were observed among the various particles; however, these could not be clearly related to\nToxicity of Titanium Dioxide (TiO2) Nanoparticles 15\nprimary particle size differences or the hydrophobicity. Some clues were found about the crystalline form (anatase or rutile) on total titanium recovery. TiO2 nanoparticles caused liver damage and induced significantly the glutathione reductase expression in male Wistar rats intravenously injected with 5 mg/kg for 5 days [128].\nvan Ravenzwaay et al. [27] intravenously injected male Wistar rats with 5 mg/kg body weight of anatase-rutile TiO2 mixture (20–30 nm) and rutile TiO2 (200 nm) and observed TiO2 distribution mostly in the liver and spleen after injection as well as inflammatory action as both TiO2 formulations increased total cell count, polymorphonuclears, total protein content, ALP, lactate dehydrogenase, Γ-glutamyl transpeptidase and N-acetyl-glucosaminidase in bronchoalveolar lavage.\nThere is another study by Onuma et al. [124] who treated female C57BL/6 mice by intravenous injections with hydrophilic rutile TiO2 (minor axis 40–70 nm; major axis 200– 300 nm) treated with ZrO2Al(OH)3; hydrophobic rutile TiO2 (minor axis: 40–70 nm; major axis 200–300 nm) treated with ZrO2Al(OH)3 and steric acid (tumour cell lines into mice (5/line)) and observed the carcinogenicity and metastatic ability due to tumour cell lines obtained fromQR-32 cells injected in site pre-implanted with both TiO2. QR-32 cells were converted tumorigenic after injection in sites implanted with hydrophilic TiO2 for 30 or 70 days.\nIntra-articular Injection\nA joint injection or the intra-articular injection is used in medicine for the treatment of joint inflammations, such as gout, rheumatoid and psoriatic arthritis, carpal tunnel syndrome, tendinitis, bursitis and sometimes osteoarthritis. Antiinflammatory agents, such as corticosteroids, are injected into the affected joint using a hypodermic needle. Sometimes, hyaluronic acid is used to replace bursa fluids due to its high viscosity. In recent times, nanomaterial coatings are being used in orthopaedic implantations, for example bone, cartilage, joint, etc. Nanoscale wear particles may generate from orthopaedic implants with nanoscale surface features because of leftover stress. Intra-articularly injected Sprague-Dawley rats with anatase (diameter 45.87±7.75 nm; thickness 10– 15 nm) TiO2 nanoparticles at the dose of 0.2–20 mg/kg in the knee joints on alternate days 4 times showed histopathological changes in the knee joint, and the aggregated TiO2 nanoparticles deposited and resulted in synovium hypotrophy, lymphocyte and plasma cell infiltration and fibroblast proliferation. In the TiO2-exposed synovium, oxidative damagewas induced, expressed by glutathione peroxidase, reduced glutathione, oxidized glutathione, MDA and increased SOD. Further, lipid peroxidation was detected in the synovium through decreased ALP and increased AST/ALT, lactate\ndehydrogenase, fatty degeneration, inflammatory cell infiltration, and proteinic liquids in renal tubules and decreased blood urea nitrogen and creatinine, which were the biochemical and histological parameters showing the effect of TiO2 nanoparticles in the liver and renal system [129].\nIn another study, intra-articular injection of TiO2 nanoparticles in rats decreased the thickness of articular cartilage in distal femur at 1, 7, 14 and 30 days post-exposure. There was a strong linear correlation. TiO2 nanoparticles decreased cartilage thickness and cartilage volume in a time-dependent manner. Oedema chondrocyte and shrunk nucleus were also observed in the radial and calcified regions of the cartilage. The degenerated chondrocytes, the condensed chromatin, the rich mitochondria, the dilated endoplasmic reticulum and the fragments of ruptured endoplasmic reticulum in the cytoplasm of chondrocytes at day 30 post-exposure were seen. These results point out the potential damage of articular cartilage caused by the particles in knee joint and suggested that bio-monitoring should be given importance in patients with prostheses replacement [130]."
    }, {
      "heading" : "Prenatal Exposure",
      "text" : "The gene expression involved in the development and function of the foetal central nervous system in offspring may be affected after maternal exposure of mice to TiO2 nanoparticles. Shimizu et al. [120] injected TiO2 subcutaneously into pregnant mice on gestational days 6, 9, 12 and 15 with 100 μL at 1 μg/μL of 25–70 nm anatase TiO2 nanoparticles. Brain tissues obtained from male foetuses on embryonic day 16 and from male pups on postnatal days 2, 7, 14 and 21 were analysed by cDNA microarray analysis. The expression level of the genes related with apoptosis as well as brain development was changed in the offspring. The genes responsible for oxidative stress in the brain were changed in the mice age 2– 3 weeks. The expression of genes for neurotransmitters and psychiatric diseases also changed [120].\nPrenatal exposure to TiO2 nanoparticles can result in modifications in the olfactory bulb, cerebral cortex and some regions closely related to dopamine systems of offspring mice [119]. Subcutaneous injection of 0.4 mg TiO2 into pregnant mice on gestational days 6–15 caused the genes related to the striatum to be differentially expressed during the perinatal period as well as the dysregulation of the genes associated with the dopamine neuron system and prefrontal region in the later infantile period.\nTakahashi et al. [121] demonstrated in mice that maternal exposure to TiO2 nanoparticles might influence the development of the central dopaminergic system in offspring. The stress during foetal life induced by prenatal exposure to TiO2 nanoparticles could be implicated in depressive-like behaviours in adulthood. In mice, maternal exposure to TiO2\n16 Shakeel et al.\nnanoparticles disturbed the antioxidant status and caused a substantial oxidative damage to the nucleic acids and lipids within the brain of newborn mice. Depressive-like behaviours during adulthood were also observed in the sucrose preference test and the force-swimming test [131]."
    }, {
      "heading" : "Intragastric Administration",
      "text" : "Cui et al. [132] found in their experiments that intragastric administration of anatase (6.9 nm) TiO2 nanoparticles to female CD-1 (ICR) mice for 60 consecutive days caused hepatocyte apoptosis in the liver, followed by increased accumulation of reactive oxygen species (O2−, H2O2, MDA, NO) and a decrease in stress-related gene expression levels that resulted in increased SOD, catalase activity, glutathione peroxidase, methoxytyramine-hydrochloride, glutathione S-transferase, heat shock protein 70 and p53 and decreased transferrin and cytochrome p450 1A. Intragastric administration of TiO2 nanoparticles induced liver toxicity (inflammation) in mice in terms of hepatocyte apoptosis, histopathological changes, accumulation of titanium and damage in the function of the mice liver. A significant increase in the mRNA and protein expression of Toll-like receptor-2 and TLR-4 and several inflammatory cytokines and a significant decrease in the mRNA and protein expression of IκB and interleukin-2 were observed [133]. When female CD-1 (ICR) mice were treated with 5, 10 and 50 mg/kg of anatase (5 nm) nanoparticles for 60 consecutive days by intragastric administration, ALT, AST, ALP, lactate dehydrogenase, pseudocholinesterase, leucine acid peptide, IKK1, IKK2, NF-κB, NF-κBP52–65, tumour necrosis factor-α, NF-κB-inducible kinase, Toll-like receptor-2 and Toll-like receptor-4 were increased and IkB and interleukin-2 were decreased. Fatty degeneration, necrosis, apoptosis and inflammation were observed in the liver.\nWang et al. [91] treated male and female CD-1 (ICR) mice with 5 g/kg body weight of 25, 80 and 155 nm TiO2 nanoparticles with intragastric administration (oral gavage). Blood urea nitrogen and creatinine increased by 25 and 80 nm TiO2. These also caused proteinic liquids in renal tubules and glomerulus swelling.\nBu et al. [92] treated male and femaleWistar rats with 0.16, 0.4 and 1 g/kg of rutile-anatase TiO2 mixture (<50 nm) once a day for 14 consecutive days by intragastric administration. High nuclear magnetic resonance urine analysis showed an increase in α-ketoglutarate, hippurate, hist idine, trimethylamine-N-oxide, taurine, citrulline, acetate, phenylacetylglycine and citrate levels and a decrease in methionine and 3-D-hydroxybutyrate levels. 1H nuclear magnetic resonance serum analysis showed an increase in t r imethylamine-N-oxide , chol ine creat ine , 3-Dhydroxybutyrate and phosphocholine and a decrease in glutamate, acetoacetate, glutathione, methionine, glutamine and\npyruvate. WBC, lymphocytes, monocytes and eosinophils were increased. However, no alterations in histology were observed in the liver and spleen.\nIntragastric administration for 60 consecutive days with TiO2 nanoparticles resulted in the accumulation of reactive oxygen species in the hippocampus of mouse [134]. Intragastric administration of anatase TiO2 nanoparticles for 30 days resulted in significant increases in the accumulation of reactive oxygen species in the mouse spleen, consequently leading to increased lipid peroxidation and the significant expression of heme oxygenase-1 via the p38-Nrf-2 signalling pathway [135].\nGui et al. [136] found that intragastric exposure in mice caused modifications in the expression of genes. Most of the genes were related to immune or inflammatory responses, cell structure, apoptosis, oxidative stress, biological and metabolic processes, cell cycle, ion transport, cell differentiation, signal transduction, transcription and translation.\nIntragastric treatment of 5 nm anatase TiO2 nanoparticle caused damage in the function of the liver as a result of the damage of the immune response and haemostasis blood system in mice treated with a higher dose, while this effect was very little in low-dose-treated mice. Liver functions were disrupted in terms of increased activities of ALT, ALP, AST, cholinesterase and lactate dehydrogenase and total protein; the reduction of albumin to globulin ratio, triglycerides, total bilirubin and total cholesterol levels; the reduction in body weight; the increased coefficients of the liver and histopathological changes in the liver. There were a decrease in red blood cells, haemoglobin, interleukin-2 activity, white blood cells, thrombocytes, reticulocytes, B lymphocytes, T lymphocytes and natural killer lymphocytes and an increase in red cell distribution width, platelets, haematocrit, NO level, mean corpuscular volume, mean corpuscular haemoglobin, mean platelet volume. Histology showed blurred hepatocytes and congested vessels [137].\nHu et al. [138] investigated that intragastric exposure to TiO2 nanoparticles (5 nm anatase; 0, 5, 10 and 50 mg/kg BW; every day for 60 days) in ICR mice can potentially impair the spatial recognition memory, which may be due to the disturbance in trace element homeostasis, neurotransmitter and enzymes in the brain. Their aim was to determine whether exposure to TiO2 nanoparticles results in significant changes in the function of the nervous system. Sixty days of exposure on a daily basis caused a significant alteration in the ion concentrations and activities in different enzymes in the brain. The Y-maze test showed that exposure to TiO2 nanoparticles can considerably harm the spatial recognition memory. TiO2 nanoparticles also impaired homeostasis of trace elements, neurotransmitter systems and enzymes in the mouse brain. There were significant changes in the contents of Mg, Na, Ca, Fe, K and Zn in the brain. TiO2 nanoparticles also considerably inhibited the activities of\nToxicity of Titanium Dioxide (TiO2) Nanoparticles 17\nCa+2-ATPase, Ca + 2/Mg + 2ATPase, Na +/K+-ATPase, nitric oxide synthase and acetylcholine esterase. Some monoamine neurotransmitters, e.g., norepinephrine, dopamine, 5-HT and its metabolite 5-HIAA, significantly decreased, whereas glutamate, acetylcholine and NO were significantly increased. Another study also revealed that TiO2 nanoparticles accumulate and induce reactive oxygen species in mouse hippocampus, cause hippocampal apoptosis and impair spatial recognition memory in mice. Caspase-3 and caspase-9 were activated, Bcl-2 was inhibited and the levels of Bax and cytochrome c were promoted significantly [134].\nThe findings of Sang et al. [139] suggest that long-term (90 days) intragastric exposure to low-dose TiO2 nanoparticles may result in spleen injury, significant increase in the spleen indices, histopathological changes, splenocyte apoptosis and reduction of immune capacity, due to alteration of inflammatory and apoptotic cytokine expression and decreased immunoglobulin, blood cells, platelets, haemoglobin and lymphocyte. Intragastric exposure to 5–6-nm-sized TiO2 nanoparticles at the dose of 2.5, 5 and 10 mg/kg every day for 90 days caused chronic spleen injury in ICR mice [139]. This also led to decreased blood cells, platelets, lymphocyte subsets (e.g. CD3, CD4, CD8, B cell, natural killer cell), haemoglobin, immunoglobulin and Bcl-2 and heat shock protein 70 expression and increased levels of necrosis factor-κB, tumour necrosis factor-α, interleukin-2, IL-4, IL-6, IL-8, IL10, IL-18, IL-1β, cross-reaction protein, transforming growth factor-β, interferon-γ, Bax and CYP1A1 expression. Longterm exposure to low-dose TiO2 nanoparticles may cause spleen injury, due to change in the expression of inflammatory and apoptotic cytokines and reduced immune capacity.\nLi et al. [144] treated female CD-1 (ICR) mice with anatase TiO2 at the dose of 5, 10, 50, 100 and 150 mg/kg for 14 consecutive days by intra-abdominal injections and observed a dose-dependent increase in Ti liver content and TiO2 bound on DNA, causing changes in DNA conformation and induced DNA cleavage.\nGui et al. [136] evaluated the nephrotoxicity, distribution, oxidative stress and gene expression profile in kidney using whole-genome microarray analysis technique in mice with intragastric exposure and found a significant decrease in the number of renal glomerulus, infiltration of inflammatory cells, tissue apoptosis and necrosis of renal tubules, reduction in body weight, unbalanced element distribution, increased kidney indices, reactive oxygen species production and lipid peroxidation, and protein and DNA peroxidation in the renal tissue of mouse. Most of the genes were related to inflammatory or immune responses, apoptosis, cell structure, biological and metabolic processes, oxidative stress, ion transport, cell cycle, signal transduction, transcription, translation and cell differentiation [136].\nIntragastric administration of TiO2 nanoparticles reduces fertility and causes injury of mouse ovaries. TiO2\nnanoparticles deposited in the ovary result in a significant reduction in body weight, relative weights of the ovaries and fertility, alterations in haematological and serum parameters and levels of sex hormones, increases in atretic follicles, inflammation and necrosis. In addition, exposure to TiO2 nanoparticles resulted in marked alterations in the expressions of proteins and enzymes [140]."
    }, {
      "heading" : "Abdominal/Intra-abdominal Exposure",
      "text" : "Abdominal exposures of mouse to anatase TiO2 nanoparticles caused oxidative stress and nephritis to the kidney. Coefficients of the kidney increased and titanium accumulated in the kidney. Histopathological changes in the kidney and an increase in the generation of reactive oxygen species and lipid peroxidation were observed. Antioxidants such as glutathione and ascorbic acid decreased. Activities of superoxide dismutase, catalase, ascorbate peroxidase and total antioxidant capacity were also decreased. In addition, the increase of creatinine, calcium and phosphonium and the reduction of uric acid and blood urea nitrogen represented the disrupted kidney functions [141].\nMa et al. [115] treated female CD-1 (ICR) mice with anatase TiO2 (5 nm) and bulk rutile TiO2 (10–15 μm) at the dose of 5–150 mg/kg body weight anatase TiO2 nanoparticles and 150 mg/kg bulk TiO2 every day for 14 days by intraabdominal injections. Biochemical serum parameters showed t h a t ALT, ALP, AST, l a c t a t e d ehyd r og en a s e , pseudocolinesterase, leucine acid peptide, total cholesterol and high-density lipoprotein cholesterol were increased by both particles, while albumin, globulin and triglycerides were increased and low-density lipoprotein cholesterol decreased by anatase TiO2. Histology revealed basophilia, ischemia and vein congestion (both TiO2) and apoptosis induced by anatase TiO2. Inflammatory action was obvious from the increased NF-κB, migration inhibitory factor, tumour necrosis factor-α, interleukin-6, interleukin-1β, cross-reaction protein, interleukin-4 and interleukin-10 by anatase TiO2. Liu et al. [114] treated female CD-1 (ICR) mice with anatase nanoparticles (5 nm) and bulk rutile (10–15 μm) at the dose of 5– 150 mg/kg anatase TiO2 and 150 mg/kg bulk TiO2 every day for 14 days using intra-abdominal injections. Uric acid and blood urea nitrogen were decreased by both TiO2. Zhao et al. [140] treated mice with anatase TiO2 nanoparticles by intra-abdominal injections. Decreased creatinine and Ca2+; increased phosphonium, blood urea nitrogen and uric acid; increased ROS and lipid peroxidation; and decreased SOD, catalase, ascorbate peroxidase, total antioxidant capacity, glutathione and ascorbic acid content were observed.\nSimilarly in another study, Ma et al. [116] found that 5 nm anatase TiO2 nanoparticles for 14 days injected to the abdominal cavity translocate to and accumulate in the brain and\n18 Shakeel et al.\nT ab\nle 1\nT iO\n2 ex po su re\nth ro ug h th e re sp ir at or y sy st em\nR ef er en ce\nM od el an im\nal /s ex /a ge\nN P si ze /ty\npe D os e\nE xp os ur e (o rg an s/ tis su es )\nO bs er va tio\nns /r es ul ts /in\nfe re nc e\nG us ta fs so n et al .[ 67 ]\nM al e D ar k A go ut ir at s\nP2 5 D eg us sa\nT iO\n2 1, 5 an d 7. 5 m g/ kg bo dy w ei gh t\nIn tr at ra ch ea li ns til la tio\nn In fl am\nm at or y ac tio\nn: tr an si en t\nin cr ea se\nin E O Ss\nan d N E U s\nin B A L ,f ol lo w ed\nby a\nre cr ui tm\nen to\nf D C s an d N K s.\nE le va te d le ve ls of\nIL -1 ,I L -2 ,\nIL -6 ,C\nIN C -1\nan d G M -C SF\nH us sa in\net al .[ 75 ]\nM al e m ic e\nA na ta se\nT iO\n2 (1 5 m m )\n40 μ L of\na N P su sp en si on\n(0 .4\nm g/ m L (∼ 0. 8 m g/ kg )\nO ro ph ar yn ge al as pi ra tio\nn A ir w ay\nre ac tiv\nity :i nc re as ed by T iO 2 in T D Ise ns iti ze d m ic e\nIn fl am\nm at or y ac tio\nn: T iO\n2 in cr ea se d N E U s an d A M s in B A L of\nT D Ise ns iti ze d m ic e\nN em\nm ar\net al .[ 61 ]\nM al e W is ta r ra ts\nR ut ile\nFe -d op ed\nna no ro d\nT iO\n2 (l en gt h 80 ;d\nia m et er\n7) 1. 5 m g/ kg\nIn tr at ra ch ea li ns til la tio\nn In fl am\nm at or y ac tio\nn: N E U s an d\nIL -6\nin cr ea se d;\nSO D ac tiv ity de cr ea se d in B A L H is to lo gy :i nf la m m at or y ce ll in fi ltr at io n\nH al ap pa na va r et al .[ 37 ]\nFe m al e tim\nem at ed\nC 57 B L /6 B om\nTa c m ic e\n1 h da ily\nto 42 .4 ± 2. 9 (S E M ) m g\nsu rf ac eco at ed\nna no -T iO\n2 /m\n3\nfo r 11\nco ns ec ut iv e da ys\nIn fl am\nm at or y ac tio\nn: in cr ea se d\nN E U s an d LY\nM s; de cr ea se d A M s in\nB A L\nH ou ga ar d et al .[ 36 ]\nFe m al e tim\nem at ed\nC 57 B L /6 B om\nTa c m ic e\n21 nm\n,a ve ra ge\ncr ys ta lli te si ze\nae ro so liz ed\npo w de r 97 nm (p ea k si ze ) ru til e el on ga te d m od if ie d w ith A l, Si an d Z r an d co at ed w ith po ly al co ho ls\n42 .4 ± 2. 9 T iO\n2 m g/ m\n3 fo r 1 h\na da y on\nge st at io n da ys\n8– 18\nIn ha la tio\nn In fl am\nm at or y ac tio\nn: in cr ea se d\nN E U s an d LY\nM s; de cr ea se d A M s in\nB A L\nM or im\not o et al .[ 44 ]\nM al e W is ta r ra ts\nR ut ile\nT iO\n2 51\n± 9 nm\n2. 8E\n+ 05 /c m\n3 fo r 4 w ee ks\n(6 h/ da y)\nIn ha la tio\nn In fl am\nm at or y ac tio\nn: no\nef fe ct\nL ep pä ne n et al .[ 45 ]\nM al e m ic e\nPr im\nar y pa rt ic le si ze\n20 nm ; ge om et ri c m ea n di am et er s of 91 ,1 13 an d 13 0 nm an at as e + br oo ki te (3 :1 )\n8– 30\nm g/ m\n3 fo r 0. 5 h (a cu te ex po su re ); 30\nm g/ m\n3 fo r\n1 h a da y, 4 da ys a w ee k fo r 4 w ee ks\n(s ub -c hr on ic\nex po su re )\nIn ha la tio\nn A ir fl ow\nlim ita tio\nn ef fe ct :r ed uc tio n in ex pi ra to ry fl ow in al lt he ex po su re si tu at io ns\nIn fl am\nm at or y ac tio\nn: no\nef fe ct\nC ho\net al .[ 71 ]\nFe m al e W is ta r ra ts\nT iO\n2 (3 0– 40 )\n50 an d 15 0 cm\n2 /r at\nIn tr at ra ch ea li ns til la tio n\nIn fl am\nm at or y ac tio\nn in\nB A L an d\nhi st ol og y of\nth e lu ng :n\no ef fe ct\nTa ng\net al .[ 66 ]\nM al e Sp\nra gu eD aw\nle y ra ts\nA na ta se\nT iO\n2 (5 ± 1)\n0. 8, 4 an d 20\nm g/ kg\nIn tr at ra ch ea li ns til la tio\nn H is to lo gy :A\nM in cr ea se ,l un g ga ps\nex pa nd ed ,h yp er em\nia ,\nal ve ol ar\nth ic kn es s\nTa ng\net al .[ 59 ]\nM al e Sp\nra gu eD aw\nle y ra ts\nT iO\n2 (5 )\n0. 8, 4 an d 20\nm g/ kg\nIn tr at ra ch ea li ns til la tio n\nT iO\n2 N P ag gr eg at io n:\npr es en t\nin lu ng\nat th e lo w es td\nos es\nH is to lo gy :l un g ga ps\nex pa nd ed ,\nhy pe re m ia\nL iu\net al .[ 68 ]\n3 m al e an d 3 fe m al e Sp ra gu eD aw\nle y ra ts\npe r gr ou p\n5 an d 20 0 nm\n0. 5, 5 or\n50 m g/ kg\nIn tr at ra ch ea li ns til la tio n\nA M\nph ag oc yt ic an d ch em\not ac tic\nab ili ty :r ed uc ed\nby T iO\n2 N Ps\nToxicity of Titanium Dioxide (TiO2) Nanoparticles 19\nT ab\nle 1\n(c on tin\nue d)\nR ef er en ce\nM od el an im\nal /s ex /a ge\nN P si ze /ty\npe D os e\nE xp os ur e (o rg an s/ tis su es )\nO bs er va tio\nns /r es ul ts /in\nfe re nc e\nL ie ta l. [5 4]\nM al e K un m in g m ic e\nA na ta se\nT iO\n2 (3 )\n3. 3 m g/ kg\nT iO\n2 on ce\na w ee k\nfo r 4 w ee ks\nIn tr at ra ch ea li ns til la tio\nn In fl am\nm at or y ac tio\nn: A C P an d A L P\nin cr ea se d in\nB A L\nH is to lo gy :d\nes tr oy ed\nal ve ol ar\nw al ls\nSc ur ie ta l. [3 5]\nW ea nl in g (2 -w\nee kol d) ,\nne w bo rn\n(2 -d ay -o ld ),\nad ul t( 12 -w\nee kol d)\nm al e an d fe m al e Fi sc he r 34 4 ra ts\nP2 5 D eg us sa\nT iO\n2 (2 1)\n12 m g/ m\n3 ;5\n.6 h/ da y fo r 3 da ys\nIn ha la tio\nn N eu ro tr op hi n ex pr es si on :N\nG F, B D N F\nan d th ei r re ce pt or s in cr ea se d in 2- da yol d an d 2- w ee kol d ra ts\nA ir w ay\nre si st an ce :i nc re as ed in 2- w ee kol d m ic e\nR os si et al .[ 43 ]\nFe m al e B A L B /c /S ca m ic e\nSi lic aco at ed\nru til e T iO\n2 (∼ 10\n× 40 )\nR ut ile\nT iO\n2 (< 5 μ m )\n10 ± 2 m g/ m\n3 T iO\n2 fo r 2 h a\nda y, 3 da ys\na w ee k, fo r 4 w ee ks\nIn ha la tio\nn In fl am\nm at or y ac tio n:\nE O Ss ,L\nY M s, A M s,\nPA S+\ngo bl et ce lls ,I L -1 β ,T\nN Fα ,I L -4 ,\nIL -1 3 an d IL -1 0 de cr ea se d by si lic a T iO 2\nA ir w ay\nre ac tiv\nity :d\nec re as ed\nby si lic a\nT iO\n2; in cr ea se d by\nfi ne\nT iO\n2\nM oo n et al .[ 11 0]\nB A L B /c m ic e\nP2 5 T iO\n2 (2 1)\n40 m g/ kg\nIn tr ap er ito\nne al in je ct io ns\nIn fl am\nm at or y ac tio n:\nN E U s, T PC\n;T N Fα ,\nIL -1 β ,M\nIP 2 in cr ea se d by\nT iO\n2 or\nT iO\n2 + L PS\nC he n et al .[ 10 6]\nM al e an d fe m al e IC R m ic e ad ul t\n80 an d 11 0 nm\n,m os tly\nbe in g 10 0 nm\n;a na ta se\n0, 32 4, 64 8, 97 2, 12 96 ,1 94 4 or 25 92 m g/ kg\nIn tr ap er ito\nne al in je ct ed\nH is to lo gy :a lv eo la r se pt al th ic ke ni ng an d in te rs tit ia lp ne um on ia\nP ar k et al .[ 55 ]\nIC R m ic e\nP2 5 T iO\n2 (2 1)\n5, 20\nan d 50\nm g/ kg ) by a si ng le in tr at ra ch ea li ns til la tio\nn In tr at ra ch ea li ns til la tio\nn In fl am\nm at or y ac tio\nn: IL -1 ,T\nN Fα ,I L -6 , IL -1 2, IF N -γ ,I L 4, IL -5 ,I L -1 0 an d Ig E in cr ea se d in B A L H is to lo gy :i nf la m m at or y pr ot ei ns , gr an ul om as G en e ex pr es si on :u pre gu la tio n of ge ne s in vo lv ed in an tig en pr es en ta tio n an d im m un e ce ll ch em ot ax is\nSa ge r an d\nC as tr an ov a [5 8]\nM al e Fi sc he r C D F (F 34 4/ D uC\nrl ) ra ts\nP2 5 T iO\n2 (2 1)\n0. 26 –1 .0 4 m g/ ra t\nIn tr at ra ch ea li ns til la tio n\nIn fl am\nm at or y ac tio\nn: in cr ea se\nin PM\nN s,\nA L B an d L D H in\nB A L\nL iu\net al .[ 57 ]\nM al e an d fe m al e Sp ra gu eD aw\nle y ra ts\n5, 21\nan d 50\nnm T iO\n2\npr im\nar y pa rt ic le s\n0. 5, 5 or\n50 m g/ kg\nIn tr at ra ch ea li ns til la tio\nn In fl am\nm at or y ac tio\nn: L D H an d A L P\nin cr ea se d in\nth e lu ng\nby 5 an d 50\nnm T iO\n2 H is to lo gy :i nf la m m at or y in fi ltr at io n, al ve ol ar w al lt hi ck en in g A M ph ag oc yt ic ab ili ty :a lte re d by 5 an d 50 nm T iO 2\nM aH oc k et al .[ 39 ]\nM al e W is ta r ra ts\nR ut ile -a na ta se\nT iO\n2 m ix tu re\n(2 5. 1)\nA er os ol s of\n2, 10\nan d 50\nm g/ m\n3\nfo r 6 h/ da y fo r 5 da ys\nIn ha la tio\nn In fl am\nm at or y ac tio n:\nPM N s, G G T,\nT PC\n,L D H ,A\nL P an d N A G\nin cr ea se d in\nB A L\nC el lr ep lic at io n:\nin cr ea se d in\nbr on ch i\nan d br on ch io le s\nva n R av en zw\naa y\net al .[ 27 ]\nM al e W is ta r ra ts\nA na ta se -r ut ile\nT iO\n2 m ix tu re\n(2 0– 30 )\nR ut ile\nT iO\n2 (2 00 )\nIn ha la tio\nn: ae ro so ls of\n10 0\nan d 25 0 m g/ m\n3 un co at ed\nIn ha la tio n In tr av en ou s in je ct io n\n20 Shakeel et al.\nT ab\nle 1\n(c on tin\nue d)\nR ef er en ce\nM od el an im\nal /s ex /a ge\nN P si ze /ty\npe D os e\nE xp os ur e (o rg an s/ tis su es )\nO bs er va tio\nns /r es ul ts /in\nfe re nc e\nan d pi gm\nen ta ry\nT iO\n2 , re sp ec tiv el y, fo r 6 h/ da y on 5 co ns ec ut iv e da ys . In tr av en ou s in je ct io ns : 5 m g/ kg\nT iO\n2 di st ri bu tio n:\nlu ng\nan d m ed ia st in al\nly m ph\nno de\naf te r in ha la tio\nn; m os tly\nliv er\nan d sp le en\naf te r in je ct io n\nIn fl am\nm at or y ac tio\nn: bo th\nT iO\n2\nin cr ea se d T C C ,P\nM N s, T PC\n,A L P,\nL D H ,G\nG T an d N A G in\nB A L\nK ob ay as hi\net al .[ 56 ]\nM al e C rl :C D (S D ) ra ts\nA na ta se\nT iO\n2 (4 .9 ) (1 st an d\n2n d ex pe ri m en ts )\nA na ta se\nT iO\n2 (2 3. 4)\nA na ta se\nT iO\n2 (1 54 .2 )\n5 m g/ kg\nIn tr at ra ch ea li ns til la tio n\nIn fl am\nm at or y ac tio\nn: 1s t: 4. 9 an d\n23 .4\nnm T iO\n2 N Ps\nin cr ea se d T C C ,\nN E U s, L D H ;2\nnd :a gg lo m er at ed\nT iO\n2\nin cr ea se d T C C ,N\nE U s, L D H\nH is to lo gy :e pi th el iu m\nhy pe rt ro ph y\nin al lt re at ed\ngr ou ps\nL ar se n et al .[ 11 7]\nIn br ed\nfe m al e B A L B /c J\nm ic e\nT iO\n2 (2 8)\nIm m un iz at io n w ith\n1 μ g O V A\nal on e or\nin co m bi na tio n w ith\nei th er\n2, 10 ,5 0 or\n25 0 μ g T iO\n2\nIn tr ap er ito\nne al in je ct io ns\nO V A -s pe ci fi c an tib od ie s in\nse ru m :T\niO 2\nin cr ea se d Ig E an d Ig G 1 le ve ls co m pa re d to th e O V A co nt ro ls\nIn fl am\nm at or y ac tio\nn: E O Ss ,N\nE U s,\nLY M s, IL -4\nan d IL -5\nin cr ea se d\nin B A L\nM üh lf el d et al .[ 26 ]\nM al e W K Y /N C rl B R ra ts\n10 ra ts w er e ex po se d to\n0. 11\nm g/ m\n3 T iO\n2 ae ro so ls fo r 1 h\nIn ha la tio\nn T iO\n2 di st ri bu tio\nn: co nn ec tiv\ne tis su e an d\nth e ca pi lla ry\nlu m en\nw er e th e\npr ef er en tia lt ar ge to\nf N Ps\nat 1 an d\n24 h, re sp ec tiv\nel y\nToxicity of Titanium Dioxide (TiO2) Nanoparticles 21\nT ab\nle 2\nT iO\n2 ex po su re\nth ro ug h th e ne rv ou s sy st em\nR ef er en ce\nM od el an im\nal /s ex /a ge\nN P si ze /ty\npe D os e\nE xp os ur e (o rg an s/ tis su es )\nO bs er va tio\nns /r es ul ts /in\nfe re nc e\nJe on\net al .[ 14 3]\nM ou se\nT iO\n2 (B ra in )\nPr ot eo m ic an al ys is :a lte re d pr ot ei n ex pr es si on O xi da tiv e st re ss :a nt io xi da nt an d A ch E ac tiv iti es re du ce d\nY am\nas hi ta et al .[ 12 7]\nPr eg na nt\nm ic e\n35 nm\n0. 8 m g T iO\n2 fo r 2 co ns ec ut iv e\nge st at io na ld\nay s\nIn tr av en ou s in je ct io n\nT id\nis tr ib ut io n:\nT iO\n2 de te ct ed\nin fo et al br ai n\nL ie ta l. [5 4]\nM al e K un m in g m ic e\nA na ta se\nT iO\n2 (3 )\n3. 3 m g/ kg\nT iO\n2 on ce\na w ee k\nfo r 4 w ee ks\nIn tr at ra ch ea li ns til la tio n\nT ib\nra in\nco nt en t: in cr ea se d ox id at iv e st re ss :\nO 2 − ,O\nH − ,H\n2 O 2 ,M\nD A in cr ea se d in\nth e\nbr ai n H is to lo gy :e xu da te s, in fl am\nm at or y in fi ltr at io n\nan d ne cr os is\nH u et al .[ 13 8]\nFe m al e m ic e\nA na ta se\nT iO\n2 (5 )\n0, 5, 10\nan d 50\nm g/ kg\nbo dy\nw ei gh te ve ry\nda y fo r 60\nda ys\nIn tr ag as tr ic ad m in is tr at io n\nN eu ro tr an sm\nitt er s: A C h, G lu ,a nd\nN O in cr ea se d;\nN E ,D\nA ,D\nO PA\nC ,5 -H\nT an d 5- H IA\nA de cr ea se d\nE nz ym\ne ac tiv\nity :d\nec re as ed\nN a+ /K\n+ ,C\na2 + ,\nC a2\n+ /M\ng2 + A T P as e; pr om\not ed\nA ch E an d iN O S\nSh in\net al .[ 11 1]\nM al e C 57 B L /6\nm ic e\n< 1 μ m\nru til e, 21\nnm (P 25 )\n40 m g/ kg\nT iO\n2 30\nm in\naf te r\nve hi cl e or\n5 m g/ kg\nL PS\nIn tr ap er ito\nne al in je ct io ns\nIn fl am\nm at or y ac tio\nn: af te r L PS\n,T iO\n2 N Ps\nin cr ea se d\nIL -1 β ,T\nN Fα an d iN O S an d in du ce d m ic ro gl ia l\nac tiv\nat io n O xi da tiv e st re ss :a ft er\nL PS\nT iO\n2 N Ps\nen ha nc ed\nR O S\nM a et al .[ 11 6]\nFe m al e IC R m ic e\n5– 15\nnm an at as e\n5– 15 0 m g/ kg\nna no -T iO\n2 an d\n15 0 m g/ kg\nbu lk\nT iO\n2 ev er y\nda y fo r 14\nda ys ,r es pe ct iv el y\nA bd om\nin al ca vi ty\nin je ct io n\nT ib\nra in\nco nt en t: hi gh er\nin cr ea se\nw ith\nna no -T iO 2 O xi da tiv e st re ss :O 2 − ,H 2 O 2 ,M D A ,N O S, iN O S an d N O in cr ea se d; an tio xi da tiv e en zy m es , G L U an d A ch E de cr ea se d H is to lo gy :f ila m en to us -s ha pe d ne ur on s an d in fl am m at or y ce lls\nTa ka ha sh ie ta l. [1 21 ]\nPr eg na nt\nSl c: IC R m ic e\nA na ta se\nT iO\n2 (2 5– 70 )\n10 0 μ L of\nT iO\n2 at 1 m g/ m L at\nge st at io na ld\nay s 6, 9, 12 ,1 5\nan d 18\nSu bc ut an eo us\nin je ct io ns\nM on oa m in e le ve ls :D\nA ,D\nO PA\nc, H V A an d 3- M T\nin cr ea se d in\nth e pr ef ro nt al co rt ex\nan d ne os tr ia tu m\nTa ke da\net al .[ 11 8]\nPr eg na nt\nSl c: IC R m ic e\nA na ta se\nT iO\n2 (2 5– 70 )\n10 0 μ L of\nT iO\n2 at 1 m g/ m L at 3,\n7, 10\nan d 14\nda ys\npo st -c oi tu m\nSu bc ut an eo us\nin je ct io ns\nT iO\n2 of fs pr in g br ai n di st ri bu tio n:\nco rt ex\nan d\nol fa ct or y bu lb\nA po pt os is :p\nre se nc e of\nm ar ke rs an d fe at ur es in ol fa ct or y ce lls\nSh im\niz u et al .[ 12 0]\nPr eg na nt\nIC R m ic e, m al e\nfo et us es\nan d pu ps\nA na ta se\nT iO\n2 (2 5– 70 )\n10 0 μ L of\nT iO\n2 at 1 μ g/ μ L on\nge st at io na ld\nay s 6, 9, 12\nan d 15\nSu bc ut an eo us\nin je ct io ns\nG en e ex pr es si on :u\npre gu la te d ce ll de at h, ap op to si s,\nbr ai n de ve lo pm\nen t, ox id at iv e st re ss ,a po pt os is ,\nne ur ot ra ns m itt er ge ne s\nW an g et al .[ 86 ]\nFe m al e C D m ic e\n25 ,8 0 an d 15 5 nm\nT iO\n2 50\nm g/ kg\nT iO\n2 B W\nev er y ot he r\nda y fo r 20\nda ys\nIn tr an as al in st ill at io n\nT ib\nra in\nco nt en t: in cr ea se d.\nN eu ro tr an sm\nitt er s: N E an d 5- H T in cr ea se d;\nD A ,\nD O PA\nC ,H\nV A ,a nd\n5- H IA\nA de cr ea se d\nW an g et al .[ 81 ]\nFe m al e C D -1\n(I C R ) m ic e\nR ut ile\nT iO\n2 (8 0)\nA na ta se\nT iO\n2 (1 55 )\n50 0 μ g T iO\n2 ev er y ot he r da y\nfo r 15\ntim es\nIn tr an as al in st ill at io n\nT ib\nra in\ndi st ri bu tio\nn: m ai nl y in\nth e ol fa ct or y bu lb\nan d\nhi pp oc am\npu s\nO xi da tiv\ne st re ss :C\nA T,\nM D A ,P\nr. ca rb .i nc re as ed ;\nSO D de cr ea se d\nN eu ro tr an sm\nitt er s: A ch E ,G\nlu an d N O in cr ea se d\nW an g et al .[ 82 ]\nFe m al e C D -1\n(I C R ) m ic e\nR ut ile\nT iO\n2 (8 0)\nA na ta se\nT iO\n2 (1 55 )\n50 0 μ g T iO\n2 ev er y ot he r da y\nfo r 15\ntim es\nIn tr an as al in st ill at io n\nT ib\nra in\ndi st ri bu tio\nn: m ai nl y in\nth e hi pp oc am\npu s\nO xi da tiv e st re ss :G\nSH -P x, G ST\n,S O D ,G\nSH an d\nM D A in cr ea se d H is to lo gy :i rr eg ul ar\nne ur on al ar ra ng em\nen t, co nd en sa te d\nch ro m at in\nIn fl am\nm at or y ac tio n:\nin cr ea se d T N Fα an d IL -1 β le ve ls\n22 Shakeel et al.\nT ab\nle 3\nT iO\n2 ex po su re\nth ro ug h th e de rm\nal an d m uc os al sy st em\nR ef er en ce\nM od el an im\nal /s ex /a ge\nN P si ze /ty\npe D os e\nE xp os ur e (o rg an s/ tis su es )\nO bs er va tio\nns /r es ul ts /\nin fe re nc e\nFu ru ka w a et al .[ 16 ]\nC D -1\n(I C R ) fe m al e m ou se\nC oa te d T iO\n2 (l on g ax is 50 –1 00 ;s ho rt ax is 10 –2 0)\n5, 10\nan d 20\nm g/ an im\nal in\nth e\npo st -i ni tia tio\nn ph as e in\na sk in\nca rc in og en es is m od el\nC ut an eo us\nap pl ic at io n\nC ar ci no ge ni ci ty :n\no in cr ea se d de ve lo pm\nen t\nof sk in\nno du le s\nM oo n et al .[ 10 9]\nM ic e\nT iO\n2 (< 25\nor < 10 0 nm\n) O nc e a da y fo r 28\nco ns ec ut iv e\nda ys\nbe fo re\nsu bc ut an eo us\nim pl an ta tio\nn w ith\nB 16 F1 0 m el an om a ce lls\nIn tr ap er ito\nne al in je ct io ns\nT um\nou r gr ow\nth :i nc re as ed\nA da ch ie ta l. [1 49 ]\nM al e ha ir le ss\nW is ta r\nY ag ir at s\nW /O\nem ul si on\nco nt ai ni ng\nan at as e T iO\n2 (2 6. 4 ± 9. 5)\n4 m g/ cm\n2 T iO\n2 on\ndo rs al sk in\nC ut an eo us\nap pl ic at io n\nT iO\n2 ab so rp tio\nn: T iO\n2 de te ct ed\nin th e ho rn y\nla ye r of\nth e in te rf ol lic ul ar\nep id er m is\nS ad ri eh\net al .[ 11 ]\nFe m al e Y uc at an\nm in ip ig s\nP2 5 D eg us sa\nT iO\n2 (3 0– 50 )\nR ut ile\nT iO\n2 co at ed\nw ith\nal um\nin iu m\nhy dr ox id e/\ndi m et hi co ne\nco po ly m er\n(d ia m et er\n20 –3 0,\nle ng th\n50 –1 50 )\nS ub m ic ro n T iO\n2 (3 00 –5 00 )\n2 m g cr ea m /c m\n2 sk in (4 ap pl ic at io ns /d ay ,5\nda ys /\nw ee k, 4 w ee ks )\nC ut an eo us\nap pl ic at io n\nT iO\n2 ab so rp tio\nn: T iO\n2 de te ct ed\nin th e up pe r\nst ra tu m\nco rn eu m\nan d fo lli cu la r lu m en ,w ith fe w pa rt ic le s ob se rv ed in de rm al la ye rs as co nt am in at io n re su lts\nW u et al .[ 19 ]\nM al e re ar ed\npi gs ,h ai rl es s m ic e (B A L B /c /n u/ nu )\nA na ta se\nT iO\n2 (5 ± 1, 10\n± 1)\nR ut ile\nT iO\n2 (2 5 ± 5, 60\n± 10 )\nP 25\nD eg us sa\nT iO\n2 (∼ 21 )\nT iO\n2 (0 .3 –0 .5\nμ m )\n24 m g T iO\n2 fo rm\nul at io ns\non th e\npi g ea r fo r 30\nda ys\nan d on\nth e\nm ou se\nin te rs ca pu la r sk in\nfo r\n60 co ns ec ut iv e da ys\nC ut an eo us\nap pl ic at io n\nT iO\n2 ab so rp tio\nn in\npi gs :T\niO 2 de te ct ed\nin th e\nst ra tu m\nco rn eu m ,g ra nu lo su m ,p ri ck le an d\nba sa lc el ll ay er ,n ot\nin th e de rm is T iO 2 ab so rp tio n in\nm ic e: in cr ea se d M D A ,\nre du ce d H Y P co nt en ta nd\nex ce ss iv e\nke ra tin\nis at io n in\nsk in\nY an ag is aw\na et al .[ 23 ]\nM al e C /N ga T nd C rj (N C /N ga ) m ic e\n15 ,5 0 or\n10 0 nm\nru til e\n20 μ g T iO\n2 In tr ad er m al in je ct io ns\nA to pi c de rm\nat iti s: al le rg en + T iO\n2 en ha nc ed\nea r\nth ic ke ni ng\nIn fl am\nm at or y ac tio\nn: al le rg en + T iO\n2 in cr ea se d\nE O S s; IL -4 ,M\nC s an d de cr ea se d IF N -γ ;T\niO 2\nin cr ea se d IL -1 3\nToxicity of Titanium Dioxide (TiO2) Nanoparticles 23\nT ab\nle 4\nT iO\n2 ex po su re\nth ro ug h th e ca rd io va sc ul ar\nsy st em\nR ef er en ce\nM od el an im\nal /s ex /a ge\nN P si ze /ty\npe D os e\nE xp os ur e (o rg an s/ tis su es )\nO bs er va tio\nns /r es ul ts /in\nfe re nc e\nN em\nm ar et al .[ 61 ]\nM al e W is ta r ra ts\nR ut ile\nF edo pe d (9\n% ) pu re\n(T iO\n2 ) na no ro ds\n(l en gt h 80 ;\ndi am\net er\n7)\n1 an d 5 m g/ kg\nIn tr at ra ch ea li ns til la tio\nn C ar di ov as cu la r pa ra m et er :H\nR an d\nS B P in cr ea se d\nC ou rt oi s et al .[ 73 ]\nM al e W is ta r or\nS pr ag ue -\nD aw\nle y ra t\nP2 5 D eg us sa\nT iO\n2 (1 5)\n10 0 μ g T iO\n2 in\n0. 5 m L sa lin\ne In tr at ra ch ea li ns til la tio\nn In tr al ob ar\nar te ri es\nva so m ot or\nre sp on se s\nto P G F 2α\n,K C l, A ch :n\not al te re d\nL eB\nla nc\net al .[ 33 ]\nM al e S pr ag ue -D\naw le y\nra ts\nP2 5 an at as eru til e T iO\n2 (2 1)\n6 m g/ m\n3 T iO\n2 fo r 24 0 m in\nIn ha la tio\nn C or on ar y ar te ri ol ar\nen do th el iu m\ndi la tio n: im pa ir ed by T iO 2\nO xi da tiv\ne st re ss :R\nO S in cr ea se d in\nco ro na ry\nm ic ro va sc ul ar\nw al ls\nL eB\nla nc\net al .[ 31 ]\nM al e S pr ag ue -D\naw le y\nra ts\nP2 5 an at as eru til e T iO\n2 (2 1)\n6 m g/ m\n3 T iO\n2 fo r 24 0 m in\nIn ha la tio\nn C or on ar y ar te ri ol ar\nen do th el iu m :T\niO 2\nin cr ea se d sp on ta ne ou s ar te ri ol ar\nto ne\nan d im\npa ir ed\nfl ow\nan d va so di la to r\nin du ce d di la tio\nn\nN ur ki ew\nic z et al .[ 30 ]\nM al e S pr ag ue -D\naw le y\nra ts\nP2 5 an at as eru til e T iO\n2 (2 1)\nR ut ile\nT iO\n2 (1\nμ m )\n1. 5– 16\nm g/ m\n3 T iO\n2 fo r\n24 0– 72 0 m in\nIn ha la tio\nn Sp\nin ot ra pe zi ou s ar te ri ol ar\nen do th el iu m\ndi la tio\nn: im\npa ir ed\nby bo th\nT iO\n2\nB ih ar ie ta l. [1 04 ]\nM al e C 57 B L /6 N cr lm\nic e\nR ut ile\nT iO\n2 (∼ 10\n× 40 )\n1 m g/ kg\nT iO\n2 10\nm in\nbe fo re\nth ro m bo si s in du ct io n\nIn tr av en ou s ad m in is tr at io n\nM es en te ri c an d cr em\nas te ri c th ro m bo si s:\nno td\net er m in ed\nB u et al .[ 92 ]\nM al e an d fe m al e W is ta r ra ts\nR ut ile -a na ta se\nT iO\n2 m ix tu re\n(< 50 )\n0. 16 ,0 .4\nan d 1 g/ kg\npe r da y\nfo r 14\nda ys\nIn tr ag as tr ic ad m in is tr at io n\nB io ch em\nic al pa ra m et er s: in cr ea se d C K\nan d L D H\nL iu\net al .[ 11 4]\nF em\nal e C D -1\n(I C R ) m ic e\nA na ta se\nT iO\n2 (5 )\nB ul k ru til e T iO\n2\n(1 0– 15\nμ m )\n5– 15 0 m g/ kg\nB W\nan at as e T iO\n2\nan d 15 0 m g/ kg\nbu lk\nT iO\n2\nev er yd ay\nfo r 14\nda ys\nIn tr aab do m in al in je ct io ns\nB io ch em\nic al pa ra m et er s: C K ,L\nD H ,A ST an d al ph aH B D H w er e in cr ea se d by bo th T iO 2\nC he n et al .[ 10 6]\nm al e an d fe m al e IC R m ic e\nA na ta se\nT iO\n2 80\nan d\n11 0 nm\n,m os tly\nbe in g\n10 0 nm\n;\n0, 32 4, 64 8, 97 2, 12 96 ,1 94 4 or 25 92 m g kg –1\nIn tr ap er ito\nne al in je ct io n:\nV as cu la r sy st em\n:p ul m on ar y th ro m bo si s\nW an g et al .[ 91 ]\nM al e an d fe m al e C D -1 (I C R ) m ic e\nT iO\n2 25 ,8 0 an d 15 5 nm\n5 g/ kg\nIn tr ag as tr ic ad m in is tr at io n\nB io ch em\nic al pa ra m et er s: 80\nan d 25 nm T iO 2 in cr ea se d L D H an d al ph aH B D H co m pa re d to co nt ro ls an d th e fi ne\ngr ou p\n24 Shakeel et al.\nT ab\nle 5\nT iO\n2 ex po su re\nth ro ug h th e liv\ner\nR ef er en ce\nM od el an im\nal /s ex /a ge\nN P si ze /ty\npe D os e\nE xp os ur e (o rg an s/ tis su es )\nO bs er va tio\nns /r es ul ts /in\nfe re nc e\nY am\nas hi ta et al .[ 12 7]\nPr eg na nt\nm ic e\nT iO\n2 (3 5)\n0. 8 m g T iO\n2 fo r 2 co ns ec ut iv e\nge st at io na ld\nay s\nIn tr av en ou s in je ct io n\nT id\nis tr ib ut io n:\nT iO\n2 de te ct ed\nin fo et al liv\ner\nN em\nm ar\net al .[ 61 ]\nM al e W is ta r ra ts\nR ut ile\nF edo pe d (9\n% )\npu re\n(T iO\n2 ) na no ro ds\n(l en gt h 80 ;d\nia m et er\n7)\n1 an d 5 m g/ kg\nIn tr at ra ch ea l in st ill at io n\nB io ch em\nic al pa ra m et er s: A S T an d\nA LT\nin cr ea se d H is to lo gy :i nf la m m at or y ce ll in fi ltr at io n, m ai nl y LY M s\nTa ng\net al .[ 66 ]\nM al e Sp\nra gu eD aw\nle y\nra ts\nA na ta se\nT iO\n2 (5 ± 1)\n0. 8, 4 an d 20\nm g/ kg\nIn tr at ra ch ea l in st ill at io n\nB io ch em\nic al pa ra m et er s: A L B an d G L U\nin cr ea se d 1H N M R se ru m\nan al ys is :k\net on e bo di es ,\nch ol in e, L D L ,a la ni ne\nan d G L U in cr ea se d;\nla ct at e, cr ea tin\ne an d py ru va te de cr ea se d\nT E M\nan al ys is :s w ol le n he pa to cy te s; co ng es te d\nsi nu so id s\nTa ng\net al .[ 59 ]\nM al e Sp\nra gu eD aw\nle y\nra ts\nT iO\n2 (5 )\n0. 8, 4 an d 20\nm g/ kg\nIn tr at ra ch ea l in st ill at io n\nB io ch em\nic al pa ra m et er s: A LT\nin cr ea se d\n1H N M R ur in e an al ys is :i nc re as e in\nva lin e, la ct at e, ac et at e, su cc in at e, 2- O G ,c re at in in e, ta ur in e, T M A O ,a lla nt oi n an d hi pp ur at e 1- 2; de cr ea se in ci tr at e an d D M A\nL ie ta l. [1 44 ]\nFe m al e C D -1\n(I C R )\nm ic e\nA na ta se\nT iO\n2 5, 10 ,5 0, 10 0 an d 15 0 m g/ kg\nfo r\n14 co ns ec ut iv e da ys\nIn tr aab do m in al in je ct io ns\nT il iv er\nco nt en t: do se -d ep en de nt\nin cr ea se\nIn te ra ct io n w ith\nD N A :T\niO 2 w as\nbo un d on\nD N A ,\nca us ed\nch an ge s in\nD N A co nf or m at io n, in du ce d\nD N A cl ea va ge\nB u et al .[ 92 ]\nM al e an d fe m al e W is ta r ra ts\nR ut ile -a na ta se\nT iO\n2\nm ix tu re\n(< 50 )\n0. 16 ,0 .4 an d 1 g/ kg\non ce\na da y fo r\n14 co ns ec ut iv e da ys\nIn tr ag as tr ic\nad m in is tr at io n\n1H N M R ur in e an al ys is :i nc re as e in\nα -k et og lu ta ra te ,\nhi pp ur at e, hi st id in e, T M A O ,t au ri ne ,c itr ul lin e, ac et at e, PA G an d ci tr at e le ve ls ;d ec re as e in m et hi on in e an d 3- D -H B le ve ls 1H N M R se ru m an al ys is :i nc re as e in T M A O , ch ol in e cr ea tin e, 3- D -H B an d ph os ph oc ho lin e; de cr ea se in gl ut am at e, ac et oa ce ta te ,g lu ta th io ne , m et hi on in e, gl ut am in e an d py ru va te H is to lo gy :n o al te ra tio ns\nC ui\net al .[ 13 2]\nFe m al e C D -1\n(I C R ) m ic e\nA na ta se\nT iO\n2 (6 .9 )\n5, 10\nan d 50\nm g/ kg\nT iO\n2 fo r 60\nco ns ec ut iv e da ys\nIn tr ag as tr ic\nad m in is tr at io n\nH is to lo gy :h\nep at oc yt e ap op to si s\nO xi da tiv\ne st re ss :O\n2 − ,H\n2 O 2 ,M\nD A ,N\nO in cr ea se d\nG en e ex pr es si on :S\nO D ,C\nA T,\nG SH\n-P x, M T,\nG ST , H S P 70 ,p 53 an d T F de cr ea se d; C Y P1 A in cr ea se d\nC ui\net al .[ 13 3]\nFe m al e C D -1\n(I C R ) m ic e\nA na ta se\nT iO\n2 (5 )\n5, 10\nan d 50\nm g/ kg\nT iO\n2 fo r 60\nco ns ec ut iv e da ys\nIn tr ag as tr ic\nad m in is tr at io n\nB io ch em\nic al pa ra m et er s: A LT\n,A ST\n,A L P,\nL D H ,P\nC hE\nan d L A P in cr ea se d\nIn fl am\nm at or y ac tio\nn: Ik B an d IL -2\nde cr ea se d;\nIK K 1,\nIK K 2, N FκB\n,N F -κ B P 52 –6 5, T N Fα ,N\nIK ,T\nL R -2\nan d T L R -4\nin cr ea se d\nH is to lo gy :f at ty\nde ge ne ra tio\nn, ne cr os is ,a po pt os is ,\nin fl am\nm at io n\nToxicity of Titanium Dioxide (TiO2) Nanoparticles 25\nT ab\nle 5\n(c on tin\nue d)\nR ef er en ce\nM od el an im\nal /s ex /a ge\nN P si ze /ty\npe D os e\nE xp os ur e (o rg an s/ tis su es )\nO bs er va tio\nns /r es ul ts /in\nfe re nc e\nD ua n et al .[ 13 7]\nFe m al e C D -1\n(I C R )\nm ic e\nA na ta se\nT iO\n2 (5 )\n62 .5 –2 50\nm g/ kg\nT iO\n2 fo r 30\nco ns ec ut iv e da ys\nIn tr ag as tr ic\nad m in is tr at io n\nB io ch em\nic al pa ra m et er s: A LT\n,A L P, A S T,\nL D H ,C\nhE ,T\nP, T G an d T C H O in cr ea se d;\nA L B /G L B an d T B IL\nde cr ea se d\nH is to lo gy :b\nlu rr ed\nhe pa to cy te s, co ng es te d ve ss el s\nW an g et al .[ 15 4]\nM al e Sp\nra gu eD aw\nle y\nra ts\nA na ta se\nT iO\n2 (d ia m et er\n45 .8 7 ± 7. 75 ; th ic kn es s 10 –1 5)\n0. 2– 20\nm g/ kg\nT iO\n2 in\nth e\nkn ee\njo in ts ev er y ot he r da y\nfo r 4 tim\nes\nIn tr aar tic ul ar in je ct io n\nB io ch em\nic al pa ra m et er s: A L P de cr ea se d;\nA S T /A LT\nan d L D H in cr ea se d\nH is to lo gy :f at ty\nde ge ne ra tio\nn, in fl am\nm at or y\nce ll in fi ltr at io n\nW u et al .[ 19 ]\nH ai rl es s m ic e\nA na ta se\nT iO\n2 (1 0 ± 1)\nR ut ile\nT iO\n2 (2 5 ± 5;\n60 ± 10 )\nP2 5 D eg us sa\nT iO\n2 (∼ 21 )\nT iO\n2 (0 .3 –0 .5\nμ m )\n24 m g of\n5 %\nT iO\n2 te st\nfo rm\nul at io n on\nth e do rs al\nin te rs ca pu la r sk in\nC ut an eo us\nap pl ic at io n\nL iv er\nhi st ol og y:\nT iO\n2 pe ne tr at ed\nth e sk in\nin du ci ng\nne cr os is\nO xi da tiv\ne st re ss :i nc re as ed\nM D A ac tiv ity in th e liv er\nM a et al .[ 39 ]\nFe m al e C D -1\n(I C R )\nm ic e\nA na ta se\nT iO\n2 (5 )\nB ul k ru til e T iO\n2 (1 0– 15\nμ m )\n5– 15 0 m g/ kg\nB W\nan at as e T iO\n2\nan d 15 0 m g/ kg\nbu lk\nT iO\n2\nev er yd ay\nfo r 14\nda ys\nIn tr aab do m in al in je ct io ns\nB io ch em\nic al se ru m\npa ra m et er s: A LT\n,A L P,\nA S T,\nL D H ,P\nC hE\n,L A P, T C H O an d H D L -C\nin cr ea se d by\nbo th\npa rt ic le s; A L B ,G\nL B an d\nT G in cr ea se d an d L D L -C\nde cr ea se d by\nan at as e T iO\n2\nH is to lo gy :b\nas op hi lia ,i sc he m ia an d ve in\nco ng es tio n (b ot h T iO 2 ). A po pt os is in du ce d by an at as e T iO 2\nIn fl am\nm at or y ac tio\nn: N FκB\n,M IF ,T\nN F -α ,I L -6 ,I L -1 β ,\nC R P, IL -4\nan d IL -1 0 in cr ea se d by\nan at as e T iO\n2\nL iu\net al .[ 11 4]\nFe m al e C D -1\n(I C R )\nm ic e\nA na ta se\nT iO\n2 (5 )\nB ul k ru til e T iO\n2\n(1 0– 15\nμ m )\n5– 15 0 m g/ kg\nB W\nan at as e\nT iO\n2 an d 15 0 m g/ kg\nbu lk\nT iO\n2 ev er y da y fo r 14\nda ys\nIn tr aab do m in al in je ct io ns\nB io ch em\nic al pa ra m et er s: A LT\n,A L P, A L B ,g lu co se ,\nT G ,T\nC H O an d H D L -C\nle ve ls w er e in cr ea se d by\nbo th\npa rt ic le s; L A P, P C hE\nan d T P w er e in cr ea se d\nan d T B IL\nw as\nre du ce d by\nan at as e T iO\n2\nO xi da tiv\ne st re ss :i nd uc ed\nby an at as e T iO\n2 in\nth e liv\ner\nC he n et al .[ 10 6]\nM al e an d fe m al e IC R m ic e\nA na ta se\nT iO\n2 (8 0– 11 0)\n32 4– 25 92\nm g/ kg\nIn tr ap er ito\nne al\nin je ct io ns\nB io ch em\nic al pa ra m et er s: A LT\nan d A S T in cr ea se d\nH is to lo gy :f ib ro si s, hy dr op ic de ge ne ra tio\nn, ne cr ot ic\nan d ap op to tic\nce lls\nan d N E U s w er e de te ct ed\nG uo\net al .[ 10 7]\nM al e IC R m ic e\n20 0 an d 50 0 m g/ kg\nT iO\n2 ev er y ot he r da y fo r 5 tim\nes In tr ap er ito\nne al\nin je ct io ns\nB io ch em\nic al pa ra m et er s: A LT\nan d A S T /A LT\nin cr ea se d\nL ia ng\net al .[ 65 ]\nM al e an d fe m al e Sp ra gu eD aw\nle y ra ts\nT iO\n2 (5 ,2 1)\n0. 5– 50\nm g/ kg\nT iO\n2 In tr at ra ch ea l in st ill at io n\nB io ch em\nic al pa ra m et er s: no\nch an ge s in\nT P,\nA L B ,A\nLT ,A\nS T\nO xi da tiv\ne st re ss :d\nec re as ed\nS O D an d\nin cr ea se d M D A ac tiv\nity\nW an g et al .[ 86 ]\nM al e an d fe m al e C D -1 (I C R ) m ic e\nT iO\n2 (2 5, 80 ,1 55 )\n5 g/ kg\nIn tr ag as tr ic\nad m in is tr at io n\nB io ch em\nic al pa ra m et er s: A LT\nan d A LT\n/A S T in cr ea se d\nH is to lo gy :h\nyd ro pi c de ge ne ra tio\nn an d ne cr os is\n26 Shakeel et al.\nT ab\nle 6\nT iO\n2 ex po su re\nth ro ug h th e ha em\nat op oi et ic an d im\nm un ol og ic al sy st em\ns\nR ef er en ce\nM od el an im\nal /s ex /a ge\nN P si ze /ty\npe D os e\nE xp os ur e (o rg an s/ tis su es )\nO bs er va tio\nns /r es ul ts /in\nfe re nc e\nW an g et al .[ 13 5]\nFe m al e C D -1\n(I C R ) m ic e\nA na ta se\nT iO\n2 5– 15 0 m g/ kg\nT iO\n2 fo r 30 co ns ec ut iv e da ys\nIn tr ag as tr ic\nad m in is tr at io n\nSp le en\nhi st ol og y:\nco ng es tio\nn, ly m ph\nno du le pr ol if er at io n O xi da tiv e st re ss :O\n2 − ,H\n2 O 2 an d M D A\nle ve ls an d p3 8, JN\nK ,N\nFκB\n,N rf -2\nan d H O -1\nex pr es si on\nin cr ea se d in\nth e sp le en\nM oo n et al .[ 10 9]\nM ic e\n< 25\nor < 10 0 nm\nT iO\n2 O nc e a da y fo r 7 da ys\nIn tr ap er ito ne al in je ct io ns\nSp le en\nce lls :s pl en oc yt es ,C\nD 4+\n,L PS - st im ul at ed N K ce lls ,C D 8+\nde cr ea se d;\nB -l ym\nph oc yt e de ve lo pm\nen ta nd\nL PS\n-s tim\nul at ed\nsp le en\nce ll pr ol if er at io n\nw er e re ta rd ed\nby T iO\n2\nN em\nm ar\net al .[ 61 ]\nM al e W is ta r ra ts\nR ut ile\nFe -d op ed\n(9 % ) pu re\n(T iO\n2) na no ro ds\n(l en gt h 80 ;\ndi am\net er\n7)\n1 an d 5 m g/ kg\nIn tr at ra ch ea li ns til la tio\nn B lo od\npa ra m et er s: W B C ,I L -6 ,S\nO D ,\nG SH\nan d PL\nTs in cr ea se d\nR os si et al .[ 43 ]\nFe m al e B A L B /c /S ca\nm ic e\nSi lic aco at ed\nru til e T iO 2 (∼ 10 × 40 )\nR ut ile\nT iO\n2 (< 5 μ m )\n10 ± 2 m g/ m\n3 T iO 2 fo r 2 h a da y, 3 da ys a w ee k, fo r 4 w ee ks\nIn ha la tio\nn In fl am\nm at or y ac tio n:\nT iO\n2 N Ps\nde cr ea se d T N F -α\nan d IL -1 3\nex pr es si on\nin sp le en\nce lls\nB u et al .[ 92 ]\nM al e an d fe m al e W is ta r ra ts\nR ut ile -a na ta se\nT iO\n2 m ix tu re\n(< 50 )\n0. 16 ,0 .4 an d 1 g kg -1 on ce a da y fo r 14\nda ys\nIn tr ag as tr ic\nad m in is tr at io n\nB lo od\npa ra m et er s: W B C ,L\nY M s, M O N s,\nE O S in cr ea se d\nSp le en\nhi st ol og y:\nno al te ra tio\nns\nD ua n et al .[ 13 7]\nFe m al e C D -1\n(I C R ) m ic e\n5 nm\nan at as e\n62 .5 –2 50\nm g/ kg\nIn tr ag as tr ic\nad m in is tr at io n\nB lo od\npa ra m et er s: W B C ,R\nB C ,H\nb, m ea n\nco rp us cu la r H b co nc en tr at io n, th ro m bo cy te s, re tic ul oc yt es\nde cr ea se d;\nm ea n co rp us cu la r vo lu m e, m ea n co rp us cu la r H b, re d ce ll di st ri bu tio n w id th ,P LT s, H T an d m ea n PL\nT vo lu m e\nin cr ea se d Im m un ol og ic al pa ra m et er s: C D 3, C D 4, C D 8, C D 4/ C D 8, B an d N K ce lls de cr ea se d In fl am m at or y ac tio n: IL -2 de cr ea se d an d N O in cr ea se d by T iO 2\nL ia ng\net al .[ 65 ]\nM al e an d fe m al e Sp\nra gu eD aw\nle y ra ts\nT iO\n2 (5 ,2 1)\n0. 5, 5 or\n50 m g/ kg\nbo dy\nw ei gh t\nIn tr at ra ch ea l in st ill at io n\nO xi da tiv e st re ss :d\nec re as ed\nSO D ac tiv ity in pl as m a\nL ie ta l. [1 08 ]\nFe m al e C D -1\n(I C R ) m ic e\nA na ta se\nT iO\n2 (∼ 6– 7)\n5– 15 0 m g/ kg\nT iO\n2 ev er y\nda y fo r 45\nda ys\nIn tr ap er ito\nne al\nin je ct io ns\nO xi da tiv e st re ss\nin sp le en :i nc re as ed\nR O S an d M D A\nSp le en\nhi st ol og y:\nco ng es tio\nn, ly m ph\nno du le pr ol if er at io n, sp le no cy te ap op to si s A po pt os is m ec ha ni sm :T iO\n2 ac tiv at ed ca sp as e3 an d ca sp as e9, de cr ea se d B cl -2 ,i nc re as ed B ax\nan d cy to ch ro m e c\nC he n et al .[ 10 6]\nM al e an d fe m al e IC R m ic e\n80 an d 11 0 nm\n,m os tly\nbe in g\n10 0 nm\n0, 32 4, 64 8, 97 2, 12 96 , 19 44 or 25 92 m g/ kg\nIn tr ap er ito\nne al\nin je ct io ns\nSp le en\nhi st ol og y:\nse ve re\nle si on s;\nN E U in fi ltr at io n\nW an g et al .[ 86 ]\nM al e an d fe m al e C D -1\n(I C R ) m ic e\n25 ,8 0 an d 15 5 nm\n5 g/ kg\nbo dy\nIn tr ag as tr ic\nad m in is tr at io n\nSp le en\nhi st ol og y:\nno al te ra tio\nns\nToxicity of Titanium Dioxide (TiO2) Nanoparticles 27\nT ab\nle 7\nT iO\n2 ex po su re\nth ro ug h th e re na ls ys te m\nR ef er en ce\nM od el an im\nal /s ex /a ge\nN P si ze /ty\npe D os e\nE xp os ur e (o rg an s/ tis su es )\nO bs er va tio\nns /r es ul ts /in\nfe re nc e\nZ ha o et al .[ 14 0]\nM ic e\nA na ta se\nT iO\n2 In tr aab do m in al in je ct io ns\nB io ch em\nic al pa ra m et er s: C r, C a2\n+ an d ph os ph on iu m\nin cr ea se d;\nB U N an d U A de cr ea se d\nO xi da tiv\ne st re ss :R\nO S an d L P O in cr ea se d;\nsu pe ro xi de\ndi sm\nut as e, ca ta la se ,a sc or ba te\npe ro xi da se ,t ot al an tio\nxi da nt\nca pa ci ty ,\ngl ut at hi on e an d as co rb ic ac id\nco nt en td\nec re as ed\nTa ng\net al .[ 66 ]\nM al e S pr ag ue -D\naw le y ra ts\nA na ta se\nT iO\n2 (5 ± 1)\n0. 8, 4 an d 20\nm g/ kg\nIn tr at ra ch ea li ns til la tio\nn B io ch em\nic al pa ra m et er s: B U N in cr ea se d\n1H N M R se ru m\nan al ys is :k\net on e, bo di es ,\nch ol in e, L D L ,a la ni ne\nan d G L U\nin cr ea se d;\nla ct at e, cr ea tin\ne an d\npy ru va te de cr ea se d\nT E M\nan al ys is :t ub ul e ep ith\nel ia lc el l\nda m ag e, va sc ul ar\nde fo rm\nity\nTa ng\net al .[ 59 ]\nM al e S pr ag ue -D\naw le y ra ts\nT iO\n2 (5 )\n0. 8. 4 an d 20\nm g/ kg\nIn tr at ra ch ea li ns til la tio\nn B io ch em\nic al pa ra m et er s: B U N an d C r in cr ea se d\n1H N M R ur in e an al ys is :i nc re as e in\nva lin\ne, la ct at e,\nac et at e, su cc in at e, 2- O G ,c re at in in e, ta ur in e, T M A O ,a lla nt oi n an d hi pp ur at e 1- 2; de cr ea se in ci tr at e an d D M A\nW an g et al .[ 15 4]\nM al e S pr ag ue -D\naw le y ra ts\nA na ta se\nT iO\n2\n(d ia m et er\n45 .8 7 ± 7. 75 ;\nth ic kn es s 10 –1 5)\n0. 2– 20\nm g/ kg\nT iO\n2 in\nth e\nkn ee\njo in ts ev er y ot he r\nda y fo r 4 tim\nes\nIn tr aar tic ul ar\nin je ct io n\nB io ch em\nic al pa ra m et er s: B U N an d C r de cr ea se d\nH is to lo gy :p\nro te in ic liq\nui ds\nin re na lt ub ul es\nG uo\net al .[ 10 6]\nM al e m ic e 6 w ee ks\n20 0 an d 50 0 m g/ kg\nev er y ot he r\nda y fo r 5 tim\nes fo r a w ee k\nIn tr ap er ito\nne al in je ct io ns\nB io ch em\nic al pa ra m et er s: B U N in cr ea se d\nL iu\net al .[ 11 4]\nFe m al e C D -1\n(I C R ) m ic e\nA na ta se\nT iO\n2 (5 )\nB ul k ru til e T iO\n2 (1 0– 15\nμ m )\n5– 15 0 m g/ kg\nB W\nan at as e\nT iO\n2 an d 15 0 m g/ kg\nbu lk\nT iO\n2 ev er yd ay\nfo r 14\nda ys\nIn tr aab do m in al in je ct io ns\nB io ch em\nic al pa ra m et er s: U A an d B U N\nde cr ea se d by\nbo th\nT iO\n2\nC he n et al .[ 10 6]\nM al e an d fe m al e IC R m ic e\n80 an d 11 0 nm , m os tly\nbe in g 10 0 nm\n0, 32 4, 64 8, 97 2, 12 96 ,1 94 4 or 25 92 m g/ kg\nIn tr ap er ito\nne al in je ct io ns\nB io ch em\nic al pa ra m et er s: no\nal te ra tio\nns in\nB U N\nH is to lo gy :g\nlo m er ul us\nsw el lin\ng, pr ot ei ni c\nliq ui ds\nin re na lt ub ul es\nL ia ng\net al .[ 65 ]\nM al e an d fe m al e Sp ra gu eD aw\nle y ra ts\nT iO\n2 (5 ,2 1)\n0. 5, 5 or\n50 m g/ kg\nbo dy\nw ei gh t\nIn tr at ra ch ea li ns til la tio\nn B io ch em\nic al pa ra m et er s: no\nal te ra tio\nns in\nB U N an d C r\nO xi da tiv\ne st re ss :d\nec re as ed\nS O D an d G S H -P X ;\nin cr ea se d M D A re na la ct iv ity\n(5 nm\nT iO\n2 )\nW an g et al .[ 86 ]\nM al e an d fe m al e C D -1\n(I C R ) m ic e\n25 ,8 0 an d 15 5 nm\n5 g/ kg\nT iO\n2 In tr ag as tr ic ad m in is tr at io n (o ra lg av ag e)\nB io ch em\nic al pa ra m et er s: B U N an d\nC r in cr ea se d by\n25 ,8 0 nm\nT iO\n2\nH is to lo gy :p\nro te in ic liq\nui ds\nin re na lt ub ul es ,\ngl om\ner ul us\nsw el lin\ng\n28 Shakeel et al.\ncause brain injury in mice. Neurons may turn into filamentous shapes or inflammatory cells. The accumulation of nanoparticles was dose dependent. The oxidative stress and injury of the brain takes place as anatase TiO2 nanoparticles can trigger a series of reactions like lipid peroxidation, decreases in total antioxidation capacity and antioxidative enzyme activities, reduction of glutamic acid, excessive release of nitric oxide and the down-regulated level of acetylcholinesterase activities.\nMohamed [142] injected 500, 1000 and 2000 mg/kg body weight suspension of nanoparticles for five consecutive days into the abdominal cavity and examined genotoxicity, mutagenicity and apoptosis in p53 exons (5–8) and myocardial cells. Comet assay showed highly significant tail length, %DNA in tail and tail moment in a dose-dependent manner. Smeared DNA and apoptotic fragmentized laddered also appeared on agarose gel. The heart of TiO2 nanoparticle-treated groups had abnormal pathology increasing gradually with increasing titanium dose as shown by the appearance of diffuse muscle hyalinosis and congested blood vessel in the low TiO2 group (500 mg/kg); diffuse muscle hyalinosis, diffuse muscular edema, haemorrhage and focal leucocytic infiltration in the medium TiO2 group (1000 mg/kg); and Zenker’s necrosis of muscles with mononuclear cell infiltration in the high TiO2 group (2000 mg/kg).\nJeon et al. [143] demonstrated the protein profile alterations in mouse brain. TiO2 nanoparticles changed the expression levels of 11 proteins by more than 2-fold (up-regulation of eight proteins and down-regulation of three portions) and reduced the activities of a number of antioxidative enzymes and acetylcholine esterase in the brain. However, no TiO2 nanoparticles were identified in the brain.\nLi et al. [144] injected 5, 10, 50, 100 and 150 mg/kg body weight anatase TiO2 nanoparticles into the abdominal cavity of mice everyday for 14 days. The weights of the livers in the mice which were treated with higher concentrations of TiO2 nanoparticles significantly increased. TiO2 nanoparticles accumulated in the DNA of the liver and were placed into DNA base pairs or bound to DNA nucleotides with three atoms of oxygen or nitrogen and two atoms of phosphorous of the DNA. The bond length of the Ti–O(N) and Ti–P were 1.87 and 2.38 Å, respectively. The nanoparticles changed the conformation of the DNA. The gel electrophoresis revealed that a higher dose of TiO2 nanoparticles caused liver DNA cleavage [144].\nIn Vitro Studies\nSince in vitro studies may be helpful in the prediction of acute toxicity, a few are mentioned here. The detailed discussion on in vitro studies and genotoxicity and carcinogenicity of the TiO2 nanoparticles will be studied in our separate review paper. The effect of TiO2 nanoparticles on erythrocytes wasT ab le 8 T iO\n2 ex po su re\nth ro ug h th e m us cu la r an d sk el et al sy st em\nR ef er en ce\nM od el an im\nal /s ex /a ge\nN P si ze /ty\npe D os e\nE xp os ur e (o rg an s/ tis su es )\nO bs er va tio\nns /r es ul ts /in\nfe re nc e\nW an g et al .[ 15 4]\nM al e Sp\nra gu eD aw\nle y ra ts\nA na ta se\nT iO\n2 (d ia m et er 45 .8 7 ± 7. 75 ;\nth ic kn es s 10 –1 5)\n0. 2, 2 an d 20\nm g/ kg\nT iO\n2 in\nth e kn ee\njo in ts ev er y ot he r da y fo r 4 tim\nes In tr aar tic ul ar\nin je ct io n\nO xi da tiv\ne st re ss\nin sy no vi um\n:G SH\n-P x,\nG SH\n,G SS\nG ,M\nD A an d SO\nD in cr ea se d\nH is to lo gy :s yn ov iu m\nhy pe rt ro ph y, LY\nM s,\npl as m a ce ll in fi ltr at io n an d fi br ob la st pr ol if er at io n\nH an se n et al .[ 12 2]\nM al e Sp\nra gu eD aw\nle y ra ts\nT iO\n2 (7 0) B ul k T iO\n2 (d ia m et er\n0. 9 m m ;\nhe ig ht\n1 m m )\nIn th e ba ck\nof ra ts fo r 6 or\n12 m on th s\nSu bc ut an eo us\n(b ul k)\nan d\nin tr am\nus cu la r( N Ps )i m pl an ta tio\nn L oc al re ac tio\nn: pr es en ce\nof gr an ul om as (N Ps ), in fl am m at or y in fi ltr at es\n(b ul k) ;\nno lo ca li nt ol er an ce\n(b ot h)\nG at ti et al .[ 12 3]\nM al e Sp\nra gu eD aw\nle y ra ts\nT iO\n2 (7 0) B ul k T iO\n2 (d ia m et er\n6– 12\nm m ;h\nei gh t2\nm m )\nIn th e ba ck\nof ra ts fo r 6 or\n12 m on th s\nSu bc ut an eo us\n(b ul k)\nan d\nin tr am\nus cu la r\n(N Ps ) im\npl an ta tio\nn\nL oc al re ac tio\nn: gr an ul om\nas (N\nPs ),\nin fl am\nm at or y in fi ltr at es\n(b ul k)\nO nu m a et al .[ 12 4]\nFe m al e C 57 B L /6\nm ic e\nH yd ro ph ili c ru til e T iO\n2 tr ea te d\nw ith\nZ rO\n2 A l( O H ) 3 (m\nin or\nax is\n40 –7 0;\nm aj or\nax is 20 0– 30 0)\nH yd ro ph ob ic ru til e T iO\n2 tr ea te d\nw ith\nZ rO\n2A l( O H ) 3 an d st er ic ac id\n(m in or\nax is 40 –7 0;\nm aj or\nax is 20 0– 30 0)\nSu bc ut an eo us\nin je ct io ns :Q\nR -3 2\nce lls\nal on e; Q R -3 2 ce lls\nm ix ed\nw ith\n5 m g/ 0. 1 m L T iO\n2 ;a nd\n5 m g/ 0. 1\nm L T iO\n2 30\nan d 70\nda ys\nbe fo re\nQ R -3 2 ce ll in je ct io n In tr av en ou s in je ct io ns :t um\nou r\nce ll lin es\nin to\nm ic e (5 /li ne )\nSu bc ut an eo us\nin je ct io ns , in tr av en ou s in je ct io ns\nC ar ci no ge ni ci ty :Q\nR -3 2 ce lls\nbe ca m e\ntu m or ig en ic af te r in je ct io n in\nsi te s im\npl an te d\nfo r 30\nor 70\nda ys\nw ith\nhy dr op hi lic\nT iO\n2\nM et as ta tic\nab ili ty :a cq ui re d by\ntu m ou r ce ll\nlin es\nde ri ve d fr om\nQ R -3 2 ce lls\nin je ct ed\nin th e\nsi te pr eim\npl an te d w ith\nbo th\nT iO\n2\nToxicity of Titanium Dioxide (TiO2) Nanoparticles 29\nexamined by Li et al. [145]. The TiO2 nanoparticles caused abnormal sedimentation, haemagglutination and dosedependent haemolysis of erythrocytes unlike TiO2 fine particles. Another study onwashed human erythrocytes after 37 °C incubation for 1 h reported haemolysis caused by TiO2 fine particles 73 times greater than nanoparticles [146]. However, the haemolysis was inhibited by plasma, which indicated the prevention of haemolysis in vivo due to the presence of plasma. In another study on mouse macrophages (Ana-1 and MHS cells) administered with anatase 5-, 10-, 25- and 100-nmsized TiO2 nanoparticles, low toxicity was induced to MH-S cells [147]. Another study found that 25- and 80-nm-sized TiO2 nanoparticles at the concentrations of 10, 20, 40 and 80 mg/L for 24-h exposure inhibited intracellular communication via gap junction between lung fibroblasts [148]. Several in vitro studies also showed the toxicity of TiO2 nanoparticles on circulatory system cells.\nAdachi et al. [149] also found no penetration of TiO2 nanoparticles into viable cell layers or any cellular changes biologically. They used skin exposed to water/oil emulsion containing 10 % by weight ultrafine TiO2 particles. The skin showed no morphological and immunohistochemical alterations by light microscopy. Electron microscopy showed the localization of most TiO2 nanoparticles in the keratinized layer of follicular infundibulum and the interfollicular stratum disjunctum. Energy-dispersive X-ray spectrometry confirmed no TiO2 nanoparticles in the viable skin. Furthermore, light microscopy or low-vacuum scanning electron microscopy with EDX showed a specific affinity of TiO2 nanoparticles to the follicular opening area.\nIn another in vitro study, similar results were found by Miquel-Jeanjean et al. [150] evaluating cutaneous penetration and localization of TiO2 nanoparticles included in a sunscreen containing the nanoparticles with ≥20 nm primary size applied for 24 h. Ti was deposited 102.35±4.20 % in intact skin and 102.84±5.67 % in damaged/irradiated skin in the surface and stratum corneum. Only 0.19±0.15 % nanoparticles were found in the viable epidermis and 0.39±0.39 % in the dermis. No Ti was found in the receptor fluid. From this study, it may\nbe concluded that TiO2 nanoparticles incorporated in sunscreens stay in the topmost layers of the stratum corneum in intact skin and even in damaged or irradiated skin with simulated solar radiation.\nBraydich-Stolle et al. [151] using a model of HEL-30 mouse keratinocyte cell line in vitro demonstrated that both crystal structure and size of the TiO2 nanoparticles contributed to cytotoxicity. The crystal structure influences themechanism of cell death. The results showed that pure anatase TiO2 nanoparticles initiated cell necrosis regardless of size, and the rutile TiO2 nanoparticles induced apoptosis bymeans of the production of ROS.\nNemmar et al. [61] have shown in vitro that intratracheal instillation dose-dependently reduced cellular viability of human lung cancer cells and human hepatoma cells. The rutile Fe-TiO2 caused direct toxicity on human lung cancer cells and human hepatoma cells. Nemmar et al. [61] also showed in vitro in Wistar rats that intratracheal instillation significantly and dose-dependently induced platelet aggregation. It affects the liver and increases thrombotic potential, systolic blood pressure and heart rate. Male Wistar rats exposed to rutile Fe-doped (9 %) pure TiO2 nanorods (length 80 nm; diameter 7 nm) at 1 and 5 mg/kg by intratracheal instillation displayed changes in cardiovascular parameters like increased heart rate and systolic blood pressure.\nSavi et al. [152] showed both in vivo and in vitro that acute exposure to TiO2 nanoparticles alters acutely cardiac excitability and increases the chances of arrhythmic events. In vivo, on a single intratracheal dose of 2 mg/kg of TiO2 nanoparticles in saline solution, cardiac conduction velocity and tissue excitability increased, resulting in an increased tendency for inducible arrhythmias. Computational modelling of ventricular action potential pointed out that a membrane leakage can explain the effects induced by the nanoparticles measured on real cardiomyocytes.\nIn a study by Wang et al. [153], about 30 % of the TiO2 nanoparticles entered into neural stem cells after 48 h of incubation with 50 and 30 nm and nanotubes 100 nm×4–6 nm regardless of the type and dose of the\nTable 9 TiO2 exposure through the reproductive system\nReference Model animal/sex/age NP size/type Dose Exposure (organs/tissues) Observations/results/inference\nTakeda et al. [118] Pregnant Slc:ICR mice Anatase TiO2 (25–70) 100 μL of TiO2 at 1 mg/mL at 3, 7, 10 and 14 days post-coitum\nSubcutaneous injections Reproductive effects: disorganised and disrupted seminiferous tubules, few mature sperm, decreased sperm production, epidididymal sperm motility, number of Sertoli cells\nGuo et al. [107] Male mice 6 weeks 200 and 500 mg/kg every other day for 5 times for a week Intraperitoneal injections Reproductive effects: reduced sperm density and motility, increased sperm abnormality and germ cell apoptosis\n30 Shakeel et al.\nnanoparticles. When the TiO2 nanoparticles were removed from the culture medium, about 35 % 50 nm TiO2 nanoparticles, 34.6 % 30 nm TiO2 nanoparticles and 41.7 % of nanotubes were released by exocytosis from the cells within the first 24 h. The release was decreased over time and became negligible at 72 h. During cell division, exocytosis did not occur. Furthermore, the study also suggested that both endocytosis and exocytosis of TiO2 nanoparticles were energydependent processes and that the serum proteins influenced the uptake of the nanoparticles by cells. In a similar study, Wang et al. [154] demonstrated that titania nanotubes (TiO2-NTs) passed through the karyotheca entering the mouse neural stem cell nucleus after coincubation for 48 h."
    }, {
      "heading" : "Conclusion",
      "text" : "In summary, the acute toxicity of TiO2 nanoparticles has been studied frequently in rat and mouse models through various exposure routes of administration (Tables 1, 2, 3, 4, 5, 6, 7, 8 and 9). The number of studies performed on the respiratory system prevails over the other exposure routes. Studies about the effects of TiO2 nanoparticles on the pulmonary system showed both local and systemic effects and intensified the pre-existing symptoms. TiO2 nanoparticles administered through the lung cause more inflammatory responses as compared to the fine particles of similar chemistry at equal dose concentrations. However, TiO2 nanoparticles and TiO2 fine particles induced similar pulmonary inflammation on the basis of equal particle surface area. The results from the other routes of exposure cannot be ignored. For example, research studies make evident the absorption of the TiO2 nanoparticles from the lungs or gastrointestinal tract into systemic circulation and distribution to different organs like the kidneys, liver, spleen or even the brain and induce organ injuries and inflammations. However, most of the doses used in the studies are too high to be implied on occupational situations. A number of in vitro studies also demonstrate the effects of TiO2 nanoparticles on the blood circulatory system."
    } ],
    "references" : [ {
      "title" : "An approach to risk assessment for TiO2",
      "author" : [ "D Dankovic", "E Kuempel", "M Wheeler" ],
      "venue" : "Inhal Toxicol 19(s1):205–212",
      "citeRegEx" : "1",
      "shortCiteRegEx" : "1",
      "year" : 2007
    }, {
      "title" : "Titanium dioxide nanoparticles in food and personal care products",
      "author" : [ "A Weir", "P Westerhoff", "L Fabricius", "N von Goetz" ],
      "venue" : "Environ Sci Technol",
      "citeRegEx" : "3",
      "shortCiteRegEx" : "3",
      "year" : 2012
    }, {
      "title" : "Toxicology of nanomaterials used in nanomedicine",
      "author" : [ "J Zhao", "V Castranova" ],
      "venue" : "J Toxicol Environ Health, Part B 14(8):593–632",
      "citeRegEx" : "4",
      "shortCiteRegEx" : "4",
      "year" : 2011
    }, {
      "title" : "Nanotitanium dioxide toxicity in mouse lung is reduced in sanding dust from paint",
      "author" : [ "AT Saber", "NR Jacobsen", "A Mortensen", "J Szarek", "P Jackson", "AM Madsen", "KA Jensen", "IK Koponen", "G Brunborg", "KB Gützkow", "U Vogel", "H Wallin" ],
      "venue" : "Part Fibre Toxicol 9:4–4",
      "citeRegEx" : "5",
      "shortCiteRegEx" : "5",
      "year" : 2012
    }, {
      "title" : "Titanium dioxide nanoparticle-induced testicular damage, spermatogenesis suppression, and gene expression alterations in male mice",
      "author" : [ "G Gao", "Y Ze", "X Zhao", "X Sang", "L Zheng", "X Ze", "S Gui", "L Sheng", "Q Sun", "J Hong", "X Yu", "L Wang", "FH Zhang" ],
      "venue" : "J Hazard Mater",
      "citeRegEx" : "6",
      "shortCiteRegEx" : "6",
      "year" : 2013
    }, {
      "title" : "Titanium dioxide nanoparticles in food and personal care products",
      "author" : [ "A Weir", "P Westerhoff", "L Fabricius", "K Hristovski", "N Goetz" ],
      "venue" : "Environ Sci Technol",
      "citeRegEx" : "7",
      "shortCiteRegEx" : "7",
      "year" : 2012
    }, {
      "title" : "Titanium dioxide nanoparticles: a review of current toxicological data",
      "author" : [ "H Shi", "R Magaye", "V Castranova", "J Zhao" ],
      "venue" : "Part Fibre Toxicol 10:15–15",
      "citeRegEx" : "8",
      "shortCiteRegEx" : "8",
      "year" : 2013
    }, {
      "title" : "Study on penetration of titanium dioxide (TiO2) nanoparticles into intact and damaged skin in vitro",
      "author" : [ "M Senzui", "T Tamura", "K Miura", "Y Ikarashi", "Y Watanabe", "M Fujii" ],
      "venue" : "J Toxicol Sci",
      "citeRegEx" : "9",
      "shortCiteRegEx" : "9",
      "year" : 2010
    }, {
      "title" : "The safety of nanosized particles in titanium dioxide- and zinc oxide-based sunscreens",
      "author" : [ "NewmanMD", "M Stotland", "JI Ellis" ],
      "venue" : "J Am Acad Dermatol",
      "citeRegEx" : "10",
      "shortCiteRegEx" : "10",
      "year" : 2009
    }, {
      "title" : "Lack of significant dermal penetration of titanium dioxide from sunscreen formulations containing nano- and submicron-size TiO2 particles",
      "author" : [ "N Sadrieh", "AM Wokovich", "NV Gopee", "J Zheng", "D Haines", "D Parmiter", "PH Siitonen", "CR Cozart", "AK Patri", "SE McNeil", "PC Howard", "WH Doub", "LF Buhse" ],
      "venue" : "Toxicol Sci 115(1):156–166",
      "citeRegEx" : "11",
      "shortCiteRegEx" : "11",
      "year" : 2010
    }, {
      "title" : "Ganem-Quintanar A (2008) The tape-stripping technique as a method for drug quantification in skin",
      "author" : [ "JJ Escobar-Chavez", "V Merino-Sanjuan", "M Lopez-Cervantes", "Z Urban-Morlan", "E Pinon-Segundo", "D Quintanar-Guerrero" ],
      "venue" : "J Pharm Pharm Sci",
      "citeRegEx" : "12",
      "shortCiteRegEx" : "12",
      "year" : 2008
    }, {
      "title" : "Stratum corneum is an effective barrier to TiO2 and ZnO nanoparticle percutaneous absorption",
      "author" : [ "P Filipe", "JN Silva", "R Silva", "JL Cirne de Castro", "M Marques Gomes", "LC Alves", "R Santus", "T Pinheiro" ],
      "venue" : "Skin Pharmacol Physiol",
      "citeRegEx" : "13",
      "shortCiteRegEx" : "13",
      "year" : 2009
    }, {
      "title" : "Safety evaluation of sunscreen formulations containing titanium dioxide and zinc oxide nanoparticles in UVB sunburned skin: an in vitro and in vivo study",
      "author" : [ "NA Monteiro-Riviere", "K Wiench", "R Landsiedel", "S Schulte", "AO Inman", "JE Riviere" ],
      "venue" : "Toxicol Sci 123(1):264–280",
      "citeRegEx" : "14",
      "shortCiteRegEx" : "14",
      "year" : 2011
    }, {
      "title" : "Skin penetration and stabilization of formulations containingmicrofine titanium dioxide as physical UV filter",
      "author" : [ "C Bennat", "CC Müller-Goymann" ],
      "venue" : "Int J Cosmet Sci 22(4):271–83",
      "citeRegEx" : "15",
      "shortCiteRegEx" : "15",
      "year" : 2000
    }, {
      "title" : "Lack of skin carcinogenicity of topically applied titanium dioxide nanoparticles in the mouse",
      "author" : [ "F Furukawa", "Y Doi", "M Suguro", "O Morita", "H Kuwahara", "T Masunaga", "Y Hatakeyama", "F Mori" ],
      "venue" : "Food Chem Toxicol",
      "citeRegEx" : "16",
      "shortCiteRegEx" : "16",
      "year" : 2011
    }, {
      "title" : "Lack of promoting effect of titanium dioxide particles on chemically-induced skin carcinogenesis in rats and mice",
      "author" : [ "Y Sagawa", "M Futakuchi", "J Xu", "K Fukamachi", "Y Sakai", "Y Ikarashi", "T Nishimura", "M Suzui", "H Tsuda", "A Morita" ],
      "venue" : "J Toxicol Sci 37(2):317–327",
      "citeRegEx" : "17",
      "shortCiteRegEx" : "17",
      "year" : 2012
    }, {
      "title" : "Toxicity of Titanium Dioxide (TiO2) Nanoparticles",
      "author" : [ "M Suzui", "H Tsuda" ],
      "venue" : "Food Chem Toxicol 49(6):1298–1302",
      "citeRegEx" : "18",
      "shortCiteRegEx" : "18",
      "year" : 2011
    }, {
      "title" : "Toxicity and penetration of TiO2 nanoparticles in hairless mice and porcine skin after subchronic dermal exposure",
      "author" : [ "J Wu", "LiuW", "C Xue", "S Zhou", "F Lan", "L Bi", "H Xu", "X Yang", "FD Zeng" ],
      "venue" : "Toxicol Lett 191(1):1–8",
      "citeRegEx" : "19",
      "shortCiteRegEx" : "19",
      "year" : 2009
    }, {
      "title" : "Development of a base set of toxicity tests using ultrafine TiO2 particles as a component of nanoparticle risk management",
      "author" : [ "DB Warheit", "RA Hoke", "C Finlay", "EM Donner", "KL Reed", "CM Sayes" ],
      "venue" : "Toxicol Lett 171(3):99–110",
      "citeRegEx" : "20",
      "shortCiteRegEx" : "20",
      "year" : 2007
    }, {
      "title" : "Experimental study on toxicity of nanosized titanium dioxide",
      "author" : [ "Q Liu", "Z Hong", "B-g Guo", "Y Zhang", "Y Li", "J Liu" ],
      "venue" : "Mod Prev Med",
      "citeRegEx" : "21",
      "shortCiteRegEx" : "21",
      "year" : 2006
    }, {
      "title" : "Aqueous synthesis and concentration-dependent dermal toxicity of TiO2 nanoparticles in Wistar rats",
      "author" : [ "J Unnithan", "M Rehman", "F Ahmad", "M Samim" ],
      "venue" : "Biol Trace Elem Res",
      "citeRegEx" : "22",
      "shortCiteRegEx" : "22",
      "year" : 2011
    }, {
      "title" : "Titanium dioxide nanoparticles aggravate atopic dermatitis-like skin lesions in NC/Nga mice",
      "author" : [ "R Yanagisawa", "TakanoH", "I K-i", "E Koike", "T Kamachi", "SadakaneK", "T Ichinose" ],
      "venue" : "Exp Biol Med",
      "citeRegEx" : "23",
      "shortCiteRegEx" : "23",
      "year" : 2009
    }, {
      "title" : "Risks from accidental exposures to engineered nanoparticles and neurological health effects: a critical review",
      "author" : [ "Simkó M", "Mattsson M-O" ],
      "venue" : "Part Fibre Toxicol 7:42–42",
      "citeRegEx" : "24",
      "shortCiteRegEx" : "24",
      "year" : 2010
    }, {
      "title" : "Lung dosimetry and risk assessment of nanoparticles: evaluating and extending current models in rats and humans",
      "author" : [ "ED Kuempel", "CL Tran", "V Castranova", "AJ Bailer" ],
      "venue" : "Inhal Toxicol 18(10):717–24",
      "citeRegEx" : "25",
      "shortCiteRegEx" : "25",
      "year" : 2006
    }, {
      "title" : "Re-evaluation of pulmonary titanium dioxide nanoparticle distribution using the Brelative deposition index^: evidence for clearance through microvasculature",
      "author" : [ "C Mühlfeld", "M Geiser", "N Kapp", "P Gehr", "B Rothen-Rutishauser" ],
      "venue" : "Part Fibre Toxicol 4:7–7",
      "citeRegEx" : "26",
      "shortCiteRegEx" : "26",
      "year" : 2007
    }, {
      "title" : "Comparing fate and effects of three particles of different surface properties: nano-TiO2, pigmentary TiO2 and quartz",
      "author" : [ "B van Ravenzwaay", "R Landsiedel", "E Fabian", "S Burkhardt", "V Strauss", "L Ma-Hock" ],
      "venue" : "Toxicol Lett 186(3):152–159",
      "citeRegEx" : "27",
      "shortCiteRegEx" : "27",
      "year" : 2009
    }, {
      "title" : "Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles",
      "author" : [ "E Bermudez", "JB Mangum", "BA Wong", "B Asgharian", "PM Hext", "DB Warheit", "JI Everitt" ],
      "venue" : "Toxicol Sci 77(2):347–357",
      "citeRegEx" : "28",
      "shortCiteRegEx" : "28",
      "year" : 2004
    }, {
      "title" : "Genotoxicity of inhaled nanosized TiO2 in mice",
      "author" : [ "HK Lindberg", "GCM Falck", "J Catalán", "AJ Koivisto", "S Suhonen", "H Järventaus", "EM Rossi", "H Nykäsenoja", "Y Peltonen", "C Moreno", "H Alenius", "T Tuomi", "KM Savolainen", "H Norppa" ],
      "venue" : "Mutat Res Gen Toxicol Environ Mutagen 745(1–2):58–64",
      "citeRegEx" : "29",
      "shortCiteRegEx" : "29",
      "year" : 2012
    }, {
      "title" : "Pulmonary nanoparticle exposure disrupts systemic microvascular nitric oxide signaling",
      "author" : [ "TR Nurkiewicz", "DW Porter", "AF Hubbs", "S Stone", "BT Chen", "DG Frazer", "MA Boegehold", "V Castranova" ],
      "venue" : "Toxicol Sci 110(1):191–203",
      "citeRegEx" : "30",
      "shortCiteRegEx" : "30",
      "year" : 2009
    }, {
      "title" : "Nanoparticle inhalation impairs endothelium-dependent vasodilation in subepicardial arterioles",
      "author" : [ "AJ LeBlanc", "JL Cumpston", "BT Chen", "D Frazer", "V Castranova", "TR Nurkiewicz" ],
      "venue" : "J Toxicol Environ Health Part A 72(24):1576–1584",
      "citeRegEx" : "31",
      "shortCiteRegEx" : "31",
      "year" : 2009
    }, {
      "title" : "Nanoparticle inhalation alters systemic ar te r io la r vasoreac t iv i ty th rough sympathe t i c and cyclooxygenase-mediated pathways",
      "author" : [ "TL Knuckles", "J Yi", "DG Frazer", "HD Leonard", "BT Chen", "V Castranova", "TR Nurkiewicz" ],
      "venue" : "Nanotoxicol 6(7):724–735",
      "citeRegEx" : "32",
      "shortCiteRegEx" : "32",
      "year" : 2012
    }, {
      "title" : "Nanoparticle inhalation impairs coronary microvascular reactivity via a local reactive oxygen speciesdependent mechanism",
      "author" : [ "AJ LeBlanc", "AM Moseley", "BT Chen", "D Frazer", "V Castranova", "TR Nurkiewicz" ],
      "venue" : "Cardiovasc Toxicol 10(1):27–36",
      "citeRegEx" : "33",
      "shortCiteRegEx" : "33",
      "year" : 2010
    }, {
      "title" : "Pulmonary particulate matter and systemic microvascular dysfunction",
      "author" : [ "TR Nurkiewicz", "DW Porter", "AF Hubbs", "S Stone", "AM Moseley", "JL Cumpston", "AG Goodwill", "SJ Frisbee", "PL Perrotta", "RW Brock", "JC Frisbee", "MA Boegehold", "DG Frazer", "BT Chen", "V Castranova" ],
      "venue" : null,
      "citeRegEx" : "34",
      "shortCiteRegEx" : "34",
      "year" : 2011
    }, {
      "title" : "Effects of titanium dioxide nanoparticle exposure on neuroimmune responses in rat airways",
      "author" : [ "M Scuri", "BT Chen", "V Castranova", "JS Reynolds", "VJ Johnson", "L Samsell", "C Walton", "G Piedimonte" ],
      "venue" : "J Toxicol Environ Health Part A 73(20):1353–1369",
      "citeRegEx" : "35",
      "shortCiteRegEx" : "35",
      "year" : 2010
    }, {
      "title" : "Effects of prenatal exposure to surface-coated nanosized titanium dioxide (UV-Titan). A study in mice",
      "author" : [ "K Hougaard", "P Jackson", "K Jensen", "J Sloth", "K Loschner", "E Larsen", "R Birkedal", "A Vibenholt", "A-M Boisen", "H Wallin", "U Vogel" ],
      "venue" : "Part Fibre Toxicol",
      "citeRegEx" : "36",
      "shortCiteRegEx" : "36",
      "year" : 2010
    }, {
      "title" : "Pulmonary response to surface-coated nanotitanium dioxide particles includes induction of acute phase response genes, inflammatory cascades, and changes in microRNAs: a toxicogenomic study",
      "author" : [ "S Halappanavar", "P Jackson", "A Williams", "KA Jensen", "KS Hougaard", "U Vogel", "CL Yauk", "H Wallin" ],
      "venue" : "Environ Mol Mutagen 52(6):425–439",
      "citeRegEx" : "37",
      "shortCiteRegEx" : "37",
      "year" : 2011
    }, {
      "title" : "Rat pulmonary responses to inhaled nano-TiO2: effect of primary particle size and agglomeration state",
      "author" : [ "A Noël", "M Charbonneau", "Y Cloutier", "R Tardif", "G Truchon" ],
      "venue" : "Part Fibre Toxicol",
      "citeRegEx" : "38",
      "shortCiteRegEx" : "38",
      "year" : 2013
    }, {
      "title" : "Development of a short-term inhalation test in the rat using nano-titanium dioxide as a model substance",
      "author" : [ "L Ma-Hock", "S Burkhardt", "V Strauss", "AO Gamer", "K Wiench", "B van Ravenzwaay", "R Landsiedel" ],
      "venue" : "Inhal Toxicol 21(2):102–118",
      "citeRegEx" : "39",
      "shortCiteRegEx" : "39",
      "year" : 2009
    }, {
      "title" : "Inhalation exposure study of titanium dioxide nanoparticles with a primary particle size of 2 to 5 nm",
      "author" : [ "VH Grassian", "PT O’Shaughnessy", "A Adamcakova-Dodd", "JM Pettibone", "PS Thorne" ],
      "venue" : "Environ Health Perspect",
      "citeRegEx" : "40",
      "shortCiteRegEx" : "40",
      "year" : 2007
    }, {
      "title" : "Cardiovascular effects of ambient particulate air pollution exposure",
      "author" : [ "Q Sun", "X Hong", "LE Wold" ],
      "venue" : null,
      "citeRegEx" : "41",
      "shortCiteRegEx" : "41",
      "year" : 2010
    }, {
      "title" : "Inhalation exposure to nanosized and fine TiO2 particles inhibits features of allergic asthma in a murine model",
      "author" : [ "EM Rossi", "L Pylkkänen", "A Koivisto", "H Nykasenoja", "H Wolff", "K Savolainen", "H Alenius" ],
      "venue" : "Part Fibre Toxicol",
      "citeRegEx" : "42",
      "shortCiteRegEx" : "42",
      "year" : 2010
    }, {
      "title" : "Airway exposure to silicacoated TiO2 nanoparticles induces pulmonary neutrophilia in mice",
      "author" : [ "EM Rossi", "L Pylkkänen", "AJ Koivisto", "M Vippola", "KA Jensen", "M Miettinen", "K Sirola", "H Nykäsenoja", "P Karisola", "T Stjernvall", "E Vanhala", "M Kiilunen", "P Pasanen", "M Mäkinen", "K Hämeri", "J Joutsensaari", "T Tuomi", "J Jokiniemi", "H Wolff", "K Savolainen", "S Matikainen", "H Alenius" ],
      "venue" : "Toxicol Sci 113(2):422–433",
      "citeRegEx" : "43",
      "shortCiteRegEx" : "43",
      "year" : 2010
    }, {
      "title" : "Investigation of gene expression of MMP-2 and TIMP-2 mRNA in rat lung in inhaled nickel oxide and titanium dioxide nanoparticles",
      "author" : [ "Y Morimoto", "T Oyabu", "A Ogami", "T Myojo", "E Kuroda", "M Hirohashi", "M Shimada", "W Lenggoro", "K Okuyama", "I Tanaka" ],
      "venue" : "Ind Health 49(3):344–352",
      "citeRegEx" : "44",
      "shortCiteRegEx" : "44",
      "year" : 2011
    }, {
      "title" : "Nanosized TiO2 caused minor airflow limitation in the murine airways",
      "author" : [ "M Leppänen", "A Korpi", "M Miettinen", "J Leskinen", "T Torvela", "E Rossi", "E Vanhala", "H Wolff", "H Alenius", "V-M Kosma", "J Joutsensaari", "J Jokiniemi", "P Pasanen" ],
      "venue" : "Arch Toxicol",
      "citeRegEx" : "45",
      "shortCiteRegEx" : "45",
      "year" : 2011
    }, {
      "title" : "Impacts after inhalation of nano- and fine-sized titanium dioxide particles: morphological changes, translocation within the rat lung, and evaluation of  32  Shakeel et al.  particle deposition using the relative deposition index",
      "author" : [ "M Eydner", "D Schaudien", "O Creutzenberg", "H Ernst", "T Hansen", "W Baumgärtner", "S Rittinghausen" ],
      "venue" : "Inhal Toxicol 24(9):557–569",
      "citeRegEx" : "46",
      "shortCiteRegEx" : "46",
      "year" : 2012
    }, {
      "title" : "Pulmonary response of rats exposed to titanium dioxide (TiO2) by inhalation for two years",
      "author" : [ "KP Lee", "HJ Trochimowicz", "CF Reinhardt" ],
      "venue" : "Toxicol Appl Pharmacol",
      "citeRegEx" : "47",
      "shortCiteRegEx" : "47",
      "year" : 1985
    }, {
      "title" : "Effects of inhaled titanium dioxide dust on the lung and on the course of experimental Legionnaires’ disease",
      "author" : [ "A Baskerville", "RB Fitzgeorge", "MI Gilmour", "AB Dowsett", "A Williams", "AS Featherstone" ],
      "venue" : "Br J Exp Pathol",
      "citeRegEx" : "48",
      "shortCiteRegEx" : "48",
      "year" : 1988
    }, {
      "title" : "Subchronic inhalation of high concentrations of low toxicity, low solubility particulates produces sustained pulmonary inflammation and cellular proliferation",
      "author" : [ "DB Warheit", "IS Yuen", "DP Kelly", "S Snajdr", "MA Hartsky" ],
      "venue" : null,
      "citeRegEx" : "49",
      "shortCiteRegEx" : "49",
      "year" : 1996
    }, {
      "title" : "Inhalation of high concentrations of low toxicity dusts in rats results in impaired pulmonary clearance mechanisms and persistent inflammation",
      "author" : [ "DB Warheit", "JF Hansen", "IS Yuen", "DP Kelly", "SI Snajdr", "MA Hartsky" ],
      "venue" : "Toxicol Appl Pharmacol 145(1):10–22",
      "citeRegEx" : "50",
      "shortCiteRegEx" : "50",
      "year" : 1997
    }, {
      "title" : "Long-term pulmonary responses of three laboratory rodent species to subchronic inhalation of pigmentary titanium dioxide particles",
      "author" : [ "E Bermudez", "JB Mangum", "B Asgharian", "BA Wong", "EE Reverdy", "DB Janszen", "PM Hext", "DB Warheit", "JI Everitt" ],
      "venue" : "Toxicol Sci 70(1):86–97",
      "citeRegEx" : "51",
      "shortCiteRegEx" : "51",
      "year" : 2002
    }, {
      "title" : "Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: uses and limitations",
      "author" : [ "KE Driscoll", "DL Costa", "G Hatch", "R Henderson", "G Oberdorster", "H Salem", "RB Schlesinger" ],
      "venue" : "Toxicol Sci 55(1):24–35",
      "citeRegEx" : "52",
      "shortCiteRegEx" : "52",
      "year" : 2000
    }, {
      "title" : "Pulmonary response to intratracheal instillation of ultrafine versus fine titanium dioxide: role of particle surface area",
      "author" : [ "TM Sager", "C Kommineni", "V Castranova" ],
      "venue" : "Part Fibre Toxicol 5:17–17",
      "citeRegEx" : "53",
      "shortCiteRegEx" : "53",
      "year" : 2008
    }, {
      "title" : "Systematic influence induced by 3 nm titanium dioxide following intratracheal instillation of mice",
      "author" : [ "Y Li", "J Li", "J Yin", "W Li", "C Kang", "Q Huang", "Q Li" ],
      "venue" : "J Nanosci Nanotechnol",
      "citeRegEx" : "54",
      "shortCiteRegEx" : "54",
      "year" : 2010
    }, {
      "title" : "Induction of chronic inflammation in mice treated with titanium dioxide nanoparticles by intratracheal instillation",
      "author" : [ "E-J Park", "J Yoon", "K Choi", "J Yi", "K Park" ],
      "venue" : "Toxicol 260(1–3):37–46",
      "citeRegEx" : "55",
      "shortCiteRegEx" : "55",
      "year" : 2009
    }, {
      "title" : "Comparative pulmonary toxicity study of nano-TiO2 particles of different sizes and agglomerations in rats: different short- and long-term post-instillation results",
      "author" : [ "N Kobayashi", "NayaM", "S Endoh", "J Maru", "K Yamamoto", "J Nakanishi" ],
      "venue" : null,
      "citeRegEx" : "56",
      "shortCiteRegEx" : "56",
      "year" : 2009
    }, {
      "title" : "Pulmonary toxicity induced by three forms of titanium dioxide nanoparticles via intra-tracheal instillation in rats",
      "author" : [ "R Liu", "L Yin", "Y Pu", "G Liang", "J Zhang", "Y Su", "Z Xiao", "B Ye" ],
      "venue" : "Prog Nat Sci 19(5):573–579",
      "citeRegEx" : "57",
      "shortCiteRegEx" : "57",
      "year" : 2009
    }, {
      "title" : "Surface area of particle administered versus mass in determining the pulmonary toxicity of ultrafine and fine carbon black: comparison to ultrafine titanium dioxide",
      "author" : [ "T Sager", "V Castranova" ],
      "venue" : "Part Fibre Toxicol",
      "citeRegEx" : "58",
      "shortCiteRegEx" : "58",
      "year" : 2009
    }, {
      "title" : "Dose dependent in vivo metabolic characteristics of titanium dioxide nanoparticles",
      "author" : [ "M Tang", "T Zhang", "Y Xue", "S Wang", "M Huang", "Y Yang", "M Lu", "H Lei", "L Kong", "P Yuepu" ],
      "venue" : "J Nanosci Nanotechnol",
      "citeRegEx" : "59",
      "shortCiteRegEx" : "59",
      "year" : 2010
    }, {
      "title" : "Acute and subchronic airway inflammation after intratracheal instillation of quartz and titanium dioxide agglomerates in mice",
      "author" : [ "M Roursgaard", "KA Jensen", "SS Poulsen", "NE Jensen", "LK Poulsen", "M Hammer", "GD Nielsen", "ST Larsen" ],
      "venue" : "Sci World J 11:801–825",
      "citeRegEx" : "60",
      "shortCiteRegEx" : "60",
      "year" : 2011
    }, {
      "title" : "Acute respiratory and systemic toxicity of pulmonary exposure to rutile Fe-doped TiO2  nanorods",
      "author" : [ "A Nemmar", "K Melghit", "S Al-Salam", "S Zia", "S Dhanasekaran", "S Attoub", "I Al-Amri", "BH Ali" ],
      "venue" : null,
      "citeRegEx" : "61",
      "shortCiteRegEx" : "61",
      "year" : 2011
    }, {
      "title" : "Pulmotoxicological effects caused by long-term titanium dioxide nanoparticles exposure in mice",
      "author" : [ "Q Sun", "D Tan", "Y Ze", "X Sang", "X Liu", "S Gui", "Z Cheng", "J Cheng", "R Hu", "G Gao", "G Liu", "M Zhu", "X Zhao", "L Sheng", "L Wang", "M Tang", "F Hong" ],
      "venue" : "J Hazard Mater 235–236:47–53",
      "citeRegEx" : "62",
      "shortCiteRegEx" : "62",
      "year" : 2012
    }, {
      "title" : "Oxidative damage of lung and its protective mechanism in mice caused by long-term exposure to titanium dioxide nanoparticles",
      "author" : [ "Q Sun", "D Tan", "Q Zhou", "X Liu", "Z Cheng", "G Liu", "M Zhu", "X Sang", "S Gui", "J Cheng", "R Hu", "TangM", "F Hong" ],
      "venue" : "J Biomed Mater Res Part A 100A(10):2554–2562",
      "citeRegEx" : "63",
      "shortCiteRegEx" : "63",
      "year" : 2012
    }, {
      "title" : "Pulmonary instillation of low doses of titanium dioxide nanoparticles in mice leads to particle retention and gene expression changes in the absence of inflammation",
      "author" : [ "M Husain", "AT Saber", "C Guo", "NR Jacobsen", "KA Jensen", "CL Yauk", "A Williams", "U Vogel", "H Wallin", "S Halappanavar" ],
      "venue" : "Toxicol Appl Pharmacol 269(3):250–262",
      "citeRegEx" : "64",
      "shortCiteRegEx" : "64",
      "year" : 2013
    }, {
      "title" : "Influence of different sizes of titanium dioxide nanoparticles on hepatic and renal functions in rats with correlation to oxidative stress",
      "author" : [ "G Liang", "Y Pu", "L Yin", "R Liu", "B Ye", "Y Su", "Y Li" ],
      "venue" : "J Toxicol Environ Health Part A 72(11–12):740–745",
      "citeRegEx" : "65",
      "shortCiteRegEx" : "65",
      "year" : 2009
    }, {
      "title" : "Metabonomic studies of biochemical changes in the serum of rats by intratracheally instilled TiO2 nanoparticles",
      "author" : [ "M Tang", "T Zhang", "Y Xue", "S Wang", "M Huang", "Y Yang", "M Lu", "H Lei", "L Kong", "Y Wang", "Y Pu" ],
      "venue" : "J Nanosci Nanotechnol 11(4):3065–3074",
      "citeRegEx" : "66",
      "shortCiteRegEx" : "66",
      "year" : 2011
    }, {
      "title" : "Lung exposure of titanium dioxide nanoparticles induces innate immune activation and long-lasting lymphocyte response in the Dark Agouti rat",
      "author" : [ "Å Gustafsson", "E Lindstedt", "LS Elfsmark", "A Bucht" ],
      "venue" : "J Immunotoxicol 8(2):111–121",
      "citeRegEx" : "67",
      "shortCiteRegEx" : "67",
      "year" : 2011
    }, {
      "title" : "Small-sized titanium dioxide nanoparticles mediate immune toxicity in rat pulmonary alveolar macrophages in vivo",
      "author" : [ "R Liu", "X Zhang", "Y Pu", "L Yin", "Y Li", "G Liang", "X Li", "J Zhang" ],
      "venue" : "J Nanosci Nanotechnol 10(8):5161–5169",
      "citeRegEx" : "68",
      "shortCiteRegEx" : "68",
      "year" : 2010
    }, {
      "title" : "Systemic immune effects of titanium dioxide nanoparticles after repeated intratracheal instillation in rat",
      "author" : [ "Y Fu", "ZhangY", "X Chang", "S Ma", "J Sui", "L Yin", "Y Pu", "G Liang" ],
      "venue" : "Int J Mol Sci 15(4):6961–6973",
      "citeRegEx" : "69",
      "shortCiteRegEx" : "69",
      "year" : 2014
    }, {
      "title" : "In vivo genotoxicity study of titanium dioxide nanoparticles using comet assay following intratracheal instillation in rats",
      "author" : [ "M Naya", "N Kobayashi", "M Ema", "S Kasamoto", "M Fukumuro", "S Takami", "M Nakajima", "M Hayashi", "J Nakanishi" ],
      "venue" : "Regul Toxicol Pharmacol 62(1):1–6",
      "citeRegEx" : "70",
      "shortCiteRegEx" : "70",
      "year" : 2012
    }, {
      "title" : "Metal oxide nanoparticles induce unique inflammatory footprints in the lung: important implications for nanoparticle testing",
      "author" : [ "W-S Cho", "R Duffin", "CA Poland", "SEM Howie", "W MacNee", "M Bradley", "IL Megson", "K Donaldson" ],
      "venue" : "Environ Health Perspect 118(12):1699–1706",
      "citeRegEx" : "71",
      "shortCiteRegEx" : "71",
      "year" : 2010
    }, {
      "title" : "Quantitative evaluation of the pulmonary microdistribution of TiO2 nanoparticles using X-ray fluorescence microscopy after intratracheal administration with a microsprayer in rats",
      "author" : [ "G Zhang", "N Shinohara", "H Kano", "H Senoh", "M Suzuki", "T Sasaki", "S Fukushima", "M Gamo" ],
      "venue" : "J Appl Toxicol 35(6):623–630",
      "citeRegEx" : "72",
      "shortCiteRegEx" : "72",
      "year" : 2015
    }, {
      "title" : "Effect of engineered nanoparticles on vasomotor responses in rat intrapulmonary artery",
      "author" : [ "A Courtois", "P Andujar", "Y Ladeiro", "T Ducret", "F Rogerieux", "G Lacroix", "I Baudrimont", "C Guibert", "E Roux", "Canal-RaffinM", "P Brochard", "F Marano", "R Marthan", "B Muller" ],
      "venue" : "Toxicol Appl Pharmacol 245(2):203–210",
      "citeRegEx" : "73",
      "shortCiteRegEx" : "73",
      "year" : 2010
    }, {
      "title" : "Lung exposure to nanoparticles modulates an asthmatic response in a mouse model",
      "author" : [ "S Hussain", "JAJ Vanoirbeek", "K Luyts", "V De Vooght", "E Verbeken", "LCJ Thomassen", "JA Martens", "D Dinsdale", "S Boland", "F Marano", "B Nemery", "PHM Hoet" ],
      "venue" : "Eur Respir J 37(2):299–309",
      "citeRegEx" : "75",
      "shortCiteRegEx" : "75",
      "year" : 2011
    }, {
      "title" : "Bio-effects of nanoTiO2 on lungs of mice",
      "author" : [ "ZhangY", "J Tao", "P He", "Y Tang", "Y Wang" ],
      "venue" : null,
      "citeRegEx" : "76",
      "shortCiteRegEx" : "76",
      "year" : 2009
    }, {
      "title" : "Acute pulmonary effects of ultrafine particles in rats and mice",
      "author" : [ "G Oberdorster", "JN Finkelstein", "C Johnston", "R Gelein", "C Cox", "R Baggs", "AC Elder" ],
      "venue" : "Res Rep Health Eff Inst",
      "citeRegEx" : "77",
      "shortCiteRegEx" : "77",
      "year" : 2000
    }, {
      "title" : "Effect of nano-TiO(2) intratracheal instillation on lipid metabolism of AopE gene-knockout mice",
      "author" : [ "JQ Hu", "CY Chen", "R Bai", "S Zhen", "XM Du", "JJ Zang", "JC Li", "YQ Gu", "G Jia" ],
      "venue" : null,
      "citeRegEx" : "78",
      "shortCiteRegEx" : "78",
      "year" : 2010
    }, {
      "title" : "Pulmonary instillation studies with nanoscale TiO2 rods and dots in rats: toxicity is not dependent upon particle size and surface area",
      "author" : [ "DB Warheit", "TR Webb", "CM Sayes", "VL Colvin", "KL Reed" ],
      "venue" : "Toxicol Sci 91(1):227–236",
      "citeRegEx" : "79",
      "shortCiteRegEx" : "79",
      "year" : 2006
    }, {
      "title" : "Changes of serum parameters of TiO2 nanoparticle-induced atherosclerosis in mice",
      "author" : [ "X Yu", "X Zhao", "Y Ze", "L Wang", "D Liu", "J Hong", "B Xu", "A Lin", "C Zhang", "Y Zhao", "B Li", "F Hong" ],
      "venue" : "J Hazard Mater 280:364–371",
      "citeRegEx" : "80",
      "shortCiteRegEx" : "80",
      "year" : 2014
    }, {
      "title" : "Potential neurological lesion after nasal instillation of TiO2 nanoparticles in the anatase and rutile crystal phases",
      "author" : [ "J Wang", "C Chen", "Y Liu", "F Jiao", "LiW", "F Lao", "Y Li", "B Li", "C Ge", "G Zhou", "Y Gao", "Y Zhao", "Z Chai" ],
      "venue" : "Toxicol Lett 183(1–3):72–80",
      "citeRegEx" : "81",
      "shortCiteRegEx" : "81",
      "year" : 2008
    }, {
      "title" : "Time-dependent translocation and potential impairment on central nervous system by intranasally instilled TiO2 nanoparticles",
      "author" : [ "J Wang", "Y Liu", "F Jiao", "F Lao", "W Li", "Y Gu", "Y Li", "C Ge", "G Zhou", "B Li", "Y Zhao", "Z Chai", "C Chen" ],
      "venue" : "Toxicol 254(1–2):82–90",
      "citeRegEx" : "82",
      "shortCiteRegEx" : "82",
      "year" : 2008
    }, {
      "title" : "Effects of titanium dioxide nano-particles on growth and some histological parameters of zebrafish (Danio rerio) after a long-term exposure",
      "author" : [ "J Chen", "DongX", "Y Xin" ],
      "venue" : "ZhaoM",
      "citeRegEx" : "83",
      "shortCiteRegEx" : "83",
      "year" : 2011
    }, {
      "title" : "Molecular mechanism of titanium dioxide nanoparticlesinduced oxidative injury in the brain of mice",
      "author" : [ "Y Ze", "L Zheng", "X Zhao", "S Gui", "X Sang", "J Su", "N Guan", "L Zhu", "L Sheng", "R Hu", "J Cheng", "Z Cheng", "Q Sun", "L Wang", "F Hong" ],
      "venue" : null,
      "citeRegEx" : "84",
      "shortCiteRegEx" : "84",
      "year" : 2013
    }, {
      "title" : "Neurotoxicity and gene-expressed profile in brain-injured mice caused by exposure to titanium dioxide nanoparticles",
      "author" : [ "Y Ze", "R Hu", "X Wang", "X Sang", "X Ze", "B Li", "J Su", "Y Wang", "N Guan", "X Zhao", "S Gui", "L Zhu", "Z Cheng", "J Cheng", "L Sheng", "Q Sun", "L Wang", "F Hong" ],
      "venue" : "J Biomed Mater Res Part A 102(2):470–478",
      "citeRegEx" : "85",
      "shortCiteRegEx" : "85",
      "year" : 2014
    }, {
      "title" : "Fine and ultrafine particles of the diet: influence on the mucosal immune response and association with Crohn’s disease",
      "author" : [ "LomerMCE", "ThompsonRPH", "Powell JJ" ],
      "venue" : "Proc Nutr Soc 61(01):123–",
      "citeRegEx" : "88",
      "shortCiteRegEx" : "88",
      "year" : 2002
    }, {
      "title" : "Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles",
      "author" : [ "JF Hillyer", "RM Albrecht" ],
      "venue" : "J Pharm Sci 90(12):1927–1936",
      "citeRegEx" : "89",
      "shortCiteRegEx" : "89",
      "year" : 2001
    }, {
      "title" : "Toxic impact of titanium dioxide (TiO2) in male albino rats with special reference to its effect on reproductive system",
      "author" : [ "NI El-Sharkawy", "SM Hamza", "EH Abou-Zeid" ],
      "venue" : "J Am Sci",
      "citeRegEx" : "90",
      "shortCiteRegEx" : "90",
      "year" : 2010
    }, {
      "title" : "Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration",
      "author" : [ "J Wang", "G Zhou", "C Chen", "H Yu", "T Wang", "Y Ma", "G Jia", "Y Gao", "B Li", "J Sun", "Y Li", "F Jiao", "Y Zhao", "Z Chai" ],
      "venue" : "Toxicol Lett 168(2):176–185",
      "citeRegEx" : "91",
      "shortCiteRegEx" : "91",
      "year" : 2007
    }, {
      "title" : "NMR-based metabonomic study of the sub-acute toxicity of titanium dioxide nanoparticles in rats after oral administration",
      "author" : [ "BuQ", "YanG", "P Deng", "F Peng", "H Lin", "XuY", "Z Cao", "T Zhou", "XueA", "WangY", "X Cen", "YL Zhao" ],
      "venue" : "Nanotechnol 21(12):125105",
      "citeRegEx" : "92",
      "shortCiteRegEx" : "92",
      "year" : 2010
    }, {
      "title" : "Ameliorative effect of quercetin and idebenone against oxidative stress, inflammation, DNA damage and apoptosis induced in rat livers after oral exposure to titanium dioxide nanoparticles",
      "author" : [ "LM Fadda", "N Abdel Baky", "NM Al-Rasheed", "YA Bassiouni" ],
      "venue" : "J Clin Toxicol 3:5",
      "citeRegEx" : "94",
      "shortCiteRegEx" : "94",
      "year" : 2013
    }, {
      "title" : "Oral toxic exposure of titanium dioxide nanoparticles on serum biochemical changes in adult male Wistar rats",
      "author" : [ "D Vasantharaja", "V Ramalingam", "G Aadinaath Reddy" ],
      "venue" : "Nanomedicine J",
      "citeRegEx" : "95",
      "shortCiteRegEx" : "95",
      "year" : 2015
    }, {
      "title" : "Effects of exposure to titanium dioxide nanoparticles on albino rat visual cortex Belectron microscopic study .̂",
      "author" : [ "YM Elbastawisy", "HA Saied" ],
      "venue" : "J Am Sci",
      "citeRegEx" : "96",
      "shortCiteRegEx" : "96",
      "year" : 2013
    }, {
      "title" : "Biochemical responses of nanosize titanium dioxide in the heart of rats following administration of idepenone and quercetin",
      "author" : [ "LM Faddah", "NA Abdel Baky", "NM Al-Rasheed" ],
      "venue" : "Afr J Pharm Pharmacol 7(38):2639–2651",
      "citeRegEx" : "97",
      "shortCiteRegEx" : "97",
      "year" : 2013
    }, {
      "title" : "The effects of exposure to titanium dioxide nanoparticles during lactation period on learning and memory of rat offspring",
      "author" : [ "A Mohammadipour", "M Hosseini", "A Fazel", "H Haghir", "H Rafatpanah", "M Pourganji", "A Ebrahimzadeh Bideskan" ],
      "venue" : null,
      "citeRegEx" : "98",
      "shortCiteRegEx" : "98",
      "year" : 2013
    }, {
      "title" : "TiO2 nanoparticles induced hippocampal neuroinflammation in mice",
      "author" : [ "Y Ze", "L Sheng", "X Zhao", "J Hong", "X Ze", "X Yu", "X Pan", "A Lin", "Y Zhao", "C Zhang", "Q Zhou", "L Wang", "F Hong" ],
      "venue" : "PLoS ONE 9(3),",
      "citeRegEx" : "99",
      "shortCiteRegEx" : "99",
      "year" : 2014
    }, {
      "title" : "Tissue distribution and elimination after oral and intravenous administration of different titanium dioxide nanoparticles in rats",
      "author" : [ "L Geraets", "A Oomen", "P Krystek", "N Jacobsen", "H Wallin", "M Laurentie", "H Verharen", "E Brandon", "W de Jong" ],
      "venue" : "Part Fibre Toxicol",
      "citeRegEx" : "100",
      "shortCiteRegEx" : "100",
      "year" : 2014
    }, {
      "title" : "Evaluating nanoparticle breakthrough during drinkingwater treatment",
      "author" : [ "TEA Chalew", "GS Ajmani", "H Huang", "KJ Schwab" ],
      "venue" : "Environ Health Perspect 121(10):1161–1166",
      "citeRegEx" : "101",
      "shortCiteRegEx" : "101",
      "year" : 2013
    }, {
      "title" : "Titanium dioxide nanoparticles induce DNA damage and genetic instability in vivo in mice",
      "author" : [ "B Trouiller", "R Reliene", "A Westbrook", "P Solaimani", "RH Schiestl" ],
      "venue" : "Cancer Res",
      "citeRegEx" : "102",
      "shortCiteRegEx" : "102",
      "year" : 2009
    }, {
      "title" : "Why i.p. therapy cannot yet be considered as a standard of care for the first-line treatment of ovarian cancer: a systematic review",
      "author" : [ "AM Swart", "S Burdett", "J Ledermann", "P Mook", "MK Parmar" ],
      "venue" : "Ann Oncol 19(4):688–95",
      "citeRegEx" : "103",
      "shortCiteRegEx" : "103",
      "year" : 2008
    }, {
      "title" : "Single-walled carbon nanotubes activate platelets and accelerate thrombus formation in the microcirculation",
      "author" : [ "P Bihari", "M Holzer", "M Praetner", "J Fent", "M Lerchenberger", "CA Reichel", "M Rehberg", "S Lakatos", "F Krombach" ],
      "venue" : null,
      "citeRegEx" : "104",
      "shortCiteRegEx" : "104",
      "year" : 2010
    }, {
      "title" : "Subacute toxicity of titanium dioxide (TiO2) nanoparticles in male rats: emotional behavior and pathophysiological examination",
      "author" : [ "NRB Younes", "S Amara", "I Mrad", "I Ben-Slama", "M Jeljeli", "K Omri", "J El Ghoul", "L El Mir", "K Rhouma", "H Abdelmelek", "M Sakly" ],
      "venue" : "Environ Sci Pollut Res",
      "citeRegEx" : "105",
      "shortCiteRegEx" : "105",
      "year" : 2015
    }, {
      "title" : "In vivo acute toxicity of titanium dioxide nanoparticles to mice after intraperitoneal injection",
      "author" : [ "J Chen", "X Dong", "J Zhao", "G Tang" ],
      "venue" : "J Appl Toxicol 29(4):330–337",
      "citeRegEx" : "106",
      "shortCiteRegEx" : "106",
      "year" : 2009
    }, {
      "title" : "Effects of nanosized titanium dioxide on the reproductive system of male mice",
      "author" : [ "LL Guo", "XH Liu", "DX Qin", "L Gao", "HM Zhang", "JY Liu", "YG Cui" ],
      "venue" : null,
      "citeRegEx" : "107",
      "shortCiteRegEx" : "107",
      "year" : 2009
    }, {
      "title" : "Spleen injury and apoptotic pathway in mice caused by titanium dioxide nanoparticles",
      "author" : [ "N Li", "Y Duan", "M Hong", "L Zheng", "M Fei", "X Zhao", "J Wang", "Y Cui", "H Liu", "J Cai", "S Gong", "H Wang", "F Hong" ],
      "venue" : "Toxicol Lett 195(2–3):161–168",
      "citeRegEx" : "108",
      "shortCiteRegEx" : "108",
      "year" : 2010
    }, {
      "title" : "An increase in mouse tumor growth by an in vivo immunomodulating effect of titanium dioxide nanoparticles",
      "author" : [ "Moon E-Y", "Yi G-H", "Kang J-S", "Lim J-S", "Kim H-M", "Pyo S" ],
      "venue" : "J Immunotoxicol",
      "citeRegEx" : "109",
      "shortCiteRegEx" : "109",
      "year" : 2011
    }, {
      "title" : "Pulmonary inflammation after intraperitoneal administration of ultrafine titanium dioxide (TiO2) at rest or in lungs primed with lipopolysaccharide",
      "author" : [ "Moon C", "Park H-J", "Choi Y-H", "Park E-M", "Castranova V", "Kang JL" ],
      "venue" : "J Toxicol Environ Health Part A",
      "citeRegEx" : "110",
      "shortCiteRegEx" : "110",
      "year" : 2010
    }, {
      "title" : "Nanosized titanium dioxide enhanced inflammatory responses in the septic brain of mouse",
      "author" : [ "JA Shin", "EJ Lee", "SM Seo", "HS Kim", "JL Kang", "EM Park" ],
      "venue" : "Neuroscience 165(2):445–454",
      "citeRegEx" : "111",
      "shortCiteRegEx" : "111",
      "year" : 2010
    }, {
      "title" : "Histologic and apoptotic changes induced by titanium dioxide nanoparticles in the livers of rats",
      "author" : [ "S Alarifi", "D Ali", "AA Al-Doaiss", "BA Ali", "AhmedM", "AA Al-Khedhairy" ],
      "venue" : "Int J Nanomedicine",
      "citeRegEx" : "112",
      "shortCiteRegEx" : "112",
      "year" : 2013
    }, {
      "title" : "Studies on liver damage induced by nanosized-titanium dioxide in mouse",
      "author" : [ "Jeon Y-M", "Kim W-J", "Lee M-Y" ],
      "venue" : "J Environ Biol",
      "citeRegEx" : "113",
      "shortCiteRegEx" : "113",
      "year" : 2013
    }, {
      "title" : "Biochemical toxicity of nano-anatase TiO2 particles in mice",
      "author" : [ "H Liu", "L Ma", "J Zhao", "J Liu", "J Yan", "J Ruan", "F Hong" ],
      "venue" : "Biol Trace Elem Res",
      "citeRegEx" : "114",
      "shortCiteRegEx" : "114",
      "year" : 2009
    }, {
      "title" : "The acute liver injury in mice caused by nano-anatase TiO(2)",
      "author" : [ "L Ma", "J Zhao", "J Wang", "J Liu", "Y Duan", "H Liu", "N Li", "J Yan", "J Ruan", "H Wang", "F Hong" ],
      "venue" : "Nanoscale Res Lett 4(11):1275–1285",
      "citeRegEx" : "115",
      "shortCiteRegEx" : "115",
      "year" : 2009
    }, {
      "title" : "Oxidative stress in the brain of mice caused by translocated nanoparticulate TiO2 delivered to the abdominal cavity",
      "author" : [ "L Ma", "J Liu", "N Li", "J Wang", "Y Duan", "J Yan", "H Liu", "WangH", "F Hong" ],
      "venue" : "Biomaterials 31(1):99–105",
      "citeRegEx" : "116",
      "shortCiteRegEx" : "116",
      "year" : 2010
    }, {
      "title" : "Nano titanium dioxide particles promote allergic sensitization and lung inflammation in mice",
      "author" : [ "ST Larsen", "M Roursgaard", "KA Jensen", "GD Nielsen" ],
      "venue" : "Basic Clin Pharmacol Toxicol",
      "citeRegEx" : "117",
      "shortCiteRegEx" : "117",
      "year" : 2010
    }, {
      "title" : "Nanoparticles transferred from pregnant mice to their offspring can damage the genital and cranial nerve systems",
      "author" : [ "K Takeda", "S K-i", "A Ishihara", "M Kubo-Irie", "R Fujimoto", "M Tabata", "S Oshio", "Y Nihei", "T Ihara", "M Sugamata" ],
      "venue" : "J Health Sci 55(1):95–102",
      "citeRegEx" : "118",
      "shortCiteRegEx" : "118",
      "year" : 2009
    }, {
      "title" : "Effect of fetal exposure to titanium dioxide nanoparticle on brain development—brain region information",
      "author" : [ "M Umezawa", "H Tainaka", "N Kawashima", "M Shimizu", "K Takeda" ],
      "venue" : "J Toxicol Sci",
      "citeRegEx" : "119",
      "shortCiteRegEx" : "119",
      "year" : 2012
    }, {
      "title" : "Maternal exposure to nanoparticulate titanium dioxide during the prenatal period alters gene expression related to brain development in the mouse",
      "author" : [ "M Shimizu", "H Tainaka", "T Oba", "K Mizuo", "M Umezawa", "K Takeda" ],
      "venue" : "Part Fibre Toxicol",
      "citeRegEx" : "120",
      "shortCiteRegEx" : "120",
      "year" : 2009
    }, {
      "title" : "Prenatal exposure to titanium dioxide nanoparticles increases dopamine levels in the prefrontal cortex and neostriatum of mice",
      "author" : [ "Y Takahashi", "K Mizuo", "Y Shinkai", "S Oshio", "K Takeda" ],
      "venue" : "J Toxicol Sci 35(5):749–756",
      "citeRegEx" : "121",
      "shortCiteRegEx" : "121",
      "year" : 2010
    }, {
      "title" : "Biological tolerance of different materials in bulk and nanoparticulate form in a rat model: sarcoma development by nanoparticles",
      "author" : [ "T Hansen", "G Clermont", "A Alves", "R Eloy", "C Brochhausen", "JP Boutrand", "AM Gatti", "CJ Kirkpatrick" ],
      "venue" : "J R Soc Interface",
      "citeRegEx" : "122",
      "shortCiteRegEx" : "122",
      "year" : 2006
    }, {
      "title" : "ESEM evaluations of muscle/nanoparticles interface in a rat model",
      "author" : [ "A Gatti", "J Kirkpatrick", "A Gambarelli", "F Capitani", "T Hansen", "R Eloy", "G Clermont" ],
      "venue" : "J Mater Sci Mater Med",
      "citeRegEx" : "123",
      "shortCiteRegEx" : "123",
      "year" : 2008
    }, {
      "title" : "Nano-scaled particles of titanium dioxide convert benign mouse fibrosarcoma cells into aggressive tumor cells",
      "author" : [ "K Onuma", "Y Sato", "S Ogawara", "N Shirasawa", "M Kobayashi", "J Yoshitake", "T Yoshimura", "M Iigo", "J Fujii", "F Okada" ],
      "venue" : "Am J Pathol 175(5):2171–2183",
      "citeRegEx" : "124",
      "shortCiteRegEx" : "124",
      "year" : 2009
    }, {
      "title" : "Acute toxicity of intravenously administered titanium dioxide nanoparticles in mice",
      "author" : [ "J Xu", "H Shi", "M Ruth", "H Yu", "L Lazar", "B Zou", "C Yang", "A Wu", "J Zhao" ],
      "venue" : "PLoS ONE 8(8),",
      "citeRegEx" : "125",
      "shortCiteRegEx" : "125",
      "year" : 2013
    }, {
      "title" : "High doses of intravenously administered titanium dioxide nanoparticles accumulate in the kidneys of rainbow trout but with no observable impairment of renal function",
      "author" : [ "TM Scown", "R van Aerle", "BD Johnston", "S Cumberland", "JR Lead", "R Owen", "CR Tyler" ],
      "venue" : "Toxicol Sci 109(2):372–380",
      "citeRegEx" : "126",
      "shortCiteRegEx" : "126",
      "year" : 2009
    }, {
      "title" : "Silica and titanium dioxide nanoparticles cause pregnancy complications in mice",
      "author" : [ "K Yamashita", "Y Yoshioka", "K Higashisaka", "K Mimura", "Y Morishita", "M Nozaki", "T Yoshida", "T Ogura", "H Nabeshi", "K Nagano", "Y Abe", "H Kamada", "Y Monobe", "T Imazawa", "H Aoshima", "K Shishido", "Y Kawai", "T Mayumi", "T S-i", "N Itoh", "T Yoshikawa", "I Yanagihara", "S Saito", "Y Tsutsumi" ],
      "venue" : "Nat Nano 6(5):321–",
      "citeRegEx" : "127",
      "shortCiteRegEx" : "127",
      "year" : 2011
    }, {
      "title" : "Beneficial effects of quercetin on oxidative stress in liver and kidney induced by titanium dioxide (TiO2) nanoparticles in rats",
      "author" : [ "AE González-Esquivel", "CL Charles-Niño", "FP Pacheco-Moisés", "GG Ortiz", "F Jaramillo-Juárez", "AR Rincón-Sánchez" ],
      "venue" : "Toxicol Mech Methods 25(3):166–175",
      "citeRegEx" : "128",
      "shortCiteRegEx" : "128",
      "year" : 2015
    }, {
      "title" : "TiO2 nanoparticles translocation and potential toxicological effect in rats after intraarticular injection",
      "author" : [ "Wang J-X", "Fan Y-B", "Gao Y", "Hu Q-H", "Wang T-C" ],
      "venue" : "Biomaterials 30(27):4590–4600",
      "citeRegEx" : "129",
      "shortCiteRegEx" : "129",
      "year" : 2009
    }, {
      "title" : "Evaluation on cartilage morphology after intra-articular injection of titanium dioxide nanoparticles in rats",
      "author" : [ "J Wang", "Y Gao", "Y Hou", "F Zhao", "F Pu", "X Liu", "Z Wu", "Y Fan" ],
      "venue" : "J Nanomat 2012:11",
      "citeRegEx" : "130",
      "shortCiteRegEx" : "130",
      "year" : 2012
    }, {
      "title" : "Prenatal exposure to nanoparticulate titanium dioxide enhances depressive-like behaviors in adult rats",
      "author" : [ "Y Cui", "X Chen", "Z Zhou", "Y Lei", "MaM", "R Cao", "T Sun", "J Xu", "HuoM", "C Wen", "Y Che" ],
      "venue" : "Chemosphere 96:99–104",
      "citeRegEx" : "131",
      "shortCiteRegEx" : "131",
      "year" : 2014
    }, {
      "title" : "Hepatocyte apoptosis and its molecular mechanisms in mice caused by titanium dioxide nanoparticles",
      "author" : [ "Y Cui", "X Gong", "Y Duan", "N Li", "R Hu", "H Liu", "M Hong", "M Zhou", "L Wang", "H Wang", "F Hong" ],
      "venue" : "J Hazard Mater 183(1–3):874–880",
      "citeRegEx" : "132",
      "shortCiteRegEx" : "132",
      "year" : 2010
    }, {
      "title" : "Signaling pathway of inflammatory responses in  Toxicity of Titanium Dioxide (TiO2) Nanoparticles  35 the mouse liver caused by TiO2 nanoparticles",
      "author" : [ "Y Cui", "H Liu", "M Zhou", "Y Duan", "N Li", "X Gong", "R Hu", "M Hong", "F Hong" ],
      "venue" : "J Biomed Mater Res Part A 96A(1):221–229",
      "citeRegEx" : "133",
      "shortCiteRegEx" : "133",
      "year" : 2011
    }, {
      "title" : "2011)Molecular mechanism of hippocampal apoptosis of mice following exposure to titanium dioxide nanoparticles",
      "author" : [ "R Hu", "L Zheng", "T Zhang", "G Gao", "Y Cui", "Z Cheng", "J Cheng", "M Hong", "TangM", "F Hong" ],
      "venue" : "J Hazard Mater 191(1–3):32–40",
      "citeRegEx" : "134",
      "shortCiteRegEx" : "134",
      "year" : 2011
    }, {
      "title" : "P38-Nrf-2 signaling pathway of oxidative stress in mice caused by nanoparticulate TiO2",
      "author" : [ "J Wang", "N Li", "L Zheng", "S Wang", "Y Wang", "X Zhao", "Y Duan", "Y Cui", "M Zhou", "J Cai", "S Gong", "H Wang", "F Hong" ],
      "venue" : "Biol Trace Elem Res",
      "citeRegEx" : "135",
      "shortCiteRegEx" : "135",
      "year" : 2011
    }, {
      "title" : "Intragastric exposure to titanium dioxide nanoparticles induced nephrotoxicity in mice, assessed by physiological and gene expression modifications",
      "author" : [ "S Gui", "SangX", "L Zheng", "Y Ze", "X Zhao", "L Sheng", "Q Sun", "Z Cheng", "J Cheng", "R Hu", "L Wang", "F Hong", "M Tang" ],
      "venue" : "Part Fibre Toxicol",
      "citeRegEx" : "136",
      "shortCiteRegEx" : "136",
      "year" : 2013
    }, {
      "title" : "Toxicological characteristics of nanoparticulate anatase titanium dioxide in mice",
      "author" : [ "Y Duan", "J Liu", "L Ma", "N Li", "H Liu", "J Wang", "L Zheng", "C Liu", "X Wang", "X Zhao", "J Yan", "S Wang", "H Wang", "X Zhang", "F Hong" ],
      "venue" : "Biomaterials 31(5):894–899",
      "citeRegEx" : "137",
      "shortCiteRegEx" : "137",
      "year" : 2010
    }, {
      "title" : "Neurotoxicological effects and the impairment of spatial recognitionmemory in mice caused by exposure to TiO2 nanoparticles",
      "author" : [ "HuR", "GongX", "DuanY", "N Li", "Y Che", "Y Cui", "ZhouM", "C Liu", "H Wang", "F Hong" ],
      "venue" : "Biomaterials 31(31):8043–8050",
      "citeRegEx" : "138",
      "shortCiteRegEx" : "138",
      "year" : 2010
    }, {
      "title" : "The chronic spleen injury of mice following long-term exposure to titanium dioxide nanoparticles",
      "author" : [ "X Sang", "L Zheng", "Q Sun", "N Li", "Y Cui", "R Hu", "G Gao", "Z Cheng", "J Cheng", "S Gui", "H Liu", "Z Zhang", "F Hong" ],
      "venue" : "J Biomed Mater Res Part A 100A(4):894– 902",
      "citeRegEx" : "139",
      "shortCiteRegEx" : "139",
      "year" : 2012
    }, {
      "title" : "Nanosized TiO2-induced reproductive system dysfunction and its mechanism in female mice",
      "author" : [ "X Zhao", "Y Ze", "G Gao", "X Sang", "B Li", "S Gui", "L Sheng", "Q Sun", "J Cheng", "Z Cheng", "R Hu", "L Wang", "F Hong" ],
      "venue" : "PLoS ONE 8(4),",
      "citeRegEx" : "140",
      "shortCiteRegEx" : "140",
      "year" : 2013
    }, {
      "title" : "The mechanism of oxidative damage in the nephrotoxicity of mice caused by nano-anatase TiO2",
      "author" : [ "J Zhao", "N Li", "S Wang", "X Zhao", "J Wang", "J Yan", "J Ruan", "H Wang", "F Hong" ],
      "venue" : "J Exp Nanosci 5(5):447–462",
      "citeRegEx" : "141",
      "shortCiteRegEx" : "141",
      "year" : 2010
    }, {
      "title" : "Attenuation of nano-TiO2 induced genotoxicity, mutagenicity and apoptosis by chlorophyllin inmice cardiac cells",
      "author" : [ "HRH Mohamed" ],
      "venue" : "Int J Sci Res",
      "citeRegEx" : "142",
      "shortCiteRegEx" : "142",
      "year" : 2014
    }, {
      "title" : "Toxicoproteomic identification of TiO2 nanoparticle-induced protein expression changes in mouse brain",
      "author" : [ "Jeon Y-M", "Park S-K", "Lee M-Y" ],
      "venue" : "Anim Cells Syst 15(2):107–114",
      "citeRegEx" : "143",
      "shortCiteRegEx" : "143",
      "year" : 2011
    }, {
      "title" : "Interaction between nano-anatase TiO2 and liver DNA from mice in vivo",
      "author" : [ "N Li", "L Ma", "J Wang", "L Zheng", "J Liu", "Y Duan", "H Liu", "X Zhao", "S Wang", "H Wang", "F Hong", "Y Xie" ],
      "venue" : "Nanoscale Res Lett 5(1):108–115",
      "citeRegEx" : "144",
      "shortCiteRegEx" : "144",
      "year" : 2010
    }, {
      "title" : "Nanotoxicity of TiO2 nanoparticles to erythrocyte in vitro",
      "author" : [ "Li S-Q", "Zhu R-R", "Zhu H", "Xue M", "Sun X-Y", "Yao S-D", "Wang S-L" ],
      "venue" : "Food Chem Toxicol",
      "citeRegEx" : "145",
      "shortCiteRegEx" : "145",
      "year" : 2008
    }, {
      "title" : "Hemolysis caused by titanium dioxide particles",
      "author" : [ "Y Aisaka", "R Kawaguchi", "S Watanabe", "M Ikeda", "H Igisu" ],
      "venue" : "Inhal Toxicol 20(9):891–893",
      "citeRegEx" : "146",
      "shortCiteRegEx" : "146",
      "year" : 2008
    }, {
      "title" : "Cytotoxicity of different sized TiO2 nanoparticles inmouse macrophages",
      "author" : [ "J Zhang", "W Song", "J Guo", "Z Sun", "L Li", "F Ding", "M Gao" ],
      "venue" : "Toxicol Ind Health 29(6):523–533",
      "citeRegEx" : "147",
      "shortCiteRegEx" : "147",
      "year" : 2013
    }, {
      "title" : "Effects of nanoscale titanium dioxide on intercellular gap junction communication in human lung fibroblasts",
      "author" : [ "K Qi", "FR Deng", "XB Guo" ],
      "venue" : null,
      "citeRegEx" : "148",
      "shortCiteRegEx" : "148",
      "year" : 2009
    }, {
      "title" : "In vivo effect of industrial titanium dioxide nanoparticles experimentally exposed to hairless rat skin",
      "author" : [ "K Adachi", "N Yamada", "K Yamamoto", "Y Yoshida", "O Yamamoto" ],
      "venue" : null,
      "citeRegEx" : "149",
      "shortCiteRegEx" : "149",
      "year" : 2010
    }, {
      "title" : "Penetration study of formulated nanosized titanium dioxide in models of damaged and sunirradiated skins",
      "author" : [ "C Miquel-Jeanjean", "F Crépel", "V Raufast", "B Payre", "L Datas", "S Bessou-Touya", "H Duplan" ],
      "venue" : "Photochem Photobiol 88(6):1513–1521",
      "citeRegEx" : "150",
      "shortCiteRegEx" : "150",
      "year" : 2012
    }, {
      "title" : "Crystal structure mediates mode of cell death in TiO2 nanotoxicity",
      "author" : [ "LK Braydich-Stolle", "NM Schaeublin", "RC Murdock", "J Jiang", "P Biswas", "J Schlager", "SM Hussain" ],
      "venue" : "J Nanoparticle Res",
      "citeRegEx" : "151",
      "shortCiteRegEx" : "151",
      "year" : 2009
    }, {
      "title" : "Titanium dioxide nanoparticles promote arrhythmias via a direct interaction with rat cardiac tissue",
      "author" : [ "M Savi", "S Rossi", "L Bocchi", "L Gennaccaro", "F Cacciani", "A Perotti", "D Amidani", "R Alinovi", "M Goldoni", "I Aliatis", "PP Lottici", "D Bersani", "M Campanini", "S Pinelli", "M Petyx", "C Frati", "A Gervasi", "K Urbanek", "F Quaini", "A Buschini", "D Stilli", "C Rivetti", "E Macchi", "A Mutti", "M Miragoli", "M Zaniboni" ],
      "venue" : "Part Fibre Toxicol 11(1):63",
      "citeRegEx" : "152",
      "shortCiteRegEx" : "152",
      "year" : 2014
    }, {
      "title" : "A quantitative study of exocytosis of titanium dioxide nanoparticles from neural stem cells",
      "author" : [ "Y Wang", "Q Wu", "K Sui", "X-X Chen", "J Fang", "X Hu", "M Wu", "Y Liu" ],
      "venue" : null,
      "citeRegEx" : "153",
      "shortCiteRegEx" : "153",
      "year" : 2013
    }, {
      "title" : "Direct imaging of titania nanotubes located in mouse neural stem cell nuclei",
      "author" : [ "Y Wang", "J Wang", "X Deng", "H Wang", "M Wu", "Z Jiao", "Y Liu" ],
      "venue" : "Nano Res",
      "citeRegEx" : "154",
      "shortCiteRegEx" : "154",
      "year" : 2009
    } ],
    "referenceMentions" : [ {
      "referenceID" : 1,
      "context" : "According to a recent study, candies, sweets and chewing gums have a higher amount of TiO2 nanoparticles (<100 nm) [3].",
      "startOffset" : 115,
      "endOffset" : 118
    }, {
      "referenceID" : 2,
      "context" : "TiO2 nanoparticulate carriers are delivered into the human body through intravenous or subcutaneous injection in nanomedicine [4].",
      "startOffset" : 126,
      "endOffset" : 129
    }, {
      "referenceID" : 3,
      "context" : "[5] investigated that titanium dioxide nanoparticles found in products like paint are less dangerous, unless they become free by sanding.",
      "startOffset" : 0,
      "endOffset" : 3
    }, {
      "referenceID" : 4,
      "context" : "[6] studied testicular damage and alterations in gene expression profiles in male mice induced by intragastric * Farhat Jabeen farjabeen2004@yahoo.",
      "startOffset" : 0,
      "endOffset" : 3
    }, {
      "referenceID" : 5,
      "context" : "It is well known that several common food products have these nanoparticles in them, along with likely daily exposure to humans of various age groups [7].",
      "startOffset" : 150,
      "endOffset" : 153
    }, {
      "referenceID" : 7,
      "context" : "Therefore, a number of in vivo and in vitro studies have been performed to investigate the penetration of TiO2 nanoparticles on both intact skin as well as on the stripped skin to evaluate the effect on the injured skin [9].",
      "startOffset" : 220,
      "endOffset" : 223
    }, {
      "referenceID" : 9,
      "context" : "[11], have shown no significant penetration of TiO2 nanoparticles through the intact skin.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 9,
      "context" : "[11] found that TiO2 nanoparticles (uncoated submicron sized, uncoated nanosized and",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 7,
      "context" : "[9] applied 35 nm non-coated TiO2 nanoparticles, 35 nm coated TiO2 nanoparticles, 100 nm TiO2 nanoparticles coated with alumina and silicon and 250 nm TiO2 nanoparticles non-coated to the intact and stripped skins of Yucatan micropigs at the rate of 2 μL suspension per cm(2) of skin.",
      "startOffset" : 0,
      "endOffset" : 3
    }, {
      "referenceID" : 10,
      "context" : "The method of tape stripping using adhesive tape is widely used for studying the localization and distribution of drugs in the stratum corneum [12].",
      "startOffset" : 143,
      "endOffset" : 147
    }, {
      "referenceID" : 11,
      "context" : "[13] found that coated 20 nm TiO2 nanoparticles dispersed in three sunscreen formulations were not likely to penetrate the stratum corneum towards the underlying keratinocytes in normal human skin even after 48 h under realistic in vivo conditions in normal and altered skin.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 12,
      "context" : "[14] demonstrated both in vivo and in vitro in pigs that penetration of TiO2 nanoparticles of sunscreen formulations was slightly enhanced in the skin damaged by ultraviolet B.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 13,
      "context" : "Bennat and Müller-Goymann [15] showed that TiO2 nanoparticles can penetrate through hairy skin on application as oilin-water emulsion.",
      "startOffset" : 26,
      "endOffset" : 30
    }, {
      "referenceID" : 14,
      "context" : "[16] found that there was no penetration of titanium dioxide nanoparticles through topical application in the epidermis of up to 20 mg silicon-coated TiO2 nanoparticles and up to 100 mg non-coated TiO2 nanoparticles in c-Ha-ras.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 15,
      "context" : "Furthermore, silicon-coated TiO2 nanoparticles could not penetrate the human epidermis model in vitro [17, 18].",
      "startOffset" : 102,
      "endOffset" : 110
    }, {
      "referenceID" : 16,
      "context" : "Furthermore, silicon-coated TiO2 nanoparticles could not penetrate the human epidermis model in vitro [17, 18].",
      "startOffset" : 102,
      "endOffset" : 110
    }, {
      "referenceID" : 17,
      "context" : "[19] found no penetration of TiO2 nanoparticles of various sizes through the stratum corneum of isolated porcine skin exposed for 24 h in vitro.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 17,
      "context" : "This study revealed that dermal exposure to TiO2 nanoparticles over a relatively prolonged time may pose a health risk in humans [19].",
      "startOffset" : 129,
      "endOffset" : 133
    }, {
      "referenceID" : 14,
      "context" : "[16] investigated that titanium dioxide nanoparticles do not possess post-initiation potential for mouse skin carcinogenesis.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 15,
      "context" : "Furthermore, silicon-coated TiO2 nanoparticles could not penetrate the human epidermis model in vitro [17].",
      "startOffset" : 102,
      "endOffset" : 106
    }, {
      "referenceID" : 16,
      "context" : "[18] with similar results on the c-Ha-ras protooncogene transgenic (Hras128) Toxicity of Titanium Dioxide (TiO2) Nanoparticles 3",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 18,
      "context" : "[20] investigated acute dermal irritation in the local lymph node assay in mice and rabbits using 0, 5, 25, 50 or 100 % anatase/rutile (80/20) TiO2 nanoparticles with the size of 129.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 19,
      "context" : "In another study, at 1, 24 or 48 h post-exposure, acute tests on the dermal, eye and vaginal mucous membrane in mice treated with TiO2 nanoparticles at the dose of 1000, 2150, 4640 and 10,000 mg/kg body weight showed no significant irritation [21].",
      "startOffset" : 243,
      "endOffset" : 247
    }, {
      "referenceID" : 20,
      "context" : "[22] at the biochemical level expressed as decreased glutathione Stransferase and catalase activity and increased lactate dehydrogenase activity and lipid peroxidation, and the levels of glutamic pyruvic transaminase and glutamic oxaloacetic transaminase in the serum, blood urea nitrogen and creatinine were also increased.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 21,
      "context" : "On treating male NC/Nga mice with 20 μg of 15, 50 or 100 nm rutile TiO2 nanoparticles by intradermal injections, allergen+TiO2 showed atopic dermatitis, enhanced ear thickening and inflammatory action (increased eosinophils, interleukin-4, mast cells and decreased interferon-γ; TiO2 increased interleukin-13) [23].",
      "startOffset" : 310,
      "endOffset" : 314
    }, {
      "referenceID" : 22,
      "context" : "Figure 2 explains the distribution of TiO2 nanoparticles after inhalation based on the study by Simkó and Mattsson [24].",
      "startOffset" : 115,
      "endOffset" : 119
    }, {
      "referenceID" : 23,
      "context" : "However, a large number of studies have been performed on rodents [25].",
      "startOffset" : 66,
      "endOffset" : 70
    }, {
      "referenceID" : 24,
      "context" : "[26] observed the transportation of a small fraction of 20-nm-sized TiO2 nanoparticles from the airway lumen to the interstitial connective tissue of adult male rats exposed to 0.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 25,
      "context" : "[27] exposed male Wistar rats to anatase-rutile TiO2 mixture (20–30 nm) and rutile TiO2 (200 nm) in the form of aerosols of 100 and 250mg/m(3) of uncoated and pigmentary TiO2, respectively, for 6 h per day and five consecutive days via inhalation.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 26,
      "context" : "There was a marked impairment in the clearance of TiO2 nanoparticles from the lung of exposed mice and rats [28].",
      "startOffset" : 108,
      "endOffset" : 112
    }, {
      "referenceID" : 27,
      "context" : "A dose-dependent deposition of Ti in the lung tissue and an increase in neutrophils in bronchoalveolar lavage (BAL) fluid indicated an inflammatory effect in mice [29].",
      "startOffset" : 163,
      "endOffset" : 167
    }, {
      "referenceID" : 28,
      "context" : "5– 16 mg/m(3) P25 anatase-rutile TiO2 (21 nm) for 240–720 min [30].",
      "startOffset" : 62,
      "endOffset" : 66
    }, {
      "referenceID" : 29,
      "context" : "Nanoparticle exposure via inhalation significantly impairs endothelium-dependent vasodilation in sub-epicardial arterioles [31].",
      "startOffset" : 123,
      "endOffset" : 127
    }, {
      "referenceID" : 30,
      "context" : "In addition, the greater adrenergic receptor sensitivity indicates an amplified sympathetic responsiveness [32].",
      "startOffset" : 107,
      "endOffset" : 111
    }, {
      "referenceID" : 32,
      "context" : "Microvascular oxidative stress was increased significantly [34].",
      "startOffset" : 59,
      "endOffset" : 63
    }, {
      "referenceID" : 33,
      "context" : "The airway resistance was increased in 2-week-old mice [35].",
      "startOffset" : 55,
      "endOffset" : 59
    }, {
      "referenceID" : 34,
      "context" : "Gestationally exposed offsprings displayed moderate neurobehavioral alterations [36].",
      "startOffset" : 80,
      "endOffset" : 84
    }, {
      "referenceID" : 35,
      "context" : "The inhalation of the surface-coated TiO2 nanoparticles causes alterations in the expression of genes in the lungs related with acute phase, inflammation and immune response with concomitant changes in several miRNAs [37].",
      "startOffset" : 217,
      "endOffset" : 221
    }, {
      "referenceID" : 36,
      "context" : "[38] found that bronchoalveolar lavage fluid (BALF) indicated that large aerosols (>100 nm) caused an acute inflammatory response, as shown by the significantly enhanced number of neutrophils, while small aerosols (5, 10–30 or 50 nm) produced significant oxidative stress damages and cytotoxicity in the lungs of male rats exposed to TiO2 nanoparticles at 20 mg/m(3) for 6 h.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 37,
      "context" : "1-nm-sized TiO2 nanoparticles by inhalation for 6 h/day for 5 days [39].",
      "startOffset" : 67,
      "endOffset" : 71
    }, {
      "referenceID" : 25,
      "context" : "[27] exposed male Wistar rats to anatase-rutile TiO2 mixture (20–30 nm) and rutile TiO2 (200 nm) in the form of aerosols of 100 and 250 mg/m(3) uncoated and pigmentary TiO2, respectively, for 6 h/day on five consecutive days through inhalation.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 38,
      "context" : "[40], when exposed to 2–5 nm TiO2 nanoparticles at the dose of 8.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 32,
      "context" : "[34] observed that inhalation of nanoparticles (21 nm) or the fine TiO2 (1 μm) at the dose of 1.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 32,
      "context" : "inflammatory and/or neurogenic mechanisms [34].",
      "startOffset" : 42,
      "endOffset" : 46
    }, {
      "referenceID" : 29,
      "context" : "In addition, it was observed that the inhalation of 6 mg/m(3) 21 nm P25 and a mixture of anatase (80 nm)/rutile (20 nm) TiO2 nanoparticles for 240 min caused an increased spontaneous arteriolar basal tone, a reduced flow and a reduced responsiveness of the coronary arterioles to dilators 1 day post-exposure in male Sprague-Dawley rats in another study [31].",
      "startOffset" : 354,
      "endOffset" : 358
    }, {
      "referenceID" : 39,
      "context" : "Exposure to particulate matter can result in significant alterations in many cardiovascular indices, like blood pressure, heart rate, heart rate variability and blood coagulability [41].",
      "startOffset" : 181,
      "endOffset" : 185
    }, {
      "referenceID" : 40,
      "context" : "[42] observed that if mice were repeatedly exposed to TiO2 nanoparticles through the airway, the airway inflammation is modulated.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 41,
      "context" : "[43], the exposure of mice by inhalation for 2 h for four consecutive days for 4 weeks to uncoated rutile and anatase TiO2 nanoparticles did not induce significant inflammation.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 42,
      "context" : "[44] also reported that inhaled TiO2 nanoparticles (rutile 51±9 nm; 2.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 43,
      "context" : "[45] showed no inflammatory action in male mice exposed to TiO2 nanoparticles (primary particle size 20 nm; geometric mean diameters of 91, 113 and 130 nm anatase+brookite (3:1); 8–30 mg/m(3) for 0.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 26,
      "context" : "A sub-chronic inhalation study comparing pulmonary responses to TiO2 nanoparticles in several species was performed [28].",
      "startOffset" : 116,
      "endOffset" : 120
    }, {
      "referenceID" : 41,
      "context" : "Silicon dioxide (SiO2)-coated 40 nm rutile TiO2 nanoparticles inhaled at the concentrations of 10mg/m(3) for 2 h on four consecutive days for 4 weeks induced pulmonary neutrophilia and increased the expression of tumour necrosis factor-α and neutrophil-attracting chemokine CXCL 1 in lung tissues [43].",
      "startOffset" : 297,
      "endOffset" : 301
    }, {
      "referenceID" : 44,
      "context" : "Minimal inflammatory effects in the lungs, leucopenia and decreased β-glucuronidase by inhalation of TiO2 nanoparticles have been observed [46].",
      "startOffset" : 139,
      "endOffset" : 143
    }, {
      "referenceID" : 45,
      "context" : "Chronic lung inhalation studies [47, 48] that exposed pigs or rats, respectively, to TiO2 nanoparticles have reported findings of pulmonary pathology such as increased incidences of pneumonia, squamous metaplasia [48], sustained pulmonary responses [49], enhanced proliferation of pulmonary cells, defects in macrophage function [50], alveolar epithelial metaplasia, progressive fibroproliferative lesions [51] and accumulation of macrophages in interalveolar septa [8, 47].",
      "startOffset" : 32,
      "endOffset" : 40
    }, {
      "referenceID" : 46,
      "context" : "Chronic lung inhalation studies [47, 48] that exposed pigs or rats, respectively, to TiO2 nanoparticles have reported findings of pulmonary pathology such as increased incidences of pneumonia, squamous metaplasia [48], sustained pulmonary responses [49], enhanced proliferation of pulmonary cells, defects in macrophage function [50], alveolar epithelial metaplasia, progressive fibroproliferative lesions [51] and accumulation of macrophages in interalveolar septa [8, 47].",
      "startOffset" : 32,
      "endOffset" : 40
    }, {
      "referenceID" : 46,
      "context" : "Chronic lung inhalation studies [47, 48] that exposed pigs or rats, respectively, to TiO2 nanoparticles have reported findings of pulmonary pathology such as increased incidences of pneumonia, squamous metaplasia [48], sustained pulmonary responses [49], enhanced proliferation of pulmonary cells, defects in macrophage function [50], alveolar epithelial metaplasia, progressive fibroproliferative lesions [51] and accumulation of macrophages in interalveolar septa [8, 47].",
      "startOffset" : 213,
      "endOffset" : 217
    }, {
      "referenceID" : 47,
      "context" : "Chronic lung inhalation studies [47, 48] that exposed pigs or rats, respectively, to TiO2 nanoparticles have reported findings of pulmonary pathology such as increased incidences of pneumonia, squamous metaplasia [48], sustained pulmonary responses [49], enhanced proliferation of pulmonary cells, defects in macrophage function [50], alveolar epithelial metaplasia, progressive fibroproliferative lesions [51] and accumulation of macrophages in interalveolar septa [8, 47].",
      "startOffset" : 249,
      "endOffset" : 253
    }, {
      "referenceID" : 48,
      "context" : "Chronic lung inhalation studies [47, 48] that exposed pigs or rats, respectively, to TiO2 nanoparticles have reported findings of pulmonary pathology such as increased incidences of pneumonia, squamous metaplasia [48], sustained pulmonary responses [49], enhanced proliferation of pulmonary cells, defects in macrophage function [50], alveolar epithelial metaplasia, progressive fibroproliferative lesions [51] and accumulation of macrophages in interalveolar septa [8, 47].",
      "startOffset" : 329,
      "endOffset" : 333
    }, {
      "referenceID" : 49,
      "context" : "Chronic lung inhalation studies [47, 48] that exposed pigs or rats, respectively, to TiO2 nanoparticles have reported findings of pulmonary pathology such as increased incidences of pneumonia, squamous metaplasia [48], sustained pulmonary responses [49], enhanced proliferation of pulmonary cells, defects in macrophage function [50], alveolar epithelial metaplasia, progressive fibroproliferative lesions [51] and accumulation of macrophages in interalveolar septa [8, 47].",
      "startOffset" : 406,
      "endOffset" : 410
    }, {
      "referenceID" : 6,
      "context" : "Chronic lung inhalation studies [47, 48] that exposed pigs or rats, respectively, to TiO2 nanoparticles have reported findings of pulmonary pathology such as increased incidences of pneumonia, squamous metaplasia [48], sustained pulmonary responses [49], enhanced proliferation of pulmonary cells, defects in macrophage function [50], alveolar epithelial metaplasia, progressive fibroproliferative lesions [51] and accumulation of macrophages in interalveolar septa [8, 47].",
      "startOffset" : 466,
      "endOffset" : 473
    }, {
      "referenceID" : 45,
      "context" : "Chronic lung inhalation studies [47, 48] that exposed pigs or rats, respectively, to TiO2 nanoparticles have reported findings of pulmonary pathology such as increased incidences of pneumonia, squamous metaplasia [48], sustained pulmonary responses [49], enhanced proliferation of pulmonary cells, defects in macrophage function [50], alveolar epithelial metaplasia, progressive fibroproliferative lesions [51] and accumulation of macrophages in interalveolar septa [8, 47].",
      "startOffset" : 466,
      "endOffset" : 473
    }, {
      "referenceID" : 6,
      "context" : "Although the studies on the exposure through inhalation are thought to be the gold standard, studies on the exposure through intratracheal instillation may prove useful for the assessment of risks [8, 52].",
      "startOffset" : 197,
      "endOffset" : 204
    }, {
      "referenceID" : 50,
      "context" : "Although the studies on the exposure through inhalation are thought to be the gold standard, studies on the exposure through intratracheal instillation may prove useful for the assessment of risks [8, 52].",
      "startOffset" : 197,
      "endOffset" : 204
    }, {
      "referenceID" : 6,
      "context" : "interstitium was significantly greater than their fine counterparts after both inhalation exposure and intratracheal instillation [8, 53].",
      "startOffset" : 130,
      "endOffset" : 137
    }, {
      "referenceID" : 51,
      "context" : "interstitium was significantly greater than their fine counterparts after both inhalation exposure and intratracheal instillation [8, 53].",
      "startOffset" : 130,
      "endOffset" : 137
    }, {
      "referenceID" : 52,
      "context" : "A small fraction of pulmonary TiO2 nanoparticles may enter the blood circulation and reach other tissues like the liver and kidneys after 28 days of being intratracheally instilled [54].",
      "startOffset" : 181,
      "endOffset" : 185
    }, {
      "referenceID" : 55,
      "context" : "5, 5 or 50 mg/kg TiO2 nanoparticles with 5, 21, and 50 nm primary particle size by intratracheal instillation showed inflammatory action (lactate dehydrogenase and ALP increased in the lung by 5 and 50 nm TiO2), inflammatory infiltration, alveolar wall thickening and alveolar macrophage phagocytic ability altered by 5 and 50 nm TiO2 [57].",
      "startOffset" : 335,
      "endOffset" : 339
    }, {
      "referenceID" : 54,
      "context" : "However, this pulmonary inflammation was remarkably recovered [56].",
      "startOffset" : 62,
      "endOffset" : 66
    }, {
      "referenceID" : 54,
      "context" : "[56], male rats were treated with 5 mg/kg anatase TiO2 (4.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 59,
      "context" : "[61] also demonstrated that intratracheal exposure to 1.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 60,
      "context" : "This may result into severe inflammatory response, pulmonary oedema and pneumonocyte apoptosis for 90 days [62].",
      "startOffset" : 107,
      "endOffset" : 111
    }, {
      "referenceID" : 61,
      "context" : "With increasing exposure, TiO2 nanoparticles may significantly accumulate and cause the production of the reactive oxygen species in the lung [63].",
      "startOffset" : 142,
      "endOffset" : 146
    }, {
      "referenceID" : 59,
      "context" : "The intratracheal exposure induced a significant and dose-dependent increase in neutrophils in the bronchoalveolar lavage and an increase in interleukin-6 and caused a dose-dependent decrease of superoxide dismutase activity [61].",
      "startOffset" : 225,
      "endOffset" : 229
    }, {
      "referenceID" : 58,
      "context" : "[60] showed sub-chronic lung inflammation in a dose-dependent manner due to an increase in BALF macrophages.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 58,
      "context" : "There was a dose-dependent acute increase in neutrophils, IL-6 and total protein in BALF in all TiO2 nanoparticle-treated groups [60].",
      "startOffset" : 129,
      "endOffset" : 133
    }, {
      "referenceID" : 60,
      "context" : "Exposure to TiO2 nanoparticles significantly enhance the reactive oxygen species and lipid peroxidation and decrease the capacity of the antioxidant in the lung [62].",
      "startOffset" : 161,
      "endOffset" : 165
    }, {
      "referenceID" : 62,
      "context" : "However, in low andmedium doses, the inflammation resolved and there was no neutrophil influx in the lung fluid [64].",
      "startOffset" : 112,
      "endOffset" : 116
    }, {
      "referenceID" : 57,
      "context" : "8, 4, 20 mg/kg) can recoverably impact metabolic function (acetate, valine, dimethylamine, taurine, hippurate and 2oxoglutarate) because the scattered nanoparticles may be transported from the lung to other organs or tissues like the liver or kidney, but particles in higher doses aggregate and deposit in the lung without migration and cause pulmonary inflammation along with expanded lung gaps and hyperemia [59].",
      "startOffset" : 410,
      "endOffset" : 414
    }, {
      "referenceID" : 63,
      "context" : "There were no apparent pathological changes in the liver and kidney [65], whereas inflammatory responses have been observed by Park et al.",
      "startOffset" : 68,
      "endOffset" : 72
    }, {
      "referenceID" : 63,
      "context" : "[65] treated male and female Sprague-Dawley rats with 5 and 21 nm at a dose of 0.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 52,
      "context" : "[54] reported the entrance of intratracheally instilled TiO2 nanoparticles into the blood and liver and kidney injury due to these particles.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 59,
      "context" : "[61] reported that the liver showed slight infiltration of inflammatory cells, mainly lymphocytes, of few portal tracts.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 59,
      "context" : "The plasma superoxide dismutase and reduced glutathione activities decreased dose-dependently, while AST and ALT increased [61].",
      "startOffset" : 123,
      "endOffset" : 127
    }, {
      "referenceID" : 64,
      "context" : "[66] in male Sprague-Dawley rats exposed to intratracheal instillation of 0.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 52,
      "context" : "TiO2 nanoparticles might pass through the blood-brain barrier and induce brain injury through oxidative stress response in mice [54].",
      "startOffset" : 128,
      "endOffset" : 132
    }, {
      "referenceID" : 64,
      "context" : "TEM analysis showed swollen hepatocytes and congested sinusoids [66].",
      "startOffset" : 64,
      "endOffset" : 68
    }, {
      "referenceID" : 53,
      "context" : "ICR mice exposed to 5, 20 and 50 mg/kg of P25 TiO2 (21 nm) by a single intratracheal instillation showed inflammatory action (interleukin-1, tumour necrosis factor-α, interleukin-6, interleukin-12, interferon-γ, interleukin-4, interleukin-5, interleukin10 and IgE increased in bronchoalveolar lavage), histology changes (inflammatory proteins, granulomas) and upregulation of genes involved in antigen presentation and immune cell chemotaxis [55].",
      "startOffset" : 442,
      "endOffset" : 446
    }, {
      "referenceID" : 65,
      "context" : "[67] have demonstrated a dynamic response in the lungs of Dark Agouti rats to TiO2 nanoparticles, starting with an activation of the innate immunity of eosinophils, neutrophils, natural killer cells and dendritic cells, followed by a long-lasting activation of lymphocytes of adaptive immunity.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 66,
      "context" : "As a result of exposure to intratracheally instilled TiO2 nanoparticles, both damage to the cell structure and dysfunction of pulmonary alveolar macrophages may happen, leading to a reduction in both specific and non-specific immune responses in individuals exposed to small-sized TiO2 nanoparticles [68].",
      "startOffset" : 300,
      "endOffset" : 304
    }, {
      "referenceID" : 59,
      "context" : "Heart rate, systolic blood pressure, plasma interleukin-6 and number of leukocyte and platelet increased [61].",
      "startOffset" : 105,
      "endOffset" : 109
    }, {
      "referenceID" : 67,
      "context" : "There were no significant changes in cytokines [69].",
      "startOffset" : 47,
      "endOffset" : 51
    }, {
      "referenceID" : 61,
      "context" : "The Nrf-2 expression induction is an intracellular adaptive response to oxidative stress induced by TiO2 nanoparticles in the mouse lung [63].",
      "startOffset" : 137,
      "endOffset" : 141
    }, {
      "referenceID" : 60,
      "context" : "However, the exposure to TiO2 nanoparticles reduced nuclear factor kappa-light-chainenhancer of activated B cells (NF-κB)-inhibiting factor and expression of heat shock protein 70 in mice [62].",
      "startOffset" : 188,
      "endOffset" : 192
    }, {
      "referenceID" : 62,
      "context" : "These effects were associated with down-regulation of genes responsible for ion homeostasis and regulation of muscle [64].",
      "startOffset" : 117,
      "endOffset" : 121
    }, {
      "referenceID" : 68,
      "context" : "[70] found in a study carried out on Sprague-Dawley male rats that intratracheal instillation of anatase TiO2 nanoparticles is not genotoxic in rats.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 69,
      "context" : "[71] also reported no inflammatory responses in the bronchoalveolar lavage and histology of the lung in rats after 24 h and 4 weeks of treatment of intratracheally instilled 50 and 150 cm(2)/rat TiO2 nanoparticles (30–40 nm).",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 70,
      "context" : "[72] evaluated the microdistribution of TiO2 nanoparticles in the lungs of rats using X-ray fluorescence microscopy.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 71,
      "context" : "[73] found no altered effect in the intralobar arteries’ vasomotor responses to prostaglandin F2α, KCl and acetylcholine in male Wistar or Sprague-Dawley rats exposed to 100μg TiO2 in 0.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 55,
      "context" : "[57] treated rats by intratracheal instillation with a single dose of 0.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 54,
      "context" : "[56] reported the time course of pulmonary responses at 1 and 7 days after intratracheal instillation of 5 mg/ml of 19 and 28 nm TiO2 nanoparticles in rats.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 66,
      "context" : "[68] investigated the effects of TiO2 nanoparticles on the immune function of rat alveolar macrophages exposed to intratracheally instilled 5 and 200 nm TiO2 nanoparticles at the concentration of 0.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 72,
      "context" : "9 % anatase 15 nm TiO2 nanoparticles in toluene diisocyanate-induced asthma mice treated on the dorsum of both ears (20 μL) on days 1 and 8 [75].",
      "startOffset" : 140,
      "endOffset" : 144
    }, {
      "referenceID" : 73,
      "context" : "[76] intratracheally instilled rats with TiO2 nanoparticles at the dose of 1 and 10 mg/kg body weight.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 74,
      "context" : "[77] observed a significant pulmonary inflammation due to TiO2 nanoparticles (20 nm) in rats and mice, expressed by the increase of total protein in branchioalveolar lavage fluid, acidglucosidase and LDH activity.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 52,
      "context" : "[54] studied the effects of intratracheally instilled 3-nm-sized TiO2 nanoparticles once a week for 28 days in mice after a total dose of 13.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 75,
      "context" : "1 mg/ml twice per week for 6 weeks induced dyslipidemia and enhanced the atherosclerosis and plaque rupture in intratracheally instilled mice [78].",
      "startOffset" : 142,
      "endOffset" : 146
    }, {
      "referenceID" : 76,
      "context" : "[79] compared several types of TiO2 fine particles and nanoparticles with different sizes, surface areas and crystal structures by intratracheal instillation of TiO2 nanoparticles with the size of 25 or 100 nm and dose of 1 and 5 mg/kg body weight for 24 h, 1 week and 3 months into rats.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 58,
      "context" : "[60] found an increase in interleukin-6 and total protein in bronchoalveolar lavage fluid as well as airway inflammation at the highest doses in the acute phase by both fine as well as nanoparticles.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 72,
      "context" : "Histological analysis revealed increased oedema, epithelial damage and inflammation in the lungs [75].",
      "startOffset" : 97,
      "endOffset" : 101
    }, {
      "referenceID" : 77,
      "context" : "[80] have also reported that chronic exposure to TiO2 nanoparticles may result in atherogenesis in combination with pulmonary inflammation.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 78,
      "context" : "[81, 82] demonstrated on murine brain that intranasally instilled 80 nm rutile and 155 nm anatase TiO2 nanoparticles at 500 μg/ml for 2, 10, 20 and 30 days can be taken up and translocated by sensory nerves to the brain.",
      "startOffset" : 0,
      "endOffset" : 8
    }, {
      "referenceID" : 79,
      "context" : "[81, 82] demonstrated on murine brain that intranasally instilled 80 nm rutile and 155 nm anatase TiO2 nanoparticles at 500 μg/ml for 2, 10, 20 and 30 days can be taken up and translocated by sensory nerves to the brain.",
      "startOffset" : 0,
      "endOffset" : 8
    }, {
      "referenceID" : 79,
      "context" : "The oxidative damage expressed as lipid peroxidation, glutathione peroxidase, glutathione S-transferase, SOD, reduced glutathione and malondialdehyde increased significantly [82].",
      "startOffset" : 174,
      "endOffset" : 178
    }, {
      "referenceID" : 78,
      "context" : "Female CD-1 (ICR) mice treated with rutile (80 nm) or anatase (155 nm) at the dose of 500 μg every other day for 15 times by intranasal instillation showed Ti brain distribution mainly in the olfactory bulb and hippocampus, causing oxidative stress (decreased catalase activity, malondialdehyde; protein carbonyls increased, SOD), and neurotransmitters like acetylcholinesterase, glutamic acid and NO were increased [81].",
      "startOffset" : 416,
      "endOffset" : 420
    }, {
      "referenceID" : 80,
      "context" : "[83] have also suggested that the TiO2 nanoparticles can translocate among the organs and pass through the blood-brain and the blood-heart barrier after long-term exposure.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 81,
      "context" : "The exposure of mouse to TiO2 nanoparticles also increased reactive oxygen species production and peroxidation of lipid, protein and DNA [84].",
      "startOffset" : 137,
      "endOffset" : 141
    }, {
      "referenceID" : 82,
      "context" : "Moreover, TiO2 nanoparticles showed significant alterations in the expression of certain genes related to oxidative stress, immune response, apoptosis, metabolic process, DNA repair, brain development, signal transduction, memory and learning, response to stimulus and cellular process [85].",
      "startOffset" : 286,
      "endOffset" : 290
    }, {
      "referenceID" : 81,
      "context" : "This damage may take place through the p38-Nrf-2 signalling pathway [84].",
      "startOffset" : 68,
      "endOffset" : 72
    }, {
      "referenceID" : 80,
      "context" : "[83] studied chronic toxicity of TiO2 nanoparticles and found obvious adverse effect to zebrafish (Danio rerio), including timedependent and concentration-dependent inhibition of growth and decrease in the liver weight ratio of zebrafish.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 77,
      "context" : "[80] observed that the long-term exposure to TiO2 nanoparticles may cause atherosclerosis and pulmonary inflammation.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 6,
      "context" : "The available data suggest the low rate of migration of nanoparticles to the circulatory system [8].",
      "startOffset" : 96,
      "endOffset" : 99
    }, {
      "referenceID" : 83,
      "context" : "The gastrointestinal tract (GIT) may be an important route for the absorption of TiO2 nanoparticles because food products, water and liquid beverages and drug carriers may contain TiO2 nanoparticles [87, 88].",
      "startOffset" : 199,
      "endOffset" : 207
    }, {
      "referenceID" : 84,
      "context" : "The gastrointestinal absorption of nanomaterials has been the subject of the recent efforts in the field of nanomedicine to develop effective carriers which increase the oral uptake of drugs and vaccines [89].",
      "startOffset" : 204,
      "endOffset" : 208
    }, {
      "referenceID" : 86,
      "context" : "Orally administered TiO2 nanoparticles caused high coefficients of the liver in rats [91].",
      "startOffset" : 85,
      "endOffset" : 89
    }, {
      "referenceID" : 86,
      "context" : "spotty necrosis of hepatocytes and the hydropic degeneration around the central vein of the liver [91], and a significant increase in serum nitric oxide, hepatic SOD, glutathione reductase (GR) enzyme activities and MDA concentration [90] were observed, which indicate the hepatic injury by the nanoparticles.",
      "startOffset" : 98,
      "endOffset" : 102
    }, {
      "referenceID" : 85,
      "context" : "spotty necrosis of hepatocytes and the hydropic degeneration around the central vein of the liver [91], and a significant increase in serum nitric oxide, hepatic SOD, glutathione reductase (GR) enzyme activities and MDA concentration [90] were observed, which indicate the hepatic injury by the nanoparticles.",
      "startOffset" : 234,
      "endOffset" : 238
    }, {
      "referenceID" : 85,
      "context" : "The liver showed vacuolar and hydropic degeneration and cell death of some hepatic cells [90].",
      "startOffset" : 89,
      "endOffset" : 93
    }, {
      "referenceID" : 88,
      "context" : "[94] observed the level of lipid peroxidation enhanced in rat liver and a dramatic increase in serum glucose level (marker of metabolic disorder) and the pro-inflammatory biomarkers including tumour necrosis factor-α, interleukin-6, C-reactive protein and immunoglobin G as well as the vascular endothelial growth factor (VEGF) (angiogenic factor) and NO, oxidative (DNA) damage, the alteration in the apoptosis marker, caspase-3, and the drug metabolizing enzymes, cytochrome P450 (CYP450), in rat livers.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 89,
      "context" : "[95] orally administered a dose of 50 and 100 mg/kg body weight TiO2 nanoparticles to adult male Wistar rats.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 87,
      "context" : "[92] observed disturbances in energy and amino acid metabolism and the gut microbes in Wistar rats orally administered with different doses of TiO2 nanoparticles that may be attributable to some injury to the liver and heart due to TiO2 nanoparticles.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 86,
      "context" : "This indicates the transportation of TiO2 particles to other tissues and organs after absorption by the gastrointestinal tract [91].",
      "startOffset" : 127,
      "endOffset" : 131
    }, {
      "referenceID" : 85,
      "context" : "The testes showed mild spermatogenesis besides congested testicular blood vessels [90].",
      "startOffset" : 82,
      "endOffset" : 86
    }, {
      "referenceID" : 90,
      "context" : "The oligodendroglial cell showed small shrunken nucleus with peripherally clumping chromatin and dilated rough endoplasmic reticulum [96].",
      "startOffset" : 133,
      "endOffset" : 137
    }, {
      "referenceID" : 91,
      "context" : "TiO2 nanoparticles caused an increase in all serum and tissue parameters in a dose-dependent manner [97].",
      "startOffset" : 100,
      "endOffset" : 104
    }, {
      "referenceID" : 92,
      "context" : "The Morris water maze and the passive avoidance tests on lactating Wistar rats showed that exposure to TiO2 nanoparticles by gavage can significantly harm the memory and learning in the offspring [98].",
      "startOffset" : 196,
      "endOffset" : 200
    }, {
      "referenceID" : 94,
      "context" : "[100] observed that titanium content levels in the liver and spleen above the detection limit were found only in some rats.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 18,
      "context" : "[20] conducted acute oral toxicity studies in rabbits.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 86,
      "context" : "Another study investigated the acute toxicity in mice after a single oral administration of 25, 80 and 155 nm TiO2 particles at the dose of 5 g/kg body weight [91].",
      "startOffset" : 159,
      "endOffset" : 163
    }, {
      "referenceID" : 87,
      "context" : "[92] treated Wistar rats with TiO2 nanoparticles at the dose of 0.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 6,
      "context" : "The use of engineered nanoparticles in consumer products results in the presence of nanoparticles in drinking water sources, although the concentration of Ti compounds in drinking water is mostly low [8].",
      "startOffset" : 200,
      "endOffset" : 203
    }, {
      "referenceID" : 95,
      "context" : "So the consequent nanoparticle increase into treated drinking water is a potential route for the exposure and threat for human health [101].",
      "startOffset" : 134,
      "endOffset" : 139
    }, {
      "referenceID" : 96,
      "context" : "[102] demonstrated in vivo in mice the genotoxicity, oxidative DNA damage and inflammation by TiO2 nanoparticles in drinking water.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 97,
      "context" : "Although this method is controversial, but still this particular use has been recommended as a standard of care [103].",
      "startOffset" : 112,
      "endOffset" : 117
    }, {
      "referenceID" : 6,
      "context" : "Intraperitoneal studies may be done to address the effects of possible TiO2 nanoparticles use in nanomedicine [8].",
      "startOffset" : 110,
      "endOffset" : 113
    }, {
      "referenceID" : 98,
      "context" : "The nanoparticles did not activate platelets in vitro but caused prothrombotic effects in the microcirculation in vivo [104], while Younes et al.",
      "startOffset" : 119,
      "endOffset" : 124
    }, {
      "referenceID" : 99,
      "context" : "[105] reported that blood cell count remained unchanged with the exception of the platelet count that increases after the intraperitoneal injection of 20 mg/kg body weight TiO2 nanoparticles every 2 days for 20 days into rats.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 100,
      "context" : "Intraperitoneal injection affects the spleen [106–109], lung [106, 110], serum, heart, kidney, liver [106, 107], brain [111], inflammatory response [110, 111] and reproductive system [107].",
      "startOffset" : 61,
      "endOffset" : 71
    }, {
      "referenceID" : 104,
      "context" : "Intraperitoneal injection affects the spleen [106–109], lung [106, 110], serum, heart, kidney, liver [106, 107], brain [111], inflammatory response [110, 111] and reproductive system [107].",
      "startOffset" : 61,
      "endOffset" : 71
    }, {
      "referenceID" : 100,
      "context" : "Intraperitoneal injection affects the spleen [106–109], lung [106, 110], serum, heart, kidney, liver [106, 107], brain [111], inflammatory response [110, 111] and reproductive system [107].",
      "startOffset" : 101,
      "endOffset" : 111
    }, {
      "referenceID" : 101,
      "context" : "Intraperitoneal injection affects the spleen [106–109], lung [106, 110], serum, heart, kidney, liver [106, 107], brain [111], inflammatory response [110, 111] and reproductive system [107].",
      "startOffset" : 101,
      "endOffset" : 111
    }, {
      "referenceID" : 105,
      "context" : "Intraperitoneal injection affects the spleen [106–109], lung [106, 110], serum, heart, kidney, liver [106, 107], brain [111], inflammatory response [110, 111] and reproductive system [107].",
      "startOffset" : 119,
      "endOffset" : 124
    }, {
      "referenceID" : 104,
      "context" : "Intraperitoneal injection affects the spleen [106–109], lung [106, 110], serum, heart, kidney, liver [106, 107], brain [111], inflammatory response [110, 111] and reproductive system [107].",
      "startOffset" : 148,
      "endOffset" : 158
    }, {
      "referenceID" : 105,
      "context" : "Intraperitoneal injection affects the spleen [106–109], lung [106, 110], serum, heart, kidney, liver [106, 107], brain [111], inflammatory response [110, 111] and reproductive system [107].",
      "startOffset" : 148,
      "endOffset" : 158
    }, {
      "referenceID" : 101,
      "context" : "Intraperitoneal injection affects the spleen [106–109], lung [106, 110], serum, heart, kidney, liver [106, 107], brain [111], inflammatory response [110, 111] and reproductive system [107].",
      "startOffset" : 183,
      "endOffset" : 188
    }, {
      "referenceID" : 101,
      "context" : "[107] treated male ICR mice with 200 and 500 mg/kg body weight TiO2 nanoparticles every other day for 5 times by intraperitoneal injections as a result of which ALT and AST/ALT as well as blood urea nitrogen were increased showing the effect on the liver and renal system.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 106,
      "context" : "Intraperitoneally injected anatase TiO2 nanoparticles interfere with antioxidant defence mechanisms that results in oxidative stress in hepatocytes due to production of reactive oxygen species promoting apoptosis and necrosis [112].",
      "startOffset" : 226,
      "endOffset" : 231
    }, {
      "referenceID" : 100,
      "context" : "Slightly elevated levels of the serum enzymes ALP and AST were found from the biochemical tests, whereas blood urea nitrogen was not significantly changed [106].",
      "startOffset" : 155,
      "endOffset" : 160
    }, {
      "referenceID" : 100,
      "context" : "The highest accumulation of TiO2 was in the spleen and resulted in the lesion and congestion and proliferation of lymph nodule of spleen tissue and caused apoptosis of the splenocyte [106, 108].",
      "startOffset" : 183,
      "endOffset" : 193
    }, {
      "referenceID" : 102,
      "context" : "The highest accumulation of TiO2 was in the spleen and resulted in the lesion and congestion and proliferation of lymph nodule of spleen tissue and caused apoptosis of the splenocyte [106, 108].",
      "startOffset" : 183,
      "endOffset" : 193
    }, {
      "referenceID" : 102,
      "context" : "TiO2 nanoparticles can induce the spleen pathological changes, apoptosis, leading to the reduction of immunity of mice [108].",
      "startOffset" : 119,
      "endOffset" : 124
    }, {
      "referenceID" : 100,
      "context" : "Moreover, hepatocellular necrosis and apoptosis, hepatic fibrosis, hydropic degeneration, swelling of renal glomerulus, proteinic liquids in renal tubules and interstitial pneumonia were also observed in the high-dose groups that may be associated with the alveolar septal thickening [106].",
      "startOffset" : 284,
      "endOffset" : 289
    }, {
      "referenceID" : 106,
      "context" : "Intraperitoneally injected anatase TiO2 nanoparticles caused hydropic degeneration and fatty degeneration of hepatocytes, portal and lobular infiltration by inflammatory cells, cloudy swelling and congested dilated central veins, cytoplasmic degeneration and damaged nuclei of hepatocytes [112].",
      "startOffset" : 289,
      "endOffset" : 294
    }, {
      "referenceID" : 101,
      "context" : "But damage on the liver and kidney function is slight in a dosedependent manner [107].",
      "startOffset" : 80,
      "endOffset" : 85
    }, {
      "referenceID" : 106,
      "context" : "Intraperitoneally injected anatase TiO2 nanoparticles changed serum alkaline phosphatase and glutamate oxaloacetate transaminase activity [112].",
      "startOffset" : 138,
      "endOffset" : 143
    }, {
      "referenceID" : 107,
      "context" : "[113] intraperitoneally injected anatase TiO2 nanoparticles with the average diameter <25 nm for 7 days.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 99,
      "context" : "An increase in the AST/ALT enzyme ratio and activity of lactate dehydrogenase was observed after sub-acute exposure to TiO2 nanoparticles as IP injection of 20 mg/kg body weight every 2 days for 20 days [105].",
      "startOffset" : 203,
      "endOffset" : 208
    }, {
      "referenceID" : 104,
      "context" : "[110] found that intraperitoneal administration of TiO2 nanoparticles induces acute lung inflammation and exhibits additive or synergistic effects with lipopolysaccharide, to some extent, at least, through activation of oxidantdependent inflammatory signalling and the nuclear factor NF-κB pathway, that results in the increase of proinflammatory mediators, e.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 102,
      "context" : "Another research shows that intraperitoneal injection of TiO2 nanoparticles in mouse effectively activated caspase-3 and caspase-9, decreased the Bcl-2 levels of gene and protein, increased the levels of Bax, cytochrome c genes and their protein expression and promoted ROS accumulation [108].",
      "startOffset" : 287,
      "endOffset" : 292
    }, {
      "referenceID" : 99,
      "context" : "[105] showed that intraperitoneal injection of 20 mg/kg body weight TiO2 nanoparticles every 2 days for 20 days induced a little inflammation overall.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 105,
      "context" : "30 min after 5 mg/kg lipopolysaccharide through intraperitoneal injections, the inflammatory action was increased by TiO2 nanoparticles as expressed by increased interleukin-1β, tumour necrosis factor-α and inducible nitric oxide synthase and induced microglial activation, as well as they showed enhanced ROS that represent oxidative stress [111].",
      "startOffset" : 342,
      "endOffset" : 347
    }, {
      "referenceID" : 103,
      "context" : "TiO2 nanoparticles (<25 or <100 nm) intraperitoneally injected once a day for 7 days into mice decreased splenocytes, CD4+ and lipopolysaccharidestimulated natural killer cells CD8+, while B-lymphocyte development and lipopolysaccharide-stimulated spleen cell proliferation were retarded [109].",
      "startOffset" : 288,
      "endOffset" : 293
    }, {
      "referenceID" : 99,
      "context" : "[105] reported significantly increased anxious index in rats shown by the elevated plus-maze test after sub-acute treatment of TiO2 nanoparticles at 20 mg/kg body weight every 2 days for 20 days injected intraperitoneally.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 108,
      "context" : "On treating female CD-1 (ICR) mice with anatase TiO2 (5 nm), bulk rutile TiO2 (10–15 μm) at the dose of 5– 150 mg/kg body weight anatase TiO2 nanoparticles and 150 mg/kg bulk TiO2 every day for 14 days by intraabdominal injections, biochemical parameters, such as creatine kinase, lactate dehydrogenase, aspartate aminotransferase and alpha-hydroxybutyrate dehydrogenase, were increased by both TiO2 [114].",
      "startOffset" : 400,
      "endOffset" : 405
    }, {
      "referenceID" : 109,
      "context" : "[115] observed inflammatory responses and liver injury by 5nm-sized TiO2 nanoparticles intraperitoneally injected at the dose of 5, 10, 50, 100 and 150 mg/kg body weight daily for 14 days.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 110,
      "context" : "Neurons turned into filamentous shapes or inflammatory cells after translocation of TiO2 nanoparticles from the abdominal cavity [116].",
      "startOffset" : 129,
      "endOffset" : 134
    }, {
      "referenceID" : 111,
      "context" : "Another study investigated an adjuvant effect of photocatalytic 28-nm-sized rutile TiO2 nanoparticles administered through intraperitoneal injection at the dose of 2, 10, 50 and 250 μg, in combination with ovalbumin (OVA) in mice [117].",
      "startOffset" : 230,
      "endOffset" : 235
    }, {
      "referenceID" : 112,
      "context" : "The reproductive system was also affected by the nanoparticles as expressed by disrupted and disorganised seminiferous tubules, decreased sperm production, few mature sperm, number of Sertoli cells and epidididymal sperm motility [118].",
      "startOffset" : 230,
      "endOffset" : 235
    }, {
      "referenceID" : 113,
      "context" : "[119] demonstrated that prenatal exposure by subcutaneous injections may affect the brain.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 114,
      "context" : "[120] injected TiO2 subcutaneously into pregnant mice on gestational days 6, 9, 12 and 15.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 114,
      "context" : "The expression of genes for neurotransmitters and psychiatric diseases was also changed [120].",
      "startOffset" : 88,
      "endOffset" : 93
    }, {
      "referenceID" : 115,
      "context" : "[121] demonstrated in mice that maternal exposure to TiO2 nanoparticles subcutaneously may affect the development of the central dopaminergic system in the next generation.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 116,
      "context" : "[122] treated male Sprague-Dawley rats with TiO2 (70 nm) and bulk TiO2 (diameter 0.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 117,
      "context" : "[123] who treated male Sprague-Dawley rats with TiO2 (70 nm) and bulk TiO2 (diameter 6–12 mm; height 2 mm) in the back of rats for 6 or 12months by subcutaneous (bulk) and intramuscular (nanoparticles) implantation and observed local reaction in the form of granulomas (nanoparticles) and inflammatory infiltrates (bulk).",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 118,
      "context" : "[124] treated female C57BL/6 mice by subcutaneous injections with hydrophilic rutile TiO2 (minor axis 40–70 nm; major axis 200–300 nm) treated with ZrO2Al(OH)3 and with hydrophobic rutile TiO2 (minor axis 40–70 nm; major axis 200–300 nm) treated with ZrO2Al(OH)3 and steric acid (only QR-32 cells or QR-32 cells mixed with 5 mg/0.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 2,
      "context" : "In recent days, in nanomedicine, TiO2 nanoparticulate carriers are intravenously injected directly into the blood and it has elevated public concerns in regard to their toxicity to humans [4, 125].",
      "startOffset" : 188,
      "endOffset" : 196
    }, {
      "referenceID" : 119,
      "context" : "In recent days, in nanomedicine, TiO2 nanoparticulate carriers are intravenously injected directly into the blood and it has elevated public concerns in regard to their toxicity to humans [4, 125].",
      "startOffset" : 188,
      "endOffset" : 196
    }, {
      "referenceID" : 120,
      "context" : "[126] quantified the content of titanium in the blood, brain, gills, liver and kidney of rainbow trout (Oncorhynchus mykiss) at time points.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 120,
      "context" : "Upon a single high-dose exposure to TiO2 nanoparticles via the bloodstream injected intravenously, TiO2 accumulates in the kidneys but has a minimal effect on kidney function such as urine production or glomerular filtration rate [126].",
      "startOffset" : 230,
      "endOffset" : 235
    }, {
      "referenceID" : 119,
      "context" : "The TiO2 nanoparticle treatment induced damage in the liver, spleen, brain, lung and kidneys; however, the heart showed no pathological effects [125].",
      "startOffset" : 144,
      "endOffset" : 149
    }, {
      "referenceID" : 121,
      "context" : "[127] showed that intravenously injected 0.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 94,
      "context" : "[100] observed the rapid distribution of titanium through the systemic circulation in the liver, spleen, kidney, brain, heart, lung and thymus and reproductive organs after single and repeated intravenous exposure.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 122,
      "context" : "TiO2 nanoparticles caused liver damage and induced significantly the glutathione reductase expression in male Wistar rats intravenously injected with 5 mg/kg for 5 days [128].",
      "startOffset" : 169,
      "endOffset" : 174
    }, {
      "referenceID" : 25,
      "context" : "[27] intravenously injected male Wistar rats with 5 mg/kg body weight of anatase-rutile TiO2 mixture (20–30 nm) and rutile TiO2 (200 nm) and observed TiO2 distribution mostly in the liver and spleen after injection as well as inflammatory action as both TiO2 formulations increased total cell count, polymorphonuclears, total protein content, ALP, lactate dehydrogenase, Γ-glutamyl transpeptidase and N-acetyl-glucosaminidase in bronchoalveolar lavage.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 118,
      "context" : "[124] who treated female C57BL/6 mice by intravenous injections with hydrophilic rutile TiO2 (minor axis 40–70 nm; major axis 200– 300 nm) treated with ZrO2Al(OH)3; hydrophobic rutile TiO2 (minor axis: 40–70 nm; major axis 200–300 nm) treated with ZrO2Al(OH)3 and steric acid (tumour cell lines into mice (5/line)) and observed the carcinogenicity and metastatic ability due to tumour cell lines obtained fromQR-32 cells injected in site pre-implanted with both TiO2.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 123,
      "context" : "Further, lipid peroxidation was detected in the synovium through decreased ALP and increased AST/ALT, lactate dehydrogenase, fatty degeneration, inflammatory cell infiltration, and proteinic liquids in renal tubules and decreased blood urea nitrogen and creatinine, which were the biochemical and histological parameters showing the effect of TiO2 nanoparticles in the liver and renal system [129].",
      "startOffset" : 392,
      "endOffset" : 397
    }, {
      "referenceID" : 124,
      "context" : "These results point out the potential damage of articular cartilage caused by the particles in knee joint and suggested that bio-monitoring should be given importance in patients with prostheses replacement [130].",
      "startOffset" : 207,
      "endOffset" : 212
    }, {
      "referenceID" : 114,
      "context" : "[120] injected TiO2 subcutaneously into pregnant mice on gestational days 6, 9, 12 and 15 with 100 μL at 1 μg/μL of 25–70 nm anatase TiO2 nanoparticles.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 114,
      "context" : "The expression of genes for neurotransmitters and psychiatric diseases also changed [120].",
      "startOffset" : 84,
      "endOffset" : 89
    }, {
      "referenceID" : 113,
      "context" : "Prenatal exposure to TiO2 nanoparticles can result in modifications in the olfactory bulb, cerebral cortex and some regions closely related to dopamine systems of offspring mice [119].",
      "startOffset" : 178,
      "endOffset" : 183
    }, {
      "referenceID" : 115,
      "context" : "[121] demonstrated in mice that maternal exposure to TiO2 nanoparticles might influence the development of the central dopaminergic system in offspring.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 125,
      "context" : "Depressive-like behaviours during adulthood were also observed in the sucrose preference test and the force-swimming test [131].",
      "startOffset" : 122,
      "endOffset" : 127
    }, {
      "referenceID" : 126,
      "context" : "[132] found in their experiments that intragastric administration of anatase (6.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 127,
      "context" : "A significant increase in the mRNA and protein expression of Toll-like receptor-2 and TLR-4 and several inflammatory cytokines and a significant decrease in the mRNA and protein expression of IκB and interleukin-2 were observed [133].",
      "startOffset" : 228,
      "endOffset" : 233
    }, {
      "referenceID" : 86,
      "context" : "[91] treated male and female CD-1 (ICR) mice with 5 g/kg body weight of 25, 80 and 155 nm TiO2 nanoparticles with intragastric administration (oral gavage).",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 87,
      "context" : "[92] treated male and femaleWistar rats with 0.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 128,
      "context" : "Intragastric administration for 60 consecutive days with TiO2 nanoparticles resulted in the accumulation of reactive oxygen species in the hippocampus of mouse [134].",
      "startOffset" : 160,
      "endOffset" : 165
    }, {
      "referenceID" : 129,
      "context" : "Intragastric administration of anatase TiO2 nanoparticles for 30 days resulted in significant increases in the accumulation of reactive oxygen species in the mouse spleen, consequently leading to increased lipid peroxidation and the significant expression of heme oxygenase-1 via the p38-Nrf-2 signalling pathway [135].",
      "startOffset" : 313,
      "endOffset" : 318
    }, {
      "referenceID" : 130,
      "context" : "[136] found that intragastric exposure in mice caused modifications in the expression of genes.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 131,
      "context" : "Histology showed blurred hepatocytes and congested vessels [137].",
      "startOffset" : 59,
      "endOffset" : 64
    }, {
      "referenceID" : 132,
      "context" : "[138] investigated that intragastric exposure to TiO2 nanoparticles (5 nm anatase; 0, 5, 10 and 50 mg/kg BW; every day for 60 days) in ICR mice can potentially impair the spatial recognition memory, which may be due to the disturbance in trace element homeostasis, neurotransmitter and enzymes in the brain.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 128,
      "context" : "Caspase-3 and caspase-9 were activated, Bcl-2 was inhibited and the levels of Bax and cytochrome c were promoted significantly [134].",
      "startOffset" : 127,
      "endOffset" : 132
    }, {
      "referenceID" : 133,
      "context" : "[139] suggest that long-term (90 days) intragastric exposure to low-dose TiO2 nanoparticles may result in spleen injury, significant increase in the spleen indices, histopathological changes, splenocyte apoptosis and reduction of immune capacity, due to alteration of inflammatory and apoptotic cytokine expression and decreased immunoglobulin, blood cells, platelets, haemoglobin and lymphocyte.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 133,
      "context" : "5, 5 and 10 mg/kg every day for 90 days caused chronic spleen injury in ICR mice [139].",
      "startOffset" : 81,
      "endOffset" : 86
    }, {
      "referenceID" : 138,
      "context" : "[144] treated female CD-1 (ICR) mice with anatase TiO2 at the dose of 5, 10, 50, 100 and 150 mg/kg for 14 consecutive days by intra-abdominal injections and observed a dose-dependent increase in Ti liver content and TiO2 bound on DNA, causing changes in DNA conformation and induced DNA cleavage.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 130,
      "context" : "[136] evaluated the nephrotoxicity, distribution, oxidative stress and gene expression profile in kidney using whole-genome microarray analysis technique in mice with intragastric exposure and found a significant decrease in the number of renal glomerulus, infiltration of inflammatory cells, tissue apoptosis and necrosis of renal tubules, reduction in body weight, unbalanced element distribution, increased kidney indices, reactive oxygen species production and lipid peroxidation, and protein and DNA peroxidation in the renal tissue of mouse.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 130,
      "context" : "Most of the genes were related to inflammatory or immune responses, apoptosis, cell structure, biological and metabolic processes, oxidative stress, ion transport, cell cycle, signal transduction, transcription, translation and cell differentiation [136].",
      "startOffset" : 249,
      "endOffset" : 254
    }, {
      "referenceID" : 134,
      "context" : "In addition, exposure to TiO2 nanoparticles resulted in marked alterations in the expressions of proteins and enzymes [140].",
      "startOffset" : 118,
      "endOffset" : 123
    }, {
      "referenceID" : 135,
      "context" : "In addition, the increase of creatinine, calcium and phosphonium and the reduction of uric acid and blood urea nitrogen represented the disrupted kidney functions [141].",
      "startOffset" : 163,
      "endOffset" : 168
    }, {
      "referenceID" : 109,
      "context" : "[115] treated female CD-1 (ICR) mice with anatase TiO2 (5 nm) and bulk rutile TiO2 (10–15 μm) at the dose of 5–150 mg/kg body weight anatase TiO2 nanoparticles and 150 mg/kg bulk TiO2 every day for 14 days by intraabdominal injections.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 108,
      "context" : "[114] treated female CD-1 (ICR) mice with anatase nanoparticles (5 nm) and bulk rutile (10–15 μm) at the dose of 5– 150 mg/kg anatase TiO2 and 150 mg/kg bulk TiO2 every day for 14 days using intra-abdominal injections.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 134,
      "context" : "[140] treated mice with anatase TiO2 nanoparticles by intra-abdominal injections.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 110,
      "context" : "[116] found that 5 nm anatase TiO2 nanoparticles for 14 days injected to the abdominal cavity translocate to and accumulate in the brain and 18 Shakeel et al.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 136,
      "context" : "Mohamed [142] injected 500, 1000 and 2000 mg/kg body weight suspension of nanoparticles for five consecutive days into the abdominal cavity and examined genotoxicity, mutagenicity and apoptosis in p53 exons (5–8) and myocardial cells.",
      "startOffset" : 8,
      "endOffset" : 13
    }, {
      "referenceID" : 137,
      "context" : "[143] demonstrated the protein profile alterations in mouse brain.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 138,
      "context" : "[144] injected 5, 10, 50, 100 and 150 mg/kg body weight anatase TiO2 nanoparticles into the abdominal cavity of mice everyday for 14 days.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 138,
      "context" : "The gel electrophoresis revealed that a higher dose of TiO2 nanoparticles caused liver DNA cleavage [144].",
      "startOffset" : 100,
      "endOffset" : 105
    }, {
      "referenceID" : 140,
      "context" : "Another study onwashed human erythrocytes after 37 °C incubation for 1 h reported haemolysis caused by TiO2 fine particles 73 times greater than nanoparticles [146].",
      "startOffset" : 159,
      "endOffset" : 164
    }, {
      "referenceID" : 141,
      "context" : "In another study on mouse macrophages (Ana-1 and MHS cells) administered with anatase 5-, 10-, 25- and 100-nmsized TiO2 nanoparticles, low toxicity was induced to MH-S cells [147].",
      "startOffset" : 174,
      "endOffset" : 179
    }, {
      "referenceID" : 142,
      "context" : "Another study found that 25- and 80-nm-sized TiO2 nanoparticles at the concentrations of 10, 20, 40 and 80 mg/L for 24-h exposure inhibited intracellular communication via gap junction between lung fibroblasts [148].",
      "startOffset" : 210,
      "endOffset" : 215
    }, {
      "referenceID" : 143,
      "context" : "[149] also found no penetration of TiO2 nanoparticles into viable cell layers or any cellular changes biologically.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 144,
      "context" : "[150] evaluating cutaneous penetration and localization of TiO2 nanoparticles included in a sunscreen containing the nanoparticles with ≥20 nm primary size applied for 24 h.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 145,
      "context" : "[151] using a model of HEL-30 mouse keratinocyte cell line in vitro demonstrated that both crystal structure and size of the TiO2 nanoparticles contributed to cytotoxicity.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 59,
      "context" : "[61] have shown in vitro that intratracheal instillation dose-dependently reduced cellular viability of human lung cancer cells and human hepatoma cells.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 59,
      "context" : "[61] also showed in vitro in Wistar rats that intratracheal instillation significantly and dose-dependently induced platelet aggregation.",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 146,
      "context" : "[152] showed both in vivo and in vitro that acute exposure to TiO2 nanoparticles alters acutely cardiac excitability and increases the chances of arrhythmic events.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 147,
      "context" : "[153], about 30 % of the TiO2 nanoparticles entered into neural stem cells after 48 h of incubation with 50 and 30 nm and nanotubes 100 nm×4–6 nm regardless of the type and dose of the Table 9 TiO2 exposure through the reproductive system",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 112,
      "context" : "[118] Pregnant Slc:ICR mice Anatase TiO2 (25–70) 100 μL of TiO2 at 1 mg/mL at 3, 7, 10 and 14 days post-coitum Subcutaneous injections Reproductive effects: disorganised and disrupted seminiferous tubules, few mature sperm, decreased sperm production, epidididymal sperm motility, number of Sertoli cells",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 101,
      "context" : "[107] Male mice 6 weeks 200 and 500 mg/kg every other day for 5 times for a week Intraperitoneal injections Reproductive effects: reduced sperm density and motility, increased sperm abnormality and germ cell apoptosis 30 Shakeel et al.",
      "startOffset" : 0,
      "endOffset" : 5
    }, {
      "referenceID" : 148,
      "context" : "[154] demonstrated that titania nanotubes (TiO2-NTs) passed through the karyotheca entering the mouse neural stem cell nucleus after coincubation for 48 h.",
      "startOffset" : 0,
      "endOffset" : 5
    } ],
    "year" : 2016,
    "abstractText" : "Nano-titanium dioxide (TiO2) is one of the most commonly used materials being synthesized for use as one of the top five nanoparticles. Due to the extensive application of TiO2 nanoparticles and their inclusion in many commercial products, the increased exposure of human beings to nanoparticles is possible. This exposure could be routed via dermal penetration, inhalation and oral ingestion or intravenous injection. Therefore, regular evaluation of their potential toxicity and distribution in the bodies of exposed individuals is essential. Keeping in view the potential health hazards of TiO2 nanoparticles for humans, we reviewed the research articles about studies performed on rats or other mammals as animal models. Most of these studies utilized the dermal or skin and the pulmonary exposures as the primary routes of toxicity. It was interesting that only very few studies revealed that the TiO2 nanoparticles could penetrate through the skin and translocate to other tissues, while many other studies demonstrated that no penetration or translocation could happen through the skin. Conversely, the TiO2 nanoparticles that entered through the pulmonary route were translocated to the brain or the systemic circulation from where these reached other organs like the kidney, liver, etc. In most studies, TiO2 nanoparticles appeared to have caused oxidative stress, histopathological alterations, carcinogenesis, genotoxicity and immune disruption. Therefore, the use of such materials in humans must be either avoided or strictly managed to minimise risks for human health in various situations.",
    "creator" : "3B2 Total Publishing System 8.07e/W Unicode "
  }
}